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VAbstract
Meningococcal disease (MCD) is the most common infective cause of 
mortality in children in the United Kingdom. It is the most common cause of 
sepsis-induced purpura fulminans in children accounting for 10% of cases.
Between January 2007 and April 2008 45 children with suspected 
meningococcal disease were prospectively recruited to an observational 
study. These children were recruited from two-centres, Alder Hey 
Children's NHS Foundation Trust and the Royal Manchester Children’s 
Hospital NHS Trust. This prospective study aimed to provide further 
understanding into the haemodynamic response in meningococcal disease, 
evaluating abnormalities in the macro- and microcirculation in children 
admitted to intensive care. In addition this study aimed to evaluate the 
performance characteristics of a new method of detecting infection in 
children, the Activated Partial Thromboplastin Time (aPTT) waveform.
During the prospective study 33 children were classed as confirmed 
meningococcal disease, and the other 12 were children with a presumed 
viral illness. There were 17 children (52%) with severe disease as defined 
by a Glasgow Meningococcal Septicaemia Prognostic Score (GMSPS) of
£ 8. 20 children were ventilated and admitted to PICU (60%). There were 
no deaths.
A significant difference in aPTT TL18 between MCD patients and those 
with presumed viral illnesses and controls was found. There was no 
significant difference between children with a presumed viral illness and
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controls. This shows that the lower the admission aPTT TL18 (the more 
severe the BPW) the higher the probability of needing intensive care 
support.
The aPTT waveform analysis as a simple, rapid and robust diagnostic 
marker in the detection of meningococcai sepsis that has translational 
potential in facilitating prompt diagnosis and real-time monitoring of patients 
with critical illnesses.
Side stream dark field imaging can be utilised in healthy awake and 
anaesthetised children to obtain sublingual microcirculatory images and 
establish normal values for disease free children. Images can be evaluated 
manually and it has been shown that good inter- and intraobserver 
agreement is possible.
Side stream dark field imaging can also be utilised in children with MCD to 
evaluate microcirculation dysfunction. A significant reduction in admission 
microcirculatory measurement was found in children with severe MCD 
when compared to both anaesthetised and healthy awake controls. These 
differences were no longer significant pre-extubation showing that 
microcirculatory recovery occurred alongside clinical recovery. The degree 
of microcirculatory dysfunction was found to predict the duration of 
ventilatory requirement, irrespective of the stage of illness at the time of 
admission to PICU is present in children with MCD. Longitudinal data 
analysis demonstrated that as the microcirculation improves over time 
lactate, pC02 and Fi02 all decrease and base excess, pH and urine output
all increase overtime.
VII
A relationship exists between the microcirculation and vasoactive 
mediators. In children with severe MCD requiring mechanical ventilation 
there is release of the ceil adhesion molecules E-selectin, Intercellular 
adhesion molecule-1 (ICAM-1) and vascular adhesion molecule-1 (VCAM- 
1) when compared to. children with MCD who do not require ventilation and 
PICU support. Children with severe MCD requiring mechanical ventilation 
also release more nitric oxide (NO) when compared to children with MCD 
who do not require ventilation and PICU support. A negative correlation 
exists between admission NO levels and the microvascular flow index for 
capillaries (MFIc) and longitudinal analysis showed that as the MFIc 
recovers NO release reduces over time. Longitudinal analysis has shown 
that as MFIc recovers over time the levels of ICAM-1, NO, IL-1 Ra, IL-6 and 
IL-8 all reduce overtime.
Children with severe MCD and septic shock have myocardial cell injury and 
cardiac systolic and diastolic dysfunction. 60% of the 20 children with 
confirmed MCD cases, requiring ventilatory support on PICU had abnormal 
cardiac troponin (cTn) values. None of the children with a presumed viral 
illness or those with a confirmed diagnosis of MCD who did not require 
admission to PICU had an elevated cardiac troponin T (cTnT) or cardiac 
troponin I (cTnl). 50% of children admitted to PICU had systolic 
dysfunction as measured on echocardiography as the fractional shortening 
and a rise in cTn. Two of the ventilated children had raised cTn values but 
normal cardiac systolic function. Positive correlations exist between peak 
cTn levels and indicators of disease severity including severity assessment 
scores, duration of inotropic and ventilatory support and hospital stay. 37% 
of the children receiving mechanical ventilation had abnormal diastolic 
function at admission as assessed by the Ea wave of the tissue doppier
VIII
imaging echocardiography (TDI). Levels of N-Terminal Pro Brain 
Natriuretic Peptide (NT-proBNP) were significantly higher in all children with 
MCD compared to those with a presumed viral illness and controls. NT-Pro 
BNP levels correlate with disease severity and declines as clinical recovery 
occurs in children with severe MCD. Admission NT-Pro BNP levels predict 
left ventricular filling pressure as assessed by the E/Ea ratio of TDI even 
when accounting for children presenting at different times in their illness.
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Chapter 1
Introduction
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1.1 Genera! Background
Meningococcal disease (MCD) is the most common infective cause of 
mortality in children in the United Kingdom (UK) (Heyderman, Ben-Shlomo 
et al. 2004). It is the most common cause of sepsis-induced purpura 
fulminans in children accounting for 10% of the total number of cases of 
purpura fulminans.
MCD has a wide spectrum of clinical presentation with early symptoms in 
children often mimicking those of self limiting viral illnesses. It is a highly 
unpredictable disease. Some children require only minimal supportive 
clinical measures but others develop fulminant sepsis, leading to a rapid 
clinical decline and the need for intensive care support. If not detected and 
treated promptly and appropriately MCD can rapidly lead to death in this 
group of patients.
Severe MCD causes a rapid progression of disease. Successful 
management of the disease is dependent on early identification of 
symptoms by care givers and health care workers and prompt 
resuscitation. In a prospective paediatric intensive care (PICU) based 
study describing management of children with MCD in the Netherlands over 
an 18 year period (Maat, Buysse et al. 2007), survival of children 
presenting to their unit with MCD correlated with year of admission with a 
significant reduction in the case fatality rate during the study period. The 
authors attributed this improvement in outcome to more effective strategies
for resuscitation and intensive care management. These findings are 
consistent with the significant reduction in mortality seen in MCD in the UK. 
The causes of this improvement in outcome are multifactorial (Booy, Habibi 
et al. 2001; Thorburn, Baines et al. 2001; Thorburn and Baines 2002). 
Figure 1.1 displays a graph of the change in mortality rates seen in MCD 
from 1996 to 2004. MCD is an important cause of long term morbidity 
including neurodevelopmental impairment. (Fellick, Sills et al. 2001) 
Survivors of invasive disease may sustain permanent sequelae. This 
includes hearing impairment, seizures, limb or digit amputation, tissue loss, 
chronic renal impairment, developmental delay and psychosocial problems, 
(Fellick, Sills et al. 2001; Belthur, Bradish et al. 2005; Slack, Hawkins et al. 
2005). Bache et al. studied orthopaedic sequelae in 143 children with MCD 
(Bache and Torode 2006). Twenty one children died, and among the 122 
survivors 40 had skeletal, vascular, or cutaneous sequelae. Seventeen 
patients lost tissue secondary to ischemia, 6 patients lost digits from their 
hands or feet and 5 underwent limb amputation. Sixteen children 
developed partial or complete epiphyseal growth arrest leading to angular 
deformities or short limbs. This study highlights some of the devastating 
consequences of MCD.
1.2 Epidemiology
The incidence of MCD can be as high as 500 per 100 000 population a 
year in developing countries during epidemics (Tikhomirov, Santamaria et 
al. 1997). In developed countries including the UK and United States of 
America, the incidence is 1 to 5 per 100 000 population a year with a 
mortality rate ranging from 5% to 25 % (Faust, Levin et al. 2001; Harrison, 
Pass et al. 2001; Heyderman, Ben-Shlomo et al. 2004), In the UK severe 
MCD has a higher incidence in males and a winter peak. Meningococcal
16
infections are however seen throughout the year. MCD has its highest 
incidence in children under the age of 5 years with another peak in 
teenagers and young adults.
Serogroups A, B, C, W135, and Y account for the majority of cases of MCD 
throughout the world (Rosenstein, Perkins et al. 2001). Invasive infection in 
Africa and Asia continue to be attributed to serogroup A infections (Kvalsvig 
and Unsworth 2003). More recently the incidence of serogroup W135 has 
increased, particularly in a region of sub-Saharan Africa called the 
“meningitis belt” which extends from The Gambia to Ethiopia. During 
epidemics, the local incidence of the disease in some sub-Saharan African 
regions may approach 1000 cases per 100,000 population {Molesworth, 
Thomson et al. 2002; Pollard and Maiden 2003). In the UK, serotype 
Group B disease has historically been the most common pathogen to 
cause invasive disease. The incidence of Group C disease increased in 
the late 80’s and early QO’s and caught up with Group B incidence. This 
prompted the development of the Meningococcal C vaccine.
In November 1999, the UK became the first country to incorporate the 
Meningococcal C vaccine into a national immunisation programme. 
Following this introduction, disease attack rates fell in vaccinated children, 
carriage rates decreased and the incidence declined among the 
unvaccinated, suggesting the development of herd immunity (Handford S 
2007). Despite the clear effect of the meningococcal C conjugate vaccine, 
the vast majority of invasive disease remains the group B serotype (Gray, 
Trotter et al. 2006). Unfortunately the widespread use of an effective group 
B vaccine is many years away. Serogroup B polysaccharide is poorly 
immunogenic in humans probably explained by its structural identity to a
17
glycoprotein found on human tissues (Lifely, Roberts et al. 1991). A 
reduction in the incidence of serotype group B disease has been seen in 
the UK (Gray, Trotter et al. 2006) . This may be attributable to a virulence 
shift in the organism causing not only less disease but less severe disease.
in an effort to reduce mortality in the UK policies have been designed to 
raise awareness at every step of the patient journey. Public awareness 
had been increased with the help of charities such as the Meningitis 
Research Foundation. This has involved education encouraging parents to 
seek medical help early for children with a high temperature and a non­
blanching rash (identified using the ‘glass or tumbler test1) and the 
importance of receiving the meningococcal serogroup C conjugate vaccine. 
In primary care, general practitioners (GP) have been made aware of the 
presenting clinical features and the need to administer penicillin to children 
prior to transfer to hospital (Hahne, Charlett et al. 2006).
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1.3 The Meningococcus
Neisseria meningitides (the meningococcus) is an encapsulated, oxidase 
positive, Gram negative dipiococcus. It is a strictly human pathogen and its 
transmission is by contact with respiratory secretions. The ceil wall of the 
meningococcus is organised into layers. The innermost layer is a 
cytoplasmic membrane which is covered by a peptidoglycan cell wall. 
Overlying this is the outer membrane which consists of lipooiigosaccharide 
(LOS) molecules. This LOS has a hydrophilic and a hydrophobic portion. 
The immunotype of the meningococcus is determined by the hydrophilic 
oligosaccharide portion. The active part of endotoxin is determined by the 
hydrophobic portion. Type IV pili are incorporated into the outer 
membrane. This outer membrane is over synthesised compared to the 
other structures during in vivo growth of the meningococcus. This causes 
‘Webbing’ (Figure 1.2) in which structures are released from the organism 
which contain endotoxin, a critical factor in meningococcal virulence (Hart 
and Rogers 1993).
Meningococci are separated into several serogroups (A, B, C, 29-E, H, I, K, 
L, W-135, X, Y, Z) according to their capsular polysaccharide antigens. Only 
A, B, C, W135 and Y are considered clinically important. The bacteria can 
be further serotyped, sero-subtyped, and immunotyped on the basis of 
outer-membrane proteins and lipopolysaccharide expression (Hart and 
Rogers 1993).
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Figure 1.2. Electron micrograph of a meningococcus showing blebbing 
Courtesy of Professor Hart (own image).
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1.4. Pathophysiology
The meningococcus can cause a wide spectrum of disease including 
septicaemia, meningitis or most frequently a combination of these two 
(Riordan, Thomson et al. 1995), conjunctivitis, arthritis, pneumonia and 
pericarditis. The host inflammatory response, consisting of the activation of 
cytokine cascade systems and the release of intercellular pro- and anti­
inflammatory mediators, acts to neutralise the meningococcus and its toxic 
products. However this response can be exaggerated leading to tissue 
damage within the host.
Invasive infection starts initially with nasopharyngeal colonization. 
Colonisation occurs asymptomatically in 10-20% of the population 
(Stephens, Hoffman et al. 1983; Stephens 1999; Glitza, Ehrhard et al. 
2008). The Meningococcus binds to the microvillous surfaces of con­
ciliated columnar mucosal cells of the nasopharynx causing colonisation 
(Stephens, Hoffman et al. 1983). Stephens et al showed that the 
meningococcus became surrounded by elongated microvilli and then was 
observed inside intracellular vacuoles. Subsequent studies demonstrated 
that the bacteria does not open the tight junctions between epithelial cells 
but invades the host ceil by transcytosis. These events are controlled by 
the interactions between virulence factors of the meningococcus, cognate 
host cell receptors and signalling between pathogen and host at numerous 
stages of the adhesion cascade. The outermembrane adhesion proteins 
such as Opa and Opc are also of importance in adherence to epithelial 
surfaces (Merz and So 1997; Merz, Enns et al. 1999; Merz and So 2000). 
Invasive disease results when translocation occurs across the
nasopharyngeal mucosa.
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1,4.1. Endotoxin and cytokines
The clinical features and sequelae observed in patients with severe MCD 
are directly related to endotoxin release and the resulting complex 
interactions between host and bacterial factors. The host response results 
in a cascade of pro and anti-inflammatory cytokine production. The 
concentration of endotoxin has a dose response relationship with disease 
severity and fatality (Brandtzaeg, Mollnes et al. 1989; Waage, Brandtzaeg 
et al. 1989). The levels of pro-inflammatory cytokines are significantly 
increased early in the disease and are also associated with disease 
severity and outcome (Waage, Halstensen et al. 1987; Westendorp, 
Langermans et al. 1995; Zhou, Arthur et al. 2001).
Toll-like receptors (TLR) are pattern recognition receptors that recognise 
pathogen associated molecular patterns produced by pathogens. They are 
part of the innate immune response. TLR4 is the major endotoxin 
signalling receptor and, with its co-factor myeloid differentiation factor 
(MD2), triggers gene transcription and the production of pro inflammatory 
cytokines and chemokines by macrophages, monocytes and endothelial 
cells (Emonts, Hazelzet et ai. 2003).
Experimental and clinical data have shown that the major proinflammatory 
cytokines upregulated in MCD are tumour necrosis factor (TNF), 
lnterleukin-1 beta (IL-1|3), lnterleukin-6 (IL-6) and lnterleukin-8 (IL-8), with 
the predominant anti-inflammatory cytokine being Interleukin-10 (IL-10) 
(Girardin, Roux-Lombard et al. 1992; Hackett, Thomson et al. 2001; 
Emonts, Hazelzet et al. 2003; Bjerre, Brusletto et al. 2004). These 
cytokines are produced by a range of cell types including neutrophils,
23
macrophages, dendritic cells and epithelial cells (Van Amersfoort, Van 
Berkel et al. 2003).
Tumour necrosis factor is released early in MCD followed by IL-6 release 1- 
4 hours later (Waage, Halstensen et al. 1989). TNF enhances antimicrobial 
activity of monocytes, macrophages and neutrophils, downregulates 
thrombomodulin expression on endothelial cells and hence contributes to 
the procoagulant state (Waage, Halstensen et al. 1987; Emonts, Hazelzet 
et al. 2003). TNF binds to cell surface receptors. These can then be 
released forming a pool of free soluble TNF receptors which can either 
inhibit or prolong the actions of TNF (Girardin, Roux-Lombard et al. 1992; 
van Deuren, van der Ven-Jongekrijg et al. 1995). IL-1p acts in a similar 
way to TNF. It has chemotactic activity for neutrophils and concentrations 
are raised in MCD, with higher levels being associated with mortality 
(Girardin, Grau etal. 1988).
IL-6 production results in synthesis of acute-phase proteins (Hazelzet, van 
et al. 1994). It also causes proliferation and antibody production by B-cells 
and has been shown to be a modulator of myocardial dysfunction 
associated with MCD (Pathan, Hemingway et al. 2004). High levels of IL-6 
in the presence of lnterleukin-1 (IL-1) are associated with fatality and levels 
of IL-6 are significantly higher in children with septic shock than in those 
with meningitis alone or meningitis and septicaemia (Girardin, Grau et al. 
1988; Casey, Balk et al. 1993). IL-6 exerts many of its effects via the 
soluble IL-6 receptor. It has recently been shown that severe MCD is 
associated with a reduction in soluble IL-6 receptor levels in relation to 
disease severity. Disease severity is inversely related to IL-6 levels
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(Pathan, Williams et al. 2005) and soluble IL-6 receptor levels return to 
normal with clinical recovery.
IL-8 is a potent chemoattractant. It causes activation of neutrophils and is 
involved in neutrophil-mediated vessel wall injury (Baggiolini, Walz et al. 
1989). Levels have been demonstrated to be elevated in MCD 
(Halstensen, Ceska et al. 1993). Muscle damage is mediated via TNF and 
IL-8 in MCD, as estimated by creatine kinase skeletal muscle isoenzyme 
(CK-MM) and cardiac isoenzyme (CK-MB) concentrations. CK-MM 
correlated significantly with TNF and IL-8 (Carrol, Thomson et al. 2002).
Counter regulatory cytokines release quickly follows the cascade of pro- 
inflammatory cytokines. These anti-inflammatory cytokines include IL-1 
receptor antagonist (IL-1Ra), soluble IL-6 receptors (siL-6R), IL-10 and 
Tumour necrosis factor alpha receptors TNFRs (Van Zee, Kohno et al. 
1992; Gerard, Bruyns et al. 1993). IL-10 levels have been shown to be 
related to outcome (Derkx, Marchant et al. 1995) and correlate with pro- 
inflammatory cytokines (Riordan, Marzouk et al. 1996). IL-10 is a potent 
inhibitor of cytokine production and suppresses the procoagulant activity 
induced by endotoxin at the surface of human monocytes (Gerard, Bruyns 
et al. 1993; Pradier, Gerard et al. 1993). This complex cascade of immune 
modulators is released in order to neutralise micro-organisms and their 
toxic products. However, the process can sometimes be overwhelming 
leading to serious tissue damage.
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1.4.2 Endothelial dysfunction
The endothelium is the cellular interface between circulating blood and 
underlying tissue. A well functioning, healthy endothelium is vital not only 
to the continual adjustments of vascular tone, but for the regulation of white 
cell movement from blood to tissue and maintenance of the equilibrium 
between the anticoagulant and the antithrombotic state in blood flow 
(Pearson 2000). The healthy vascular endothelium is lined by the 
endothelial glycocalyx, a network of membrane-bound proteoglycans and 
glycoproteins.
The release of endotoxin and cytokines such as TNF and IL-1 in sepsis 
activates vascular endothelial ceils. This leads to alterations in the 
structure and function of endothelial cells and separation of the tight 
junctions between endothelial ceils leading to capillary leakage, 
intravascular fluid and high molecular protein loss. (Klein, Shennan et al. 
1992; Lampugnani, Caveda et al. 1993) If not corrected by therapeutic 
intervention circulatory collapse will occur, leading to septic shock due to a 
low systemic vascular resistance.
Nitric oxide (NO) is produced as a result of cytokine stimulation of 
endothelial cells in sepsis. NO is a potent vasodilator and has also been 
found to impair cardiac function further exacerbating the adverse circulatory 
response (Balligand, Kelly et al. 1993; Balligand, Ungureanu et al. 1993). 
Endothelial damage can also be caused by other factors. The adherence 
of activated neutrophils and platelets to endothelial cells can cause 
dysfunction of the cells directly. (Bone 1991; Finn, Naik et al. 1993; Varani 
and Ward 1994) Additionally, the endothelial glycocalyx itself has been
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shown to become dysfunctional following exposure to TNF and endotoxin in 
animal models. (Chappell, Hofmann-Kiefer et al. 2008; Marechal, Favory et 
al. 2008)
Endothelial activation by circulating pro-inflammatory cytokines leads to the 
release of a number of mediators which can be measured in the central 
circulation. There is increased expression of endothelial adhesion 
molecules, including P-selectin, intercellular adhesion molecule-1 (ICAM-1), 
vascular cell adhesion molecuie-1 (VCAM-1) and E-selectin (Carlos and 
Harlan 1994; Jakobsen, Morris-Jones et al. 1994; Bruserud, Akselen et al. 
1995). Levels of E-selectin and ICAM-1 have been shown to be elevated in 
children with MCD (Baines, Marzouk et al. 1999). In small vessels, 
leukocyte adhesion may contribute to disordered microvascular flow and 
potentially increase the inflammatory response within these local capillary 
beds by mediating the release of pro-inflammatory cytokines, reactive 
oxygen species, proteases and other inflammatory mediators. Ultimately 
endothelial dysfunction leads to increased vascular permeability and 
profound interstitial oedema. Without supportive management to 
counteract the pathophysiological processes there will be persistent 
hypovolaemia followed by impaired microvascular blood flow, organ 
dysfunction and death.
1.4.3 Cardiac dysfunction
The primary cause of circulatory collapse in MCD is thought to be 
peripheral circulatory impairment, myocardial involvement, however, is also 
crucial in determining the patient’s outcome (Hardman and Earle 1969; 
Monsaive, Rucabado et al. 1984; Mercier, Beaufils et al. 1988; Thiru, 
Pathan et al. 2000; Briassoulis, Narlioglou et al. 2001; Pathan, Sandiford et
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al. 2002). When myocardial dysfunction is severe it will lead to vascular 
collapse and impaired tissue perfusion culminating in multiple organ failure. 
Boucek et al performed echocardiography in 12 children with MCD, finding 
impairment of the left ventricular function in seven (Boucek, Boerth et al. 
1984). Three of these children died. Children with normal cardiac function 
survived. Cardiac dysfunction preceded clinical collapse in several of the 
children.
The cause of this dysfunction is not fully elucidated. Acidosis, hypoxia, 
electrolyte imbalances are likely to contribute and are known to be 
associated with severe MCD. A myocardial depressant factor may also be 
present (Pathan, Sandiford et al. 2002). Pathan et al found that exposing 
rat myocytes to serum from a child with MCD impaired contraction. 
Recombinant IL-6 induced dose-dependent myocardial depression on the 
rat myocyte. They also found that TNF had little effect on myocyte 
contractility and that adding TNF to the IL-6 did not increase the myocardial 
depressant effect. They concluded that IL-6 is a mediator of myocardial 
depression in meningococcal disease, and concentrations of serum IL-6 
strongly predicted the degree of myocardial dysfunction and severity of 
disease in children with meningococcal septic shock (Pathan, Hemingway 
et al. 2004).
1,4,4 Coagulopathy
The most severe manifestation of coagulopathy is disseminated 
intravascular coagulation (DIG), a pathological activation of coagulation. It 
is a complex and frequently fatal condition associated with gross 
abnormalities of thrombosis, haemostasis, vascular function and 
inflammation. Multiple microvascular thrombi form leading to the
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consumption of all available coagulation proteins and platelets resulting in 
abnormal bleeding.
Tissue plasminogen activator (tPA) catalyzes the conversion of 
plasminogen to plasmin and is the major enzyme responsible for 
fibrinolysis. Levels of tPA have been shown to be related to outcome and 
disease severity. Voss et al. showed that activation of coagulation is 
accompanied by an activation of fibrinolysis in the microcirculation. They 
also demonstrated that increased levels of inhibitors of fibrinolysis (tPA and 
plasminogen activator inhibitor (PAI)) induce a decrease of the fibrinolytic 
capacity of the blood (Voss, Matthias et al. 1990). Significant differences in 
the initial levels of tPA in survivors and non-survivors with meningococcal 
septic shock have not been demonstrated (Hazelzet, Risseeuw-Appel et al. 
1996; Kornelisse, Hazelzet et al. 1996).
Tissue factor (TF) is a protein present in subendothelial tissue, platelets 
and leukocytes. It is needed for the initiation of thrombin formation from 
prothrombin. Endotoxin and TNF release lead to production of tissue factor. 
Increased levels of tissue factor have been demonstrated in circulating 
monocytes isolated from blood of patients with MCD. The highest values 
were found in non-survivors (Osterud and Flaegstad 1983). There is also a 
reduction of plasma tissue factor pathway inhibitor (TFPI), which is a potent 
inhibitor of the TF-dependent coagulation system. (Eling, Stephens et al. 
2001)
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Levels of natural antithrombotics including Protein C (PC), antithrombin III 
(AT HI) levels and protein S are markedly decreased in severe MCD. The 
decrease in AT III, protein C and protein S levels is associated with the 
presence of DIG and poor outcome. Thrombin normally binds to 
thrombomodulin on the endothelial surface. This leads to protein C 
activation which acts with protein S to inactivate coagulation factors, as well 
as downregulating PAL Severe MCD impairs these processes (Powars, 
Rogers et al. 1987; Brandtzaeg, Sandset et al. 1989; Fourrier, Lestavel et 
al. 1990; Faust, Levin et al. 2001). Recombinant activated Protein C 
inhibits activated coagulation factors and could be beneficial in the 
management of severe MCD. This was demonstrated in a study of adults 
with severe sepsis (Bernard, Vincent et al. 2001). A randomised controlled 
trial of the administration of a recombinant form of human activated protein 
C recruited 477 children with sepsis, including 237 receiving placebo and 
240 in the treatment arm. The use of recombinant activated protein C 
failed to reduce morbidity or mortality significantly and there were 
numerically more intracranial bleeding events in the group receiving 
recombinant activated protein C (Nadel, Goldstein et al. 2007).
1.5. Diagnosis
The clinical diagnosis of children with severe MCD is usually clear to the 
health care professional due to the fast evolution of clinical signs such as a 
spreading purpuric rash and shock requiring intensive volume resuscitation. 
In some cases of severe disease and in less severe manifestations the 
diagnosis may be less clear. The gold standard for confirmation of the 
presence of the meningococcal bacteria is the polymerase chain reaction 
test (PCR) (Carrol, Thomson et al. 2000; Hackett, Carrol et al. 2002). This 
is more sensitive than blood cultures, which require viable bacteria to give a
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positive result. Blood cultures may give a false negative result if the child 
has been receiving antibiotics prior to hospital arrival. PCR will detect both 
viable and non-viable organisms. The drawback of PCR is that most 
hospitals do not have the capacity to perform this investigation. Samples 
must be transported to the Meningococcal Reference Unit laboratory for 
analysis. The PCR analysis is not time consuming, but a result can take 
several days to be relayed back to the referring hospital because of delays 
in transporting the sample.
A rapid, easily accessible investigation for the detection of early sepsis in 
children would be of great benefit in paediatric clinical practice particularly 
in the Accident and Emergency department. Children frequently attend 
hospital with a non-blanching rash and a fever. Although some of these 
children will have meningococcal sepsis some will have a viral infection 
(e.g. Human Herpes Viruses 6 (HHV6) or 7 (HHV7), or the Enteroviruses) 
which may also cause a non-blanching rash and a fever leading to 48 hours 
of unnecessary intravenous antibiotics. As many of the clinical symptoms 
of early bacterial illnesses mimic those of a non-specific viral infection, a 
test that could aid doctors in deciding whether a child has a significant 
bacterial infection would be of value.
C-reactive protein (CRP) is the main biochemical indicator used currently 
for the detection of sepsis in children but has limitations. A lack of 
sensitivity means that a CRP cannot be used to exclude all bacterial 
infection (Marzouk, Bestwick et al. 1993; Sanders, Barnett et al. 2008). The 
role of procalcitonin (PCT) in the identification of sepsis in both adults and 
children has been extensively studied. It has been shown to be a better 
diagnostic marker of early sepsis with a higher specificity that CRP in
31
critically ill children. CRP as well as PCI could be used to identify early 
sepsis (Simon, Gauvin et al. 2004; Arkader, Troster et al. 2006; Rey, Los et 
al. 2007). PCT has been shown to be a better diagnostic and prognostic 
marker in MCD when compared to CRP (Bohuon, Assicot et al. 1998; 
Bohuon and Gendrel 1999; Carrol, Newiand etal. 2002; Carrol, Newland et 
al. 2005; Chalumeau, Leroy et al. 2007).
Adult studies have shown the presence of a biphasic wave form in the 
aPTT test in severe infection and this has been suggested as a marker for 
the early detection of infection (Downey, Kazmi et al. 1997; Toh, Ticknor et 
al. 2003; Dempfle, Lorenz et al. 2004). Chopin et al (Chopin, Floccard et 
ai. 2006) found that the biphasic waveform was more accurate than PCT 
and CRP for differentiating patients with severe sepsis and septic shock, 
with 90% sensitivity and 92% negative predictive value. The result on day 3 
of intensive care admission had a specificity of 91% and negative predictive 
value of 98% for predicting sepsis-related mortality. There have been no 
paediatric studies of the biphasic waveform in sepsis and an aPTT test is 
not a routine investigation in children with suspected infection. The aPTT 
waveform could potentially be used as a prognostic and diagnostic marker 
in paediatric patients on intensive care units.
1.6 Clinical manifestations and management
1.6.1 Signs and symptoms
The commonest presentations of MCD are meningitis alone (15-50% of 
cases), meningitis and septicaemia (40-50%) or septicaemia alone (10- 
36%) (Riordan, Marzouk et ai. 1995; Kirsch, Barton et al. 1996). The 
classic features of meningococcal septicaemia are fever and a spreading
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non-blanching rash in an ill child (Thomson APJ 2000). If purpura is 
present in a child who is clearly unwell and has a fever then meningococcal 
disease is very likely. The classic features may be preceded by a few days 
of a non-specific viral illness. Up to 30% of children with meningococcal 
disease present with a non-specific maculopapular rash. This type of rash 
will blanch. However the majority will have a non-blanching rash present 
as well (Marzouk, Thomson et al. 1991). Features of meningitis include 
fever, headache, loss of appetite, vomiting, drowsiness, photophobia and 
neck stiffness but these be absent in infants and small children. A non­
blanching rash can also be present but a small group present with classic 
features of meningitis and no rash. In this clinical situation the diagnosis is 
confirmed at lumbar puncture. The diagnosis is relatively straightforward 
when the older patient presents in this manner. A younger child however 
may display more insidious signs such as poor feeding, irritability and 
maybe a bulging fontanelle. The clinical presentation of children with a 
rapidly progressing septicaemia is shock, tachycardia, poor peripheral 
perfusion, tachypnoea, oliguria and hypotension. Patients with pure 
septicaemia generally have a more severe and rapid progression.
1.6.2. Management
A study by Minis et al determined three factors that were independently 
associated with an increased risk of death in children with MCD (Minis, 
Phillips et al. 2005). These were failure to be looked after by a 
paediatrician, failure of sufficient supervision of junior staff, and failure of 
staff to administer adequate inotropes. When complications were not 
recognised this was also a significant risk factor for death, although this 
was not independent of the absence of paediatric care (Minis, Phillips et al.
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2005). A skilled multidisciplinary paediatric team in the resuscitation, 
stabilisation and transfer of any child requiring intensive care support is 
clearly paramount and if performed poorly will lead to worse outcomes 
(Peters, Petros et al. 2002).
1.6.2.1 Emergency Department management
All critically ill .children should follow a structured algorithm of care as taught 
in Acute Paediatric Life Support training commencing with assessment of 
airway, breathing, circulation, and disability (Theilen, Wilson et al. 2008). 
Effective management relies on the early recognition of the illness in a 
shocked child followed by swift, aggressive fluid resuscitation and antibiotic 
administration. A third generation cephalosporin such as cefotaxime or 
ceftriaxone is the preferred initial therapy. Ceftriaxone monotherapy once 
daily may be used if parenteral agents containing calcium (such as 
intravenous calcium, parenteral nutrition, or Hartmann’s solution), have not 
been used in the preceding 48 hours (Callaghan, Buckee et al. 2008; 
Theilen, Wilson et al. 2008). Early, aggressive fluid resuscitation is 
associated with improved survival in paediatric septic shock (Carcillo, Davis 
et al. 1991). Initial therapy with 20ml/kg of colloid as a bolus is required 
and repeated as necessary. Fluid administration should be titrated to 
clinical markers of cardiac output including heart rate, capillary refill and 
level of consciousness (Carcillo, Davis et al. 1991). If signs of shock 
persist after 40-60 ml/kg of fluid resuscitation, there is a significant risk of 
pulmonary oedema and elective intubation and ventilation is recommended, 
even in the absence of signs of respiratory failure (Carcillo and Fields 2002; 
Theilen, Wilson et al. 2008). Children not responding to 60 ml/kg of initial 
fluid resuscitation have ‘fluid refractory shock* and require intubation, 
mechanical ventilation and the administration of inotropic agents.
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Intubation and ventilation protects the airway, reduces the risk of pulmonary 
oedema, facilitates adequate oxygenation and ventilation, and reduces the 
work of breathing and oxygen consumption (Ledingham and McArdle 1978; 
Theilen, Wilson et al. 2008).
1.6.2.2. Inotropes
Inotropic support is frequently necessary in order to maintain end-organ 
tissue perfusion. Appropriate inotrope selection is only one facet of the 
effective management of the critically ill child with shock. The Surviving 
Sepsis Campaign international guidelines for the management of severe 
sepsis and septic shock recommend dopamine as the first choice of 
inotrope to support the paediatric patient with hypotension refractory to fluid 
resuscitation in an emergency department setting (Dellinger, Levy et al. 
2008). The administration of dobutamine as an initial inotrope should be 
reserved for patients who still have features of low cardiac output following 
fluid resuscitation, but who have a normal blood pressure and clinical 
evidence of elevated systemic vascular resistance (SVR). These features 
are a prolonged capillary refill, cool extremities and a widened core­
peripheral temperature gap.
The inotropes should ideally be administered through a central venous 
catheter, but may also be infused through an intraosseous line. Powered 
intraosseous access devices such as the EZ-IO® device allow secure 
vascular access to be obtained within 60 seconds and facilitate the 
administration of inotropes in the Emergency Department (ED) or General 
Paediatric areas. Patients requiring inotropic support should have an in­
dwelling arterial, and urinary catheter sited and should be referred to a 
PICU. Children not responding to this level of therapy have ‘fluid refractory-
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dopamine resistant shock’ and require the administration of additional 
inotropic agents.
1.6.2.3 Management on PICU
The choice of inotropic and vasoactive agents, such as whether to 
commence dopamine or dobutamine first and the decision to commence 
adrenaline or noradrenaline, is determined by clinical examination and an 
estimation of the cardiac output (CO). In most cases physical examination 
and therapeutic end points, which can be applied in any clinical setting, are 
adequate to guide management although cardiac output monitors may also 
be employed in PICU.
Therapeutic end points in the management of shock should include 
normalisation of the heart rate, a capillary refill time of less than 2 seconds, 
normal volume pulses with no differential between peripheral and central 
pulses, warm extremities with a modest core-peripheral temperature gap, 
urine output >1 ml/kg/hr and normal mental status. Blood gas measurement 
should show a decreasing lactate and an improving base deficit. Central 
venous pressure should be maintained at 8-12 mmHg. Central venous 
(Scv02) and mixed venous (SvOa) oxygen saturations are measurements of 
the relationship between oxygen consumption and oxygen delivery in the 
body and are easily measured therapeutic end points in the management of 
shock. Normal values for Scv02 will be slightly higher than the Sv02 as 
blood has not mixed with the venous blood from the coronary sinus. In 
shock the therapeutic end point for Scv02 should be > 70% and £ 65% for 
the Sv02 (Arkader, Troster et al. 2006). Oliveria et al. showed that utilising 
a goal-directed therapy strategy in children and adolescents with septic 
shock using the endpoint of a Scv02 £ 70% had a significant and additive
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impact on the outcome of these children in terms of fewer new organ 
dysfunctions and less mortality (de Oliveira, de Oliveira et ai. 2008)
in the child with ‘fluid refractory-dopamine resistant shock’ typical choices 
for a ‘second-line’ inotrope would be adrenaline for the child with low blood 
pressure and high SVR (so-called ‘cold shock’) or noradrenaline for the 
child with low blood pressure and low SVR (so-called ‘warm shock’). 
Children with a persistent low cardiac output state with high SVR despite 
fluid resuscitation and inotropic support may benefit from vasodilator or 
inodilator therapy, particularly if the arterial blood pressure is relatively well 
maintained. A typical choice in this circumstance would be a type III 
phosphodiesterase inhibitor such as milrinone (Lindsay CA 1998).
When cardiac output monitoring is available the cardiac index can be 
measured and other parameters such as the systemic vascular resistance 
calculated. These devices have become more reliable and less invasive 
over time; pulmonary artery catheters are now rarely used in PICU, and 
have largely been superseded by less invasive thermodilution systems 
such as Pulse Contour Cardiac Output Monitoring (PiCCO), Lithium dilution 
cardiac output (LiDCO) and the more recently developed pressure 
recording analytical method (PRAM) devices. The Ultrasound Cardiac 
Output Monitor (USCOM) is a non-invasive transcutaneous continuous 
wave Doppler ultrasound with software that calculates cardiac output, 
stroke volume and systemic vascular resistance and additional parameters 
such as cardiac power, stroke work and oxygen delivery. It is non-invasive 
and so ideal for use in children and has been used in paediatric critical care 
studies (Brierley and Peters 2008). As this is not an automated method of 
measuring haemodynamics a level of operator error is inevitable.
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Therapeutic end points include the cardiac index (Cl - CO corrected for 
body surface area) >3.3 and <6.0 l/min/m2 with normal coronary perfusion 
pressure (mean arterial pressure minus central venous pressure) for age. 
Frequent re-assessment of children with shock is necessary as the 
haemodynamic profile of critically ill children rapidly changes, particularly 
during the early phase of their illness.
1.6.2.4 Adjunctive therapy
Profound derangements in metabolism associated with MCD may 
contribute to a worsening of clinical condition, including myocardial 
depression (Nadel, Levin et al. 1995). Anaemia and deranged glucose and 
electrolyte regulation are common and need active correction (Britto, Nadel 
et al. 1996; Goldhill 1997; Weisinger and Bellorin-Font 1998; Baines, 
Thomson et al. 2000). Adult data suggested that strict blood glucose 
control has a favourable effect on mortality (van den, Wouters et al. 2001). 
Day et al. showed a significant associated between outcome and peak 
glucose level in children with MCD (Day, Haub et al. 2008). Correction of 
DIC with fresh frozen plasma, platelets and cryoprecipitate may be 
required. Recombinant activated protein C administration in paediatric 
sepsis has not been shown to be of benefit by the RESOLVE study. This 
may have been due to the heterogeneous population that was recruited 
and the outcome measures used (Nadel, Goldstein et al. 2007). Further 
studies using activated protein C in paediatric sepsis would be welcomed.
1.6.2.5 Novel therapies
A double-blind, randomized, placebo-controlled trial of a human monoclonal 
antibody to endotoxin (HA1A) in the treatment of children with MCD
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demonstrated no significant reduction in the 28-day all-cause mortality rate 
when compared to placebo (Derkx, Wittes et al. 1999).
Bactericidal permeability-increasing protein (BPI) is a potent bactericidal 
protein produced by neutrophils. It is stored in the azurophilic granules and 
is also expressed on the cell surface. The bactericidal activity of BPI is 
caused by the strong affinity of BPI for LOS (Weiss, Elsbach et al. 1978). In 
addition to bactericidal capacity, BPI also neutralizes LOS activity in vitro 
and in vivo (Marra, Wilde et al. 1992). A double-blind, randomized, 
placebo-controlled trial of recombinant bactericidal permeability-increasing 
protein (rBPI) showed an improved outcome with fewer amputations, 
decreased blood product transfusions and improved functional outcome but 
was not sufficiently powered to detect a reduction in mortality (Giroir, 
Scannon et al. 2001). Recombinant tissue plasminogen activator may 
reduce peripheral necrosis and minimise the risk of amputation in children 
with MCD, but its use in patients with severe MCD and purpura fulminans 
was associated with a high risk of intracranial haemorrhage and therefore 
its use is not routinely recommended (Zenz, Zoehrer et al. 2004).
The CORTICUS trial is the largest prospective randomised controlled trial 
to date to study the effects of low dose replacement steroids in adults with 
sepsis (Sprung, Annane et al. 2008). There was no improvement in survival 
or reversal of shock in patients given hydrocortisone in the presence or 
absence of adrenal insufficiency. However when shock was reversed, the 
time to shock reversal was quicker in those patients treated with 
hydrocortisone. Replacement steroids are being increasingly used in 
children with refractory septic shock. There is however no clear evidence
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supporting their use. As a small proportion of children with MCD have 
adrenal insufficiency (Bone, Diver et al. 2002) administration of low dose 
maintenance steroids in patients with unresponsive shock is logical 
(Riordan, Thomson et al. 1999).
1.7 The Microcirculation and Tissue Perfusion
The microcirculation is the interface between blood and tissue and is vital to 
maintain cell function and survival. Under diseased conditions when the 
circulation becomes compromised, cells will receive insufficient quantities 
of vital substances and the build up of waste products will cause toxic 
effects. Cell activity within a tissue bed determines the demand for 
substances and waste removal. Increased demand must be met by 
increased exchange of substances between the capillary blood supply and 
the tissue bed. This exchange can be limited either by the rate of transport 
across the capillary walls or by the quantity of a substance available in the 
capillary blood supply.
The maintenance of an adequate supply of oxygen to all tissues is vital to 
ensure tissue viability. Human tissues have a limited capacity for anaerobic 
metabolism and although some cells can produce energy anaerobically for 
a short time, it is inefficient. Maintaining adequate tissue perfusion and 
tissue oxygenation is, therefore, an important goal in the clinical 
management of any critical illness. When the demand for oxygen by the 
tissues is met by the supply of oxygen to tissue adequate tissue 
oxygenation can occur. The relationship between oxygen delivery and 
oxygen consumption in a tissue can be represented by Figure 1.3.
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Figure 1.3. Schematic representation of the relationship between oxygen 
delivery and oxygen consumption in tissue.
41
At high levels of oxygen delivery tissue oxygen requirements are met and 
changes in the rate of delivery have no effect on the rate of consumption. 
(Leach and Treacher 1992; Treacher 1998) Oxygen consumption is 
assumed to be supply independent. At low levels of oxygen delivery, tissue 
oxygen requirements are not met. This leads to changes in oxygen 
delivery which are matched by changes in oxygen consumption, oxygen 
consumption is said to be supply dependant and tissue hypoxia occurs. 
This biphasic model of the relationship between oxygen delivery and 
oxygen consumption has been demonstrated in animals and in humans 
(Kolar and Jansky 1984). The rate of oxygen delivery at which oxygen 
consumption changes from being supply dependant to being supply 
independent is known as the critical oxygen delivery. The aim of intensive 
care is to maintain oxygen delivery at or above the critical oxygen delivery 
to ensure adequate tissue oxygenation (Leach and Treacher 1998).
Tissue delivery of oxygen is by the arterial blood and is mostly carried 
bound to haemoglobin. Tissue oxygen delivery therefore relies on the 
haemoglobin concentration of blood, the oxygenation of the arterial blood 
and the rate of flow of that blood through the tissues.
1.8 Tissue perfusion assessment
The quantification of tissue perfusion in critical illness has been attempted 
by various methods in addition to previously used markers such as capillary 
refill time, base deficit, lactate and urine output.
1.8.1 Near Infrared Spectroscopy (NIRS)
NIRS is a non-invasive continuous method to evaluate peripheral tissue 
oxygen metabolism. The first observations of spectroscopy of tissues using
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near infrared light were made by Jobsis in 1977 (Jobsis 1977). He noted 
that the penetration of tissue by light with a wavelength shorter than 700nm 
is poor, due to increased scattering at short wavelengths, and that light with 
a wavelength longer than 1300nm is absorbed within a few millimetres by 
tissue water. However between these two wavelengths, in the near 
infrared, light penetrates tissue well. It can therefore be used with 
computer analysis of spectra in the near-infrared range, 680 to 800 nm, to 
determine tissue haemoglobin oxygen saturation. This technique has 
shown lower tissue haemoglobin oxygen saturation values in adult septic 
shock (Poeze 2006; Skarda, Mulier et al. 2007; Muiier, Skarda et al. 2008). 
NIRS may therefore be a reasonable non-invasive indicator of systemic 
oxygen delivery in severe sepsis. The first application in paediatrics was in 
1985 in the bedside monitoring of cerebral oxygenation in sick preterm 
infants (Brazy, Lewis et al. 1985; Brazy, Lewis et al. 1985). Further studies 
have been performed in paediatric and neonatal practice although mainly in 
the areas of brain injury or congenital heart defect surgery (Fallon, Roberts 
et ai. 1994; Toet, Flinterman et al. 2005; Kirshbom, Forbess et al. 2007; 
Subbaswamy, Hsu et al. 2008). A limitation of NIRS is that it is necessary 
to perform continuous monitoring during a therapeutic or experimental 
intervention or a particular clinical event in order to determine the effect on 
oxygenation or haemodynamics. Also the method is limited to the outer 
cortex of the brain with a penetrable depth of 25 mm, it is time consuming 
to assemble and there are motion artefacts when measuring. NIRS is not 
routinely used in clinical practice and has not been evaluated in children
with MCD.
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1.8.2. Laser doppler flowmetry
Laser doppler uses a laser of a wavelength of 770-790 nm, which is 
directed onto the skin surface. It is a repeatable method of studying 
microvascular reactivity function (Yvonne-Tee, Rasool et al. 2005). Light 
that is reflected off a piece of stationary tissue undergoes no shift. Light 
that is reflected off celts that have a velocity like red blood cells undergoes 
a Doppler shift. The degree to which this Doppler shift occurs is 
proportional to the velocity of the cells. The light is then randomly reflected 
back onto a photodetector. This calculates the mean velocity of the cells 
within the tissue. Studies in adults have shown microvascular 
abnormalities in sepsis using this method (Knotzer, Maier et al. 2007). 
Laser doppler has not been used to investigate childhood sepsis.
1.8.3. Gastric tonometry
Gastric tonometry measures carbon dioxide (C02) production. Gastric C02 
rises in states of low perfusion because of anaerobic metabolism and/or 
decreased clearance (Friedman, Berlot et al. 1995; Baines 2001; Marik 
2005). A nasogastric tube with a C02 permeable balloon is placed into the 
stomach to measure gastric C02. Carbon dioxide from the gastrointestinal 
tract diffuses into the balloon over a period of 30 to 90 minutes, and the 
C02 of the balloon content is then analyzed once removed. It has been 
shown to be an effective way of assessing tissue perfusion in children with 
severe MCD (Baines 2001). Its limitations are that the tube can be difficult 
to place, must be placed each time a reading is to be taken, and can cause 
discomfort. Additionally gastric enteral nutrition can produce gastric 
hypersecretion and lower the pH (Marik and Lorenzana 1996).
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1.8.4. Sublingual Capnometry
Sublingual capnometry is performed with a silicone-covered disposable 
probe filled with a fluorescent dye. The probe is placed under the tongue 
for 5 to 10 minutes. This allows CO2 to diffuse into the dye. A light is then 
transmitted into the dye via an optic fibre and the amount of fluorescence is 
analysed (Marik 2005). It can detect microcirculatory changes in adults 
with severe sepsis but has not been studied in children (Weil, Nakagawa et 
ai. 1999; Boswell and Scalea 2003; Marik and Bankov 2003; Creteur 2006).
1.8.5 Intravital Microscopy
Intravital microscopy has contributed significantly to the understanding of 
leukocyte-endothelial cell interactions in-vivo (Smedegard, Bjork et al. 
1985). It is used to track the movements of white cells through the 
inflammatory microcirculation in real time. The method requires sections of 
tissue to be illuminated with light and is appropriate for animal studies but 
could not be used to obtain real time images of the microcirculation in 
humans.
1.9 Orthogonal Polarisation Spectral imaging and Side Stream 
Darkfieid imaging
Orthogonal polarization spectral (OPS) imaging was first introduced in 1999 
as a method of assessing tissue perfusion. OPS and sidestream darkfieid 
imaging (SDF) are incorporated into a small, hand held device that non- 
invasively visualises the microcirculation. OPS uses polarised light of a 
wavelength within the haemoglobin absorption spectrum (e.g. 548 nm) and 
red blood cells appear dark when visualised on a computer screen. An 
objective lens focuses the light onto a region of approximately 1 mm in 
diameter (Groner, Winkelman et al. 1999). The polarised light is scattered
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by the tissue and the majority is reflected back from the tissue surface. The 
reflected light is collected by the objective lens. A polarization filter 
orthogonal to the original beam of light eliminates the scattered reflected 
light but retains the light that remains polarised. High contrast images of the 
microcirculation are formed by the absorbing red blood cells that are close 
to the mucosal surface giving real- time images of microcircuiatory blood 
flow. A thin layer of mucosal tissue is needed for image attainment.
OPS has been superseded by SDF imaging which uses the same principle 
of OPS but without polarised light. Instead light-emitting diodes are 
incorporated into the image attainment probe resulting in higher quality 
images. Both techniques enable images to be obtained at the bed-side 
most conveniently by placing the imaging probe sublingually in a fashion 
similar to an oral thermometer (Groner, Winkelman et al. 1999; Nadeau and 
Groner 2001). Images can be obtained from any mucosal surface and 
video sequences have been obtained from the brain surface, stomas and 
tumour surfaces (Thomale, Schaser et ai. 2001; Pahernik, Harris et al. 
2002; Boerma, Mathura et al. 2005) OPS imaging, after validation 
(Mathura, Vollebregt et al. 2001), was introduced into surgery giving the 
first direct observations of the microcirculation of human internal organs 
(Groner, Winkelman et al. 1999; Mathura, Vollebregt et al. 2001; Pennings, 
Bouma et al. 2004).
1.10 OPS and SDF in monitoring the microcirculation in sepsis
The regulatory mechanisms controlling microcircuiatory perfusion are 
multifactorial. The endothelial cells lining the microvessels sense blood 
flow and metabolic and regulatory substances to modulate smooth muscle 
cell tone and capillary recruitment (Vallet 2002). The endothelium is vital in
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regulating coagulation and immune function, which directly affect 
microcirculatory function. Sepsis significantly disrupts endothelial and 
microcirculatory function (De Backer and Dubois 2001; De Backer, Creteur 
et al. 2002; Spronk, Zandstra et al. 2004). Biood flow becomes abnormal 
with some capillaries having low flow or even stagnant blood flow within 
them while others have normal to abnormally high blood flow (De, Creteur 
et al. 2002; Spronk, Zandstra et al. 2004). Functionally vulnerable 
microcirculatory units become hypoxic, leading to an oxygen extraction 
deficit (Lam, Tyml et al. 1994; Sinaasappel, van et ai. 1999; Goldman, 
Bateman et al. 2004) and varying degrees of functional shunting occur, 
more severely in sepsis than in haemorrhage (Ince and Sinaasappel 1999; 
Sinaasappel, van et al. 1999). In consequence, monitoring of systemic 
haemodynamic-derived and oxygen-derived variables may not detect such 
microcirculatory dysfunction.
In sepsis, the microcirculatory endothelial cells are unable to perform their 
regulatory function (Lidington, Tyml et al. 2002; Vallet 2002). The precise 
nature of this reaction within the endothelial cells has not been fully 
elucidated and could well be an adaptive response. Contributing factors 
include the NO system which is severely disturbed by heterogeneous 
expression of inducible nitric oxide synthase (INOS) in different areas of 
organ beds, causing pathological shunting (Revelly, Ayuse et al. 1996; 
Morin, Unno et al. 1998). Activated leucocytes generate reactive oxygen 
species that directly disrupt microcirculatory structures, cellular interactions 
and coagulation (Cerwinka, Cooper et al. 2003; Martins, Kallas et al. 2003; 
Victor, Rocha et al. 2004). These, and other inflammatory mediators, alter 
barrier function in the microcirculation, leading to tissue oedema and further 
oxygen extraction deficit.
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Several studies have investigated the microcirculation in adults with severe 
sepsis. The first, by De Backer et al., found a lower proportion of perfused 
small vessels (capillaries) and a lower capillary density when compared to 
controls and that these changes were more severe in non-survivors (De, 
Creteur et al. 2002). Studies visualising the sublingual microcirculation in 
adult sepsis have directly correlated the degree of microcircuiatory distress 
with disease severity, mortality and response to therapy (Spronk, Ince et al. 
2002; Sakr, Dubois et al. 2004). Sakr and colleagues showed that in adults 
microcircuiatory dysfunction left uncorrected for 24 hours was the single 
most important independent factor predicting patient outcome. Only one 
paediatric study has been published using OPS imaging in sepsis. Top et 
al. showed that there was poor microcircuiatory recovery in non-survivors of 
paediatric sepsis (Top, Ince et al. 2011)
The dysfunctional capillary blood flow associated with sepsis is 
characterized by sluggish or obstructed blood flow in the smallest 
capillaries with near to norma! flow in the larger microcircuiatory vessels. 
The relevance of the redistribution of oxygen to the pathophysiology of 
sepsis is uncertain. Fluid resuscitation, while correcting systemic 
haemodynamics, can leave areas of the microcirculation hypoxic (Ince and 
Sinaasappel 1999; Goldman, Bateman et al. 2004). In adult septic shock 
the sublingual microcirculation remained sluggish after pressure-guided 
resuscitation, despite the endothelial vasodilatory response being intact 
(De, Creteur et al. 2002). Sublingual OPS imaging in septic patients 
demonstrated that resuscitation of mean arterial pressure (MAP) and CO 
alone is not enough to resuscitate the microcirculation (Sakr, Dubois et al. 
2004; Boerma, Mathura et al. 2005). There is increasing evidence that
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organ function improves and mortality decreases when resuscitation also 
improves microcirculatory flow.
A number of strategies are suggested for resuscitating the microcirculation 
in septic patients. While vasopressor therapy alone is insufficient, the 
combination of adequate volume resuscitation, vasopressor agents and 
blood transfusion ensure adequate global oxygen delivery. This targeted 
strategy improves organ function and survival as demonstrated by the work 
of Rivers and colleagues (Rivers, Nguyen et al. 2001; Rivers, Nguyen et al. 
2004; Otero, Nguyen et al. 2006; Rivers 2006). SDF and OPS imaging 
have been incorporated into the concept of goal directed therapy (Trzeciak, 
Dellinger et al. 2006; Trzeciak, Dellinger et al. 2007). These studies 
confirmed that early microvascular dysfunction is more severe in non­
survivors despite the utilisation of goal directed therapy on cardiovascular 
variables and is also more severe in those patients with global 
cardiovascular dysfunction.
If enhanced microcirculatory flow is essential for oxygen transport and this 
may be achieved by vasodilator agents, it can be hypothesised that 
vasodilator therapy will improve both regional perfusion and oxygen 
availability during sepsis. Several animal studies have suggested that 
prostacyclin preferentially protects vessels in the microcirculation (Muller, 
Schmidtke et al. 1987; Bouskela and Rubanyi 1995). Clinical studies have 
shown that prostacyclin improves microvascular skin blood flow and global 
oxygen variables such as oxygen delivery and consumption in septic 
patients (Pittet, Lacroix et al. 1990; Pittet, Lacroix et al. 1992). Nitric oxide 
has also been shown to stabilise the microcirculation in animal models 
(Nishida, McCuskey et al. 1994; Gundersen, Saetre et al. 1996). In the
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study by Spronk in adult septic patients , OPS imaging revealed that there 
was enhanced microcirculatory blood flow with nitroglycerin after pressure- 
guided resuscitation (Spronk, Ince etal. 2002).
There are limitations to using OPS and SDF imaging in the assessment of 
the microcirculation in sepsis. Obtaining sublingual images may not be 
representative of other organs. It has been shown that sublingual and gut 
microvascular blood flow had a similar response when exposed to 
endotoxin (and resulting shock) implying that the sublingual circulation is a 
good central area for images to be obtained (Fries, Weil et a!. 2006). The 
area of tissue being visualised is very small leading to the possibility of 
pressure effects affecting the area of blood flow being visualised. Image 
attainment and analysis is largely subjective resulting in possible bias.
Although correction of hypotension is an important clinical target in the 
management of MCD, the use of vasopressor therapy to achieve this could 
be detrimental to microcirculatory perfusion and oxygenation. In this 
complex situation new clinical techniques for monitoring the 
microcirculation could significantly improve management.
OPS imaging and SDF could be used to target management or be used as 
a criteria for inclusion in clinical trials. Assessment of the microcirculation 
in MCD by using SDF or OPS could have an impact on the management of 
the disease.
1.12 Monitoring of the Macrocirculation in Sepsis
The characteristic ‘macro’-haemodynamic feature of fulminant adult 
meningococcal sepsis is hyperdynamic shock, with increased cardiac
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output and reduced peripheral resistance (Parker, Shelhamer et al. 1987). 
The cardiovascular features of sepsis in children may be different from 
those of critically ill adults. Children with sepsis have a low indexed CO, a 
low vascular resistance alone, or combined cardiac and vascular 
dysfunction (Ceneviva, Paschall et al. 1998). Furthermore, the 
cardiovascular pathophysiology may change during the evolution of sepsis 
requiring changes in therapy and the need for continuing monitoring if 
possible. Peters et al. demonstrated that the haemodynamic patterns of 
fluid-resistant paediatric septic shock differs according to the underlying 
cause. Children with central venous catheter (CVC) infections having a 
different pattern of septic shock, compared with those with community 
acquired infections. A greater proportion of CVC infections presented with 
a low systemic vascular resistance index and high cardiac index whereas a 
normal or low cardiac index was predominant in children with community 
acquired sepsis (Brierley and Peters 2008).
Studies investigating the microcirculation in severe illness must also look at 
cardiac function. Two-dimensional echocardiography is valuable for 
examining sepsis induced cardiac dysfunction (Boucek, Boerth et al. 1984; 
Mercier, Beaufils et al. 1988; Hagmolen of ten, Wiegman et al. 2000; 
Briassoulis, Narlioglou et al. 2001). Echocardiography assesses both 
cardiac systolic and diastolic function. Reliable estimates of cardiac output 
and when corrected for body surface area, cardiac index, can be 
calculated. When this data, although subjective, is combined with clinical 
haemodynamic variables reasonable estimates of systemic vascular 
resistance can be produced.
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Haemodynamic information available from pulmonary artery catheters 
(PACs) has been helpful in understanding MCD, Children with MCD have 
a lower CO despite a higher pulmonary artery occlusion pressure (PAOP) 
and CO does not increase in response to volume loading in MCD, 
compared with other forms of Gram negative sepsis (Monsalve, Rucabado 
et at. 1984). Furthermore SVR in survivors is abnormally high. This 
suggests that there may be a specific problem with cardiac performance in 
those children who die (Mercier, Beaufils et al. 1988). Similar information 
can be obtained from thermodilution catheters. The insertion of PACs or 
thermodilution devices is uncommon in paediatric critical care. They are 
invasive, a possible source of infection and thrombus may form at the 
catheter site. Laboratory investigations and non-invasive methods of 
assessing haemodynamic dysfunction, such as echocardiography, could 
give more information on the state of the cardiovascular system in sepsis.
1.12.1 Troponin
Changes in the intracellular calcium concentration control cardiac and 
skeletal muscle activity. A rise in intracellular calcium causes muscle 
contraction, and a decrease, muscle relaxation. Troponin is a component 
of thin filaments (along with actin and tropomyosin) and is the protein to 
which calcium binds to accomplish this regulation. Damaged myocytes 
release cardiac troponins (cTn). Troponin has three subunits, Troponin C 
(TnC), Troponin I (Tnl), and Troponin T (TnT). When calcium binds to TnC, 
the structure of the thin filament changes. This causes myosin to attach to 
thin filaments and produces force and/or movement, which results in 
muscle contraction. If levels of calcium are absent or low, tropomyosin 
interferes with this action of myosin (Clark 2002). This then leads to 
muscles remain relaxed. Individual subunits serve different functions:
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• Troponin C binds to calcium ions to produce movement;
• Troponin T binds to tropomyosin, interlocking them to form a 
troponin- tropomyosin cross-bridge formation;
• Troponin I binds to actin in thin myofilaments to hold the troponin- 
tropomyosin complex in place (Clark 2002)
Troponin measurement has replaced the measurement of cardiac enzymes 
for the detection of cardiac cell death due to a myocardial infarction in 
adults. In 2000 both the European Society of Cardiology and the American 
College of Cardiology recommended replacing the traditional CK-MB with 
cardiac troponins cTnT and cTnl as markers of a myocardial infarction. 
They are more sensitive markers of myocardial damage than CK-MB 
(Gerhardt, Katus et al. 1991; Hawkins and Tan 1999; Alpert, Thygesen et 
al. 2000). cTnT levels are detectable as early as three hours following a 
myocardial infarction, peaking between 10-20 hours and remain elevated 
for up to 20 days (Katus, Remppis et al. 1991; Uji, Sugiuchi et al. 1992; 
Murthy and Karmen 1997; Wu, Feng et al. 1998) despite a half-life in blood 
of approximately two hours (Gerhardt, Katus et al. 1991) The persistence 
of a raised cTnT level does not necessarily represent continuing myocyte 
death or damage as it may be due to the ongoing release of cTnT from 
previously damaged myocytes into blood.
Increased troponin levels have been observed in diseases other than 
myocardial infarction. Viral myocarditis can produce myocyte damage and 
raised troponin (Narula, Southern et al. 1991; Dec, Waldman et al. 1992; 
Narula, Khaw et al. 1993). Patients with pericarditis can have involvement 
of the epicardium with myocyte injury and cTnl is elevated in approximately 
one third of these patients (Brandt, Filzmaier et al. 2001). Bodor et al found 
that patients with Duchenne muscular dystrophy and polymyositis had
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raised serum levels of cTnT and concluded that cTnT is found in 
regenerating muscle (Bodor, Survant et al. 1997). High levels of cTnT have 
been found in a young dialysis population indicating that cTnT is expressed 
in the skeletal muscle of dialysis patients or that there is possible cardiac 
damage from ongoing hypertension (McLaurin, Apple et al. 1997).
Elevated cTnT and clnl have been found in adults with sepsis and have 
been shown to correlate with ejection fraction and mortality. They have 
also been shown to correlate with TNF, sTNFR levels, IL-6 and ICAM-1 in 
sepsis (Spies, Haude et al. 1998; Fernandes, Akamlne et al. 1999; Turner, 
Tsamitros et al. 1999; Ammann, Fehr et al. 2001; Ammann, Maggiorini et 
al. 2003; Mehta, Khan et al. 2004). cTnl has been found to be elevated in 
MCD. in a study by Thiru et al 62% of children admitted to PICU with MCD 
has a raised cTnl troponin l and cTnl levels correlated with disease severity 
scores, inotropic support and cardiac function in that a lower ejection 
fraction was seen in children with a raised cTnl (Thiru, Pathan et al. 2000). 
These findings have been reproduced by other paediatric studies 
investigating MCD (Briassoulis, Narlioglou et al. 2001; Gurkan, Alkaya et al. 
2004). The pathophysiological process involved in the release in cardiac 
troponins in sepsis is not clear.
1.12.2 N-Terminal Pro Brain Natriuretic Peptide
Of recent interest in monitoring cardiac performance are the natriuretic 
peptides. Atrial natriuretic peptide (ANP) was the first member of the 
natriuretic peptides to be isolated. This group of neuropeptides include 
brain natriuretic peptide (BNP), and C-type natriuretic peptide (Levin, 
Gardner et al. 1998). The pro-hormones of ANP and BNP split into the 
inactive N-terminals, NT-Pro ANP and NT-Pro BNP. The biologically active 
COOH-terminals are the ANP and BNP peptides. ANP is the dominant
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peptide released by the cardiac atria and BNP, the ventricles. Both are 
produced in response to increased myocardial wall stress and improve 
myocardial performance due to their potent natriuretic and vasorelaxant 
activity (Krupicka, Janota et al. 2008). The natriuretic peptides are now a 
validated marker in the diagnosis of heart failure in adults as they are early 
markers of myocardial dysfunction (Maisel, Krishnaswamy et al. 2002; 
Sirithunyanont, Leowattana et ai. 2003; Machado, Falcao et al. 2004; 
Wang, Larson et al. 2004). They are sensitive and specific and 
measurement is rapid and reasonably cheap (Collinson, Barnes et al. 2004) 
There has been recent interest in the measurement of NT-Pro BNP in 
sepsis to detect poor cardiac function, Chua et al noted that six patients 
admitted to intensive care with septic shock had markedly elevated levels 
of NT-Pro BNP within 6 hours of admission (Chua and Kang-Hoe 2004). In 
a larger study of adults admitted to intensive care with severe sepsis and 
congestive cardiac failure, those with severe sepsis or septic shock had 
highly elevated levels of BNP and NT-Pro BNP and despite significant 
hemodynamic differences that these levels were comparable with patients 
admitted due to acute heart failure (Rudiger, Gasser et al. 2006). BNP has 
also been shown to be inversely related to cardiac index in critically ill 
adults (Witthaut, Busch et al. 2003). NT-Pro BNP is measured rather than 
BNP because the different pathways of peptide clearance mean that the 
half-life of NT-proBNP is longer than BNP (Hall 2005). Levels of NT-Pro 
BNP in severe sepsis have also shown to predict outcome. Varpula et al 
found significantly higher values in non-survivors and NT-Pro BNP was an 
independent prognostic marker of mortality in adults with severe sepsis and 
septic shock. (Varpula, Pulkki et al. 2007).
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NT-Pro BNP has been measured in children with cardiac dysfunction (Nir 
and Nasser 2005; Nasser, Perles etal. 2006; Geiger, Hammerer-Lercher et 
ai. 2007), Fried et al were the first group to assess whether NT-Pro BNP 
levels could differentiate paediatric patients with critical illnesses due to 
sepsis from those with acute left ventricular dysfunction from other causes. 
They found that NT-Pro BNP levels were elevated in patients with sepsis 
but were significantly higher in patients with acute left ventricular 
dysfunction from known congenital cardiac disease. NT-Pro BNP levels of 
patients with sepsis and impaired systolic function were not different from 
those of patients with sepsis and normal systolic function measured with 
echocardiography. In a further group of patients, not admitted to PICU, 
attending or admitted to hospital with a self limiting viral illness, levels of 
NT-Pro BNP were significantly lower than the two groups admitted to PICU 
(Fried, Bar-Oz et al. 2006). A larger study found that children with septic 
shock had an elevated BNP level on admission to PICU when compared 
with healthy children and PICU controls. They also found that BNP 
measured at 12 hrs had a strong positive correlation with Pediatric Risk of 
Mortality III score and a strong negative correlation with fractional 
shortening as a measure of echocardiographic cardiac dysfunction 
(Domico, Liao et al. 2008). There have been no studies that have 
investigated NT-Pro BNP production in children with MCD.
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1.12 Aims of current prospective study
1. To determine whether activated Partial Thromboplastin Time 
waveform analysis and Procalcitonin could be used as early 
diagnostic markers in sepsis.
2. To assess the microcirculation of normal healthy children using 
side-stream dark-field imaging to validate its use in children.
3. To visualise the microcirculation in children with severe 
meningococcal disease using side-stream dark-field imaging.
4. To correlate microcirculatory variables of children with severe MCD 
with disease severity, cardiac function and plasma vasoactive 
endothelial mediators and cytokines.
5. To study cardiac systolic and diastolic function in children with 
severe meningococcal disease using echocardiography and 
determine the relationship between plasma cardiac troponin and NT 
Pro-BNP with cardiac function in children with severe MCD.
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Chapter 2
Materials and Methods
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2.1 Patient Recruitment
2.1.1 Study Design
The study was a two-centre, prospective, observational study. The study 
was conducted at Alder Hey Children's NHS Foundation Trust (AH) and the 
Royal Manchester Children’s Hospital NHS Trust (RMCH). The Research 
and Development Committees at both hospitals granted approval for the 
study. Ethical Committee approval was obtained from the South Sefton 
Research Ethics Committee in November 2006. The study was carried out 
between January 2007 and April 2008, at AH and March 2007 and April 
2008 at RMCH. The AH and RMCH admit children from the North west of 
England (or Merseyside and Greater Manchester) and North Wales. Both 
serve as tertiary centres admitting children to the regional PICU from other 
districts including North Wales, Lancashire and the Lake District.
Of the 45 children in the prospective study 33 were classed as confirmed 
meningococcal disease, and the other 12 were children with a presumed 
viral illness. 17 (38%) were male and 28 were female (62%). The age 
range was from 0.16 to 15.17 years, median age 2.16 years, interquartile 
range (IQR) 0.92 to 4.33 years. There were 17 children (52%) with severe 
disease as defined by a Glasgow Meningococcal Septicaemia Prognostic 
Score (GMSPS) of > 8. 20 children were ventilated and admitted to PICU 
(60%). Blood was taken from a control population of 23 children who were 
group of well patients undergoing elective dental surgery. Of the 23 control 
children, 12 (52%) were male and 11 (48%) female. The age range was 
from 0.25 to 11 years, median age 2.5 years, interquartile range (IQR) 0.6 
to 4.4 years.
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As this study also evaluated a new technique for visualisation of the 
microcirculation control children were recruited to assess ‘normal’ images. 
Three groups were recruited. The first were children attending for routine 
general surgery. Twenty children were recruited 10 (50%) were male and 
10 (50%) female. The age range was from 0.75 to 4.5 years, median age 
2.5 years, interquartile range (IQR) 0.75 to 4.5 years. The second group 
were older children who could co-operate with image attainment. Twenty 
children were recruited 11 (55%) were male and 11 (45%) female. The age 
range was from 8.2 to 11.2 years, median age 10.4 years, interquartile 
range (IQR) 8.2 to 10.4 years. The third group were children who were 
attending hospital for cardiac surgery The median age of the children was 
2.1 years (IQR 0.7 to 2.6), 5 (50%) were male and 5 (50%) female.
2.1.2 Notification of cases and controls
The Research Fellow was notified whenever a child with suspected 
meningococcal septicaemia or meningitis was admitted to the Emergency 
department (ED), or if the Regional PICU Transport Teams at AH or RMCH 
had received a referral from a district general hospital for admission to 
PICU. Once notified, the Research Fellow attended as soon as possible 
after the arrival to hospital. In the majority of cases this was within one hour 
of being contacted. Notification was by the doctors involved in these 
children’s clinical care. In the case of PICU admissions, the Research 
Fellow saw the child on arrival to PICU, and subsequently followed their 
course throughout their hospital stay.
Admissions via the ED at AH were seen in the ED, and their subsequent 
course followed throughout their hospital stay. Children referred as having
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possible or probable MCD, but who were later felt to have an alternative 
diagnosis were also recruited. Their hospital progress was followed in an 
identical way as the confirmed cases. These children were used as a 
separate clinical group and were assumed to have a viral infection. Blood 
samples were sent for viral analysis including PCR for adenovirus, 
enterovirus, HHV6, HHV7, influenza A and B, cytomegalovirus, parovovirus 
and rubella. This group was included for determination of blood analytes 
and gene expression studies.
The control population was recruited from a group of well patients 
undergoing elective surgery for non-infective conditions at AH. Patients 
were identified by discussing prospective theatre lists with hospital theatre 
co-ordinators and anaesthetists. On arrival to AH, these patients and their 
parents were approached regarding entry into the study. Control patients 
who had clinical symptoms of an acute illness in the last 2 weeks were 
excluded, as were patients where there was evidence on examination of a 
possible systemic infection. No control patients who were excluded on the 
basis of above.
Children for the cardiac surgery comparative group was recruited from list 
of children listed for cardiac surgery at AH. Patients were identified by 
discussing prospective theatre lists with hospital theatre co-ordinators and 
anaesthetists. These patients and their parents were approached 
regarding entry into the study the day prior to surgery. Only children who 
were undergoing surgery requiring cardiac bypass were included.
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2.1.3 Assessment of patients
Children were recruited into the study once the Research Fellow had 
obtained informed consent or assent from the parents or children 
themselves. Informed consent entailed the details of this study being 
explained to the patients and parents and written information being 
supplied. Those giving informed consent were told that even if consent 
was given if could be withdrawn at any time. Demographic data, duration 
and nature of symptoms, severity of disease assessments, clinical 
assessment, laboratory results, SDF image recording, echocardiography 
recording and outcome were recorded on a specifically designed proforma.
2.1.4 Disease severity assessment.
For each patient a prospective GMSPS (Sinclair, Skeoch et al. 1987; 
Thomson, Sills et al. 1991), the Pediatric Logistic Organ Dysfunction Score 
(PELOD) (Leteurtre, Martinot et al. 2003; Lacroix and Cotting 2005) and the 
Paediatric Risk of Mortality III (PRISM III ) (Pollack, Ruttimann et al. 1988) 
were calculated at admission as detailed in Tables 2.1, 2.2 and 2.3 
respectively. Inotrope score was also calculated using the following 
equation:
[1 x (dopamine dose + dobutamine dose) + 100 x (epinephrine dose + 
norepinephrine dose)] (Skippen and Krahn 2005)
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CLINICAL SIGNS OR SYMPTOMS
SCORE
Low BP
■ Age <4, <75mmHg
■ Age >4, <85mmHg
3
Skin / rectal temp, difference > 3°C 3
GCS < 8 or deterioration 3 points 3
Deterioration last hour 2
Absence of meningism 2
Extending/widespread petechiae 1
Base deficit > -8 1
Table 2.1. Glasgow Meningococcal Septicaemia Prognostic Score
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fliYfamt Child! Vaitie- Score
Svarolic blood pressure 
{BP, muaiHe)
: 40* <5 O' 7
40-54 50‘-64 6
55-65 65-75 _L
13 0*-160* 150'-200‘ 6
■160 ■200 7
Diastolic BP (muaHg) .=■110 •no 6
Heai't Kate
■160 ■150 4
-90' <3 O' 4
Re^piratoi*?.- Kate 61-90 51-70 t
■90 ■71 5
F-n.02/Ft02 (muaHg) 200-3Ci'0
-.200 3
FaC 02 51-65 1
•' - 65 5
dnsgoTv Coma Score ■=■8 6
Fupillai’y rejictioii Unequal or dilated 4
Fijced dilated 10
FT ■ APTT 1.5x control PT =* 22.5 
APTT -54
Bilirtibin (umoL'L) --60 6
Potassium (mmoLT)
3.0 5
3-3.5 1
6.5-7.5 1
>7.5 5
Calcium (mmol/L)
<1.75 6
1.75-2.00
3-3.75
>3.75 6
Glucose (mmolT.)
<2 ^ S
2.2-3.3 4
13.9-22.2 4
■> S
Bicarbonate (mmol.'lL> <16
3
<32 3
Total Mas: 76
Table 2.2. Pediatric Risk of Mortality III Score
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Scoring system
0 1 10 20
Organ dysfunction and variable
Neurological
Glasgow coma score 12-15
and
7-11 4—6
or
3
Pupillary reactions Both
reactive
NA Both
fixed
NA
Cardiovascular
Heart rate {beats/m in)
<12 years *£195 NA >195 NA
c-12 years ^•150
and
NA >150
or
NA
Systolic blood pressure (mm Hg}
<1 month >65 NA 35-65 <35
1 month-1 year >75 NA 35-75 <35
1-12 years >85 NA 45-85 <45
^12 years >95 NA 55-95 <55
Renal
Creatinine (junol/L)
<7 days <140 NA >140 NA
7 days-1 year <55 NA >55 NA
1-12 years <100 NA >100 NA
>12 years <140 NA >140 NA
Respiratory
PaO? (RPa)/FIO: ratio >9-3
and
NA >9*3
or
NA
PaCO. (kPa) *■411-7
and
NA >11-7 NA
Mechanical ventilation § No
ventilation
Ventilation NA NA
Haem ato logical
White blood cel! count (x icP/L) >4*5
and
1* 5-4*4
or
<1*5 NA
Platelets (x loVL) >35 <35 NA NA
Hepatic
Aspartate transaminase (IU/L) <950
and
>950
or
NA NA
Prothrombin time (or INR) >60
(<l-40)
>60
{>1*40)
NA NA
Table 2.3. Pediatric Logistic Organ Dysfunction score
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2.1.5 Definitions
Children were recruited if presenting with fever and a non blanching rash.
Cases were classified as either confirmed, probable or possible cases
(Stuart, Monk et al. 1997):
• Confirmed cases - Clinical cases with microbiological confirmation 
of Neisseria meningitidis infection, either positive cultures from a 
normally sterile site (blood, cerebrospinal fluid (CSF) or joint fluid), 
or a positive meningococcal PCR from normally sterile sites.
• Probable cases - Clinical diagnosis of meningococcal meningitis or 
septicaemia without confirmation. The clinician managing the case 
considers that meningococcal disease is the likeliest diagnosis. In 
the absence of an alternative diagnosis a feverish, ill patient with a 
petechial or purpuric rash was regarded as a probable case.
• Possibie cases - The clinician managing the case considers that 
diagnoses other than meningococcal disease were as likely. This 
included cases treated with antibiotics whose probable diagnosis is 
viral meningitis.
• Presumed viral illness - A possible case where Neisseria 
meningitidis infection has been excluded via blood or CSF culture 
from normally sterile sites and a negative meningococcal PCR from 
normally sterile sites.
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2.1.6 Patient Inclusion Criteria
Prospective demographic data regarding diagnostic test results were 
collected on all patients referred to the Research Fellow with a diagnosis of 
possible MCD. Age was limited to 3 months to 16 years. Blood sampling 
was not undertaken if patients had been treated for 24 or more hours 
before consent could be obtained. These children were not included in any 
analysis.
2.1.7 Patient Exclusion Criteria
Patients with an underlying immune deficiency or congenital abnormalities 
that could have adversely affected outcomes were excluded from the data 
analysis - there were no patients in this group.
2.2 Blood Sampling
Blood samples in patients were collected as soon as possible after 
admission to hospital. For patients admitted to the general paediatric 
wards, samples were obtained at admission. For patients admitted to PICU 
samples were obtained at admission, 12, 24, and 72 hours, where possible, 
from indwelling arterial lines. Blood samples were taken for the 
determination of meningococcal bacterial load, viral detection, cytokines 
list) VCAM, ICAM, P-selectin, E-selectin, NO, cTnT, cTnl, NT-Pro BNP, 
PCI and aPTT waveform analysis. Blood samples taken at admission 
consisted of the following:
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Three millilitre blood samples were collected into a 5mL Ethylene-diamine- 
tetra-acetic acid (EDTA) tube and placed immediately on ice for bacterial 
load, viral detection, cytokine, VCAM-1, ICAM-1, NO, P-selectin, E-selectin, 
cTnT, cTnl and NT-Pro BNP estimation. The blood pellet that remained 
after separation of plasma from the spun EDTA sample was used for 
bacterial load analysis. 1.3mls of blood was placed into a citrated tube for 
aPTT waveform analysis. Blood samples taken at 12, 24, and 72 hours 
consisted of 3 millilitre blood samples were collected into a 5ml_ Ethylene- 
diamine-tetra-acetic acid (EDTA) tube and placed immediately on ice
Coagulation samples are taken daily from children in intensive care into 
citrate tubes. These samples are processed by the haematology laboratory 
at AH and RMCH. The citrated blood is centrifuged 4000 x g for 5 minutes 
at room temperature and the plasma removed. Once the coagulation 
studies have been carried out the plasma remaining is frozen at -70 °C and 
if there is no further clinical use for the sample the laboratory disposes of it 
after 7 days. These samples were retrieved from the Haematology 
laboratories at AH and RMCH after the 7 days for serial aPTT waveform 
analysis.
Control patients undergoing elective surgery routinely had a cannula 
inserted in the anaesthetic room prior to surgery and it was during this 
procedure that 5mL of blood was obtained for cytokine estimation, VCAM- 
1, ICAM-1, NO, P-selectin, E-selectin, cTnT, cTnl, NT-Pro BNP and aPTT 
waveform analysis.
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2.2.1 Blood sample separation and storage
Blood analysis for clinical purposes was performed in the haematology, 
biochemistry and microbiology laboratories at AH and RMCH. Separation 
was performed by centrifugation of the 3 ml EDTA samples at 4000 x g for 
5 minutes at 4 °C and the serum decanted with fine tipped disposable 
Pasteur pipettes into a sterile container. 250 microlitre plasma aliquots 
were then pipetted into 2.0ml Nalgene cryogenic vials using Eppendorf 
micropipettes and the pellet was separated into a further cryogenic vial. 
Separation was performed by centrifugation of the 1.3 ml citrate sample at 
4000 x g for 5 minutes at room temperature. The citrate plasma was 
decanted with fine tipped disposable Pasteur pipettes into a 2.0ml 
cryogenic vial. The samples were then all frozen at -70 °C until analysed. 
This occurred within 30 min of sampling. Citrate samples were analysed by 
the haematology laboratories at AH and RMCH as part of clinical 
coagulation studies. Frozen citrated plasma was stored in the haematology 
laboratories for 7 days following blood sampling. After 7 days if the sample 
was no longer needed for clinical purposes, it was retrieved from the 
laboratory for aPTT waveform analysis. The results of blood analysis are 
included in Chapters 3, 6 and 7.
2.3. Analysis of blood samples
2.3.1 aPTT waveform analysis.
Plasma aPTT waveform analysis was determined on the MDA 180 
(Organon Teknika, Cambridge, United Kingdom) analyzer using Platelin 
IS. The methodology for this is described in chapter 3.
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2.3.2. Quantification of Procalcitonin.
PCT was measured using an automated immunofluorescent assay: the 
BRAHMS PCT sensitive KRYPTOR kit and the BRAHMS KRYPTOR 
machine.
2.3.3 Quantification of endothelial cell adhesion molecules.
VCAM-1, ICAM-1 and P Selectin concentrations were measured using 
commercially produced Enzyme-Linked Immunosorbent Assay (ELISA) 
marketed by R&D Systems, Minneapolis, Minnesota, USA. E-Selectin 
concentrations were measured using commercially produced ELISAs 
marketed by Hycult Biotechnology. All samples and standards were 
assayed in duplicate in 96 well plates. All samples and controls were 
diluted 1:20 with sample diluent. For all assays a standard curve was 
constructed from the standard values using commercially available 
software and sample concentrations were obtained from this standard 
curve. The concentration of a sample was taken from the mean of the two 
wells.
2.3.3.1. ICAM-1 
2.3.3.1a Materials
Wash Buffer - 20 mis of Wash Buffer concentrate was diluted with distilled 
water to prepare 500 mis of Wash Buffer.
ICAM-1 Standard - The slCAM-1 standards were reconstituted with 1.0 ml 
of distilled water. The vials were allowed to sit at room temperature for at 
least 10 minutes prior to use. Concentrations were: 0, 1.56, 3.13, 6.25, 
12.5,25, 50 ng/ml.
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ICAM-1 Control - The slCAM-1 control was reconstituted with 500 ijI of 
distilled water. The vial was allowed to sit at room temperature for at least 
10 minutes prior to use.
ICAM-1 Conjugate concentrate - 250 pi of the conjugate concentrate was 
pipetted into the bottle of conjugate diluent and gently mixed.
Stop solution.
2.3.3.1b Method
100pl of ICAM-1 diluted conjugate was pipetted to each well.
100pl of standard, control, or sample was pipetted into each well.
An adhesive plate was covered was applied and incubated for 1.5 hours at 
room temperature
Each well was aspirated and washed using an autowasher with 400pl of 
wash buffer. This step was repeated five times for a total of 6 washes.
After the last wash any remaining wash buffer was removed by inverting 
the plate and blotting it against clean paper towels.
100 pi of substrate solution was pipetted into each well.
The plate was incubated for 30 minutes at room temperature, protected 
from light.
100 pi of stop solution was pipetted into each well.
The optical density of each well was read within 30 minutes, using a 
microplate reader set to 450 nm subtracting the blank well absorbance from 
all other values.
2.3.3.1c Performance characteristics of the assay
The inter-assay coefficient of variation of 4.4-6.8 % and an intra-assay
coefficient of variation of 3.6-5 %.
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2.3.3.2 VCAM-1 
2.3.3.2a Materials
Wash Buffer - 20 mis of Wash Buffer concentrate was diluted with distilled 
water to prepare 500 mis of Wash Buffer.
Substrate Solution - Colour Reagents A and B were mixed together in 
equal volumes and used within 15 minutes.
Calibrator Diluent - 20 mis of calibrator diluent concentrate was diluted with 
80 mis of distilled water to prepare 100 mis of calibrator diluent.
VCAM-1 Standard - The VCAM-1 standard vial was reconstituted with 1.0 
ml of distilled water. This reconstitution produces a stock solution of 400 
ng/ml and was allowed to sit for a minimum of 15 minutes with gentle 
agitation prior to making dilutions.
500 pi of calibrator diluent was pipetted into each tube. The stock solution 
was used to produce a dilution series (Figure 6.3). Each tube was 
thoroughly mixed before the next transfer. The 200 ng/mL standard served 
as the high standard. The calibrator diluent served as the zero standard (0 
ng/mL).
Stop solution.
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Figure 2.1 Serial dilution of VCAM-1 Standard for standard curve determination
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2.3.3.2b Method
100jjI of sVCAM-1 diluted conjugate was pipetted to each well.
100pl of standard, control, or sample was pipetted into each well.
The plate was covered with the adhesive strip and incubated for 1.5 hours 
at room temperature
Each well was aspirated and washed using an autowasher with 400pl of 
wash buffer. This step was repeated three times for a total of 4 washes. 
After the last wash any remaining wash buffer was removed by inverting 
the plate and blotting it against clean paper towels.
100 pi of substrate solution was pipetted into each well.
The plate was incubated for 20 minutes at room temperature, protected 
from light.
50 pi of stop solution was pipetted into each well.
The optical density of each well was read within 30 minutes, using a 
microplate reader set to 450 nm subtracting the blank well absorbance from 
all other values.
2.3.3.2c Performance characteristics of the assay
The inter-assay coefficient of variation of 5.5-8.7 % and an intra-assay 
coefficient of variation of 2.3-3.6%.
2.3.3.3. P-Selectin
2.3.3.3a Materials
Wash Buffer - 20 mis of Wash Buffer concentrate was diluted with distilled 
water to prepare 500 mis of Wash Buffer.
P-Selectin Standard - The P-Selectin standards were reconstituted with 1.0 
ml of distilled water. The vials were allowed to sit at room temperature for at
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least 10 minutes prior to use. Concentrations were: 0, 1.56, 3.13, 6.25, 
12.5, 25, 50 ng/mt.
P-Selectin Control - The P-Selectin control was reconstituted with 500 pi of 
distilled water. The vial was allowed to sit at room temperature for at least 
10 minutes prior to use.
P-Selectin Conjugate concentrate - 250 pi of the conjugate concentrate was 
pipetted into the bottle of conjugate diluent and gently mixed.
Stop solution.
2.3.3.3b Method
100pl of P-Selectin diluted conjugate was pipetted to each well.
100pl of standard, control, or sample was pipetted into each well.
The plate was covered with the adhesive strip and incubated for 1hour at 
room temperature.
Each well was aspirated and washed using an autowasher with 300pl of 
wash buffer. This step was repeated two times for a total of 3 washes.
After the last wash any remaining wash buffer was removed by inverting 
the plate and blotting it against clean paper towels.
100 pi of substrate solution was pipetted into each well.
The plate was incubated for 15 minutes at room temperature, protected 
from light.
100 pi of stop solution was pipetted into each well.
The optical density of each well was read within 30 minutes, using a 
micropiate reader set to 450 nm subtracting the blank well absorbance from
all other values.
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2.3.3.3c Performance characteristics of the assay
The inter-assay coefficient of variation of 7.9-Q.9 % and an intra-assay 
coefficient of variation of 5.1-5.6 %.
2.3.3.4 E-Selectin
E-Selectin concentrations were measured using commercially produced 
ELiSAs marketed by Hycult Biotechnology.
2.3.3.4a Materials
Vial of tetramethylbenzidine (TMB)
Wash Buffer - 40 mis of Wash Buffer concentrate was diluted with distilled 
water to prepare 960 mis of Wash Buffer. 5ml of a concentrated 
magnesium and calcium solution was added.
E-Selectin Standard - The E-Selectin standards were reconstituted with 1.0 
ml of distilled water. The vials were allowed to sit at room temperature for at 
least 10 minutes prior to use. Concentrations were: 0, 3.2, 16, 80, 400, 
2000, 10,000 pg/ml.
E-Selectin tracer was reconstituted with 1.0 ml of distilled water and 11 mis 
of wash buffer added.
E-Selectin streptavidin-peroxidise conjugate was reconstituted with 1.0 ml 
of distilled water and 24 mis of wash buffer added and gently mixed.
Stop solution.
2.3.3.4b Method
100pl of standard, control, or sample was pipetted into each well.
An adhesive plate cover was applied and incubated for 2 hours at 18-25 °C 
Each well was aspirated and washed using an autowasher with 200pl of 
wash buffer. This step was repeated three times for a total of 4 washes. 
100jjl of E-Selectin diluted tracer was pipetted to each well.
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An adhesive plate cover was applied incubated for 1 hour at 18-25 °C 
Each well was aspirated and washed using an autowasher with 200pl of 
wash buffer. This step was repeated three times for a total of 4 washes. 
100pl of E-Selectin diluted streptavidin-peroxidise conjugate was pipetted 
to each well. An adhesive cover was applied to the plate and incubated for 
1 hour at 18-25 °C. Each well was aspirated and washed using an 
autowasher with 200pi of wash buffer. This step was repeated three times 
for a total of 4 washes.
100pl of E-Selectin TMB substrate solution was pipetted to each well.
The plate was covered with the adhesive strip and incubated for 20-30 
minutes at room temperature.
100 pi of stop solution was pipetted into each well.
The optical density of each well was read within 30 minutes, using a 
microplate reader set to 450 nm subtracting the blank well absorbance from 
all other values.
2.3.3.4c Performance characteristics of the assay
The inter-assay coefficient of variation of 3.9-7.8 % and an intra-assay
coefficient of variation of 4.2-4.9 %.
2.3.4 Quantification of cytokines
Cytokine determination was carried out using Luminex technology in the 
Bio-plex Protein Array System marketed by Bio-Rad.
2.3.4a. Materials
Bio-Plex® Human 27-plex Multi-Cytokine Standard 
Bio-Plex® Human 27-Plex Multi-Cytokine Beads
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Bio-Plex® Human 27-plex Multi-Cytokine, Biotin 
Bio-Plex® Streptavidin-Phycoerythrin 
Bio-PIex® Cytokine Assay Buffer 
Bio-Plex® Stop Solution 
Bio-Plex® 96-well Filter Plate
2.3.4b. Reagent Preparation
Human 27-plex Multi-Cytokine Standard was resuspended in 1ml of serum 
standard diluent (SSD). It was vortexed on medium speed for 15 seconds 
and placed on ice for 5 minutes. This was standard A which was serially 
diluted (1:4) as shown in Figure 2,2. Bio-Plex®Streptavidin-Phycoerythrin 
was diluted 1:12.5 in Bio-Plex® Cytokine Assay Buffer using the mixing vial 
provided - 200pL in 2.6 ml.
2.3.4c. Assay Procedure
25pl of Bio-Plex® Cytokine Assay Buffer was pipetted into each well, 
vortexed, and a vacuum was applied to the bottom of plate. The bottom of 
plate was blotted on clean paper towel.
25pl of SSD + 15pL sample were pipetted into each well and the plate 
incubated at room temperature on a plate shaker for 20 minutes.
The Bio-Plex® Human 27-plex Multi-Cytokine Beads were vortexed at high 
speed for 15 sec.
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25|jl of bead solution was pipetted into each well. A plate cover was placed 
upon the plate and the plate incubated for 2 hours in the dark at room 
temperature on a plate shaker.
A vacuum was applied to the bottom of the filter plate. 50pl of Bio-Plex® 
Cytokine Assay Buffer was pipetted into each well and vacuum extracted. 
This wash step was repeated twice to make a total of 3 washes. The 
bottom of plate was blotted onto a clean paper towel following the final 
wash.
75pl of Bio-Plex® Cytokine Assay Buffer was pipetted into each well. A plate 
cover was applied and the plate was vortexed at low speed on a plate 
shaker.
25pl Bio-Plex® Human 27-plex Multi-Cytokine biotin was pipetted into each 
well. A plate cover was applied and the plate vortexed at low speed. It was 
then incubated for 1.5 hour in the dark at room temperature on a plate 
shaker.
A vacuum was applied to the bottom of the filter plate. 50pl of Bio-Plex® 
Cytokine Assay Buffer was pipetted into each well and vacuum extracted. 
This wash step was repeated twice to make a total of 3 washes. The 
bottom of plate was blotted onto a clean paper towel following the final 
wash.
25pl of diluted Bio-Plex® Streptavidin-Phycoerythrin was pipetted into each 
well. A plate cover was applied and the plate vortexed at low speed. It was 
then incubated for 30 minutes in the dark at room temperature on a plate
shaker.
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25|jl of Bio-Plex® Stop Solution was pipetted into each well, the plate 
vortexed gently on a plate shaker and incubated for 5 minutes at room 
temperature in the dark.
A vacuum was applied to the bottom of the filter plate. 50pl of Bio-Plex® 
Cytokine Assay Buffer was pipetted into each well and vacuum extracted. 
This wash step was repeated twice to make a total of 3 washes. The 
bottom of plate was blotted onto a clean paper towel following the final 
wash.
125pl of sheath fluid was pipetted into each well, the plate vortexed at low 
speed and placed on a plate shaker for 1 minute.
Results were read on a Luminex 100 System. The concentration of each 
cytokine in the sample was automatically calculated from a standard curve 
derived from serial dilutions of the cytokine standard using the Bio-Plex 
Manager software.
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n
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V %
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Multiplex standard stock 
153.03C og/ml)
Stock Oil)
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72
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150
50
150
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150
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53 50
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7.8 1.95
Figure 2.2 Serial dilution of Multiplex standard for standard curve determination
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2.3.5. Quantification of Nitric Oxide Metabolites
Nitric oxide metabolite concentrations were measured by the Griess 
reaction using a commercially produced, 96 well plate, enzyme reduction 
assay marketed by R&D Systems Minneapolis, Minnesota, USA. Samples 
were 10,000 molecular weight filtered using 10,000 molecular weight cut-off 
filters. Samples and Controls were diluted 1:2 in assay buffer before being 
assayed (10 pi sample + 10 pi assay buffer) and were assayed in duplicate.
2.3.5a Materials
Reaction Diluent: 30 mis of Reaction Diluent Concentrate was diluted with 
300 mis of distilled water to prepare 300 mis of Reaction Diluent to make a 
10x solution.
Nitrate Reductase
Reconstitution - Nitrate Reductase was reconstituted with 1.0 ml of Nitrate 
Reductase Storage Diluent. The solution was vortexed vigorously and 
allowed to sit for 15 minutes at room temperature. This step was repeated 
and the solution then used immediately.
Dilution - Immediately before use the Nitrate Reductase was diluted using 
the following equation:
A. Nitrate Reductase (pi) = (number of wells required + 2) x 5 pi.
B. Reaction Diluent (pi) = volume from step A x 4.
C. Volumes from steps A and B were added to a clean test tube and 
vortexed.
D. The test tube was placed on ice and use within 15 minutes of dilution.
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Nicotinamide adenine dinucleotide. (NADH) Reagent - Reconstituted with 
5.0 mis of distilled water. The NADH was allowed to sit for 3 minutes and 
was gently agitated prior to use.
Nitrite and Nitrate Standard - 900 pi of Reaction Diluent was pipetted into 
the 200 pmol/l tube. 500 pi of Reaction Diluent was pipetted into the 
remaining tubes. Using the appropriate 2000 pi mol/l standard stock a 
dilution series was produced as shown in figure 2.3. The tubes were mixed 
thoroughly and pipette tips changed between each transfer. The 200 pmol/l 
standard served as the high standard and the Reaction Diluent served as 
the blank (Opmoi/I).
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•& 9 9 9 I~
2000 200 100 50 25 12.5 6.25 3.12
umol/L ^imol/L umol/L umol/L umol/L ^mol/L pmol/L nmol/L
Figure 2.3 Serial dilution of Nitrite or Nitrate Standard for standard curve determination
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2.3.5b Method
Nitrite Assay
50[jl of Reaction Diluent was pipetted into the blank wells.
50pl of Nitrite Standard or sample was pipetted into the remaining wells. 
50pl of Reaction Diluent was pipetted into all wells.
50pl of Griess Reagent I was pipetted into all wells.
50 pi of Griess Reagent II was pipetted to all wells.
The plate was incubated for 10 minutes at room temperature and the 
optical density of each well was read using a microplate reader set at 540 
nm.
Nitrate Reduction Assay
50 pi of Reaction Diluent was pipetted to the Blank wells.
50 pi of Nitrate Standard or sample was pipetted into the remaining wells.
25 pi of NADH was pipetted into ail wells.
25 pi of diluted Nitrate Reductase was pipetted into all wells.
The plate was mixed well and incubated for 30 minutes at 37° C.
50 pi of Griess Reagent I was pipetted into all wells.
50 pi of Griess Reagent II was pipetted into all wells.
The plate was incubated for 10 minutes at room temperature.
The optical density of each well was red using a microplate reader set at
540 nm
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Calculation of Results
A standard curve was constructed from the standard values using 
commercially available software and sample concentrations were obtained 
from this standard curve. The concentration of a sample was taken from the 
mean of the two wells. The Nitrite assay measures the concentration of 
endogenous nitrite present in the sample. The nitrate assay measures the 
total nitrite by converting nitrate to nitrite. To determine the nitrate 
concentration in the sample, the endogenous nitrite concentration 
measured from the Nitrite Assay Procedure was subtracted from the 
converted nitrite concentration measured in this procedure.
2.3.5c Performance characteristics of the assay
The inter-assay coefficient of variation of 3.4 -4.6% and an intra-assay 
coefficient of variation of 1.6-2.5%.
2.3.6. Quantification of NT ProBNP
Concentrations of plasma NT ProBNP were measured using commercially 
produced ELlSAs marketed by Biomedica Gruppe, Austria. Full 
methodology is described in chapter 7.
2.3.7. Quantification of Cardiac Troponin I and Cardiac Troponin T
cTnl and cTnT were measured by an automated Troponin I and T STAT 
(Short Turn Around Time) assay, using Elecsys 10:10 apparatus, Roche 
Diagnostics GmbH, Mannheim. This involves an Electro-Chemical- 
Luminescence ImmunoAssay (ECLIA).
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2.3.8. Quantification of Bacterial Load and viral detection
Nucleic acid extraction was performed at the Meningococcal Reference 
Unit (MRU) by the automated Qiagen MDX system (Roche Applied 
Science, Indianapolis, IN) using robotics, precision pipetters, and silica 
matrix to purify RNA. The samples were dissolved and simultaneously 
stabilised by incubation with a buffer containing denaturing agents and 
proteinase K. Several washing steps remove the unbound substances 
leaving the nucleic acids bound to the surface of the silica matrix. The 
purified nucleic acids were then eluted with 100 pL elution buffer. PGR 
detection of meningococcal, pneumococcal, Haemophilus influenzae type 
b, adenovirus, enterovirus, influenza A and B, cytomegalovirus and 
paraecho virus, was performed on the extracted samples. Meningococcal 
DNA was quantified to enable determination of bacterial load. 
Meningococcal DNA detection and quantification was performed on all 
samples using the Taqman PGR on the ABI PRISM 7500 Sequence 
Detection System (Perkins-Elmer Applied Biosystems 7500 automated 
PGR platform, Norwalk, Connecticut) using a fluorescence-based closed 
tube system. Quantification of bacterial load was calculated from the cycle 
threshold values.
Detection of human herpesviruses 6 and 7 rubella, measles and parvovirus 
B19 was carried out at the Department of Virology, University College 
Hospital, London by PGR.
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2.3. Microcirculation visualisation
Sublingual microcirculatory visualisation was carried out using SDF 
imaging. The SDF device used to obtain images was the Microscan™1 2 3 4(Fig 
2.1) The device was linked to a computer via a Canopus™ ADVC 110 
device which converts analogue video to digital capturing from a FireWire 
port. The WinDV™ programme, a Windows™ application for capturing 
videos from digital video device into Audio Video interleave files, was used 
to capture the images. This enabled rea! time visualisation of the sublingual 
microcirculation on the computer screen. The images were stored 
anonymously onto Digital Video Discs (DVD). Due to the level of co­
operation needed for image attainment only children with MCD who 
required ventilation were recruited for microcirculatory visualisation. 
Microcirculatory image acquisition was carried out within an hour of 
admission to PICU then at 6, 12 and 24 hours post admission and 24 
hourly thereafter, untii extubation. Whenever OPS images were being 
obtained, the pH, lactate, haematocrit, systolic blood pressure (SBP), 
diastolic blood pressure (DBP), MAP, CVP, inotropic support, ventilatory 
support and amount and type of sedation or other medications being 
administered were recorded. The operating procedure for microcirculatory 
image acquisition was as follows:
1. The dentition of child was examined to ensure no teeth were loose.
2. Secretions were removed from the surface of the sublingual mucosa 
with a suction catheter or gauze.
3. A sterile disposable cap was placed on the Microscan™ probe.
4. The probe was positioned on the sublingual mucosal surface.
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5. The probe was manoeuvred until the microcirculation came into 
view.
6. The image was focused
7. Up to 5 video clips, of 20 seconds each, were recorded, it was 
ensured that both sides of the tongue were visualised.
8. The images were immediately saved to DVD and anonymised.
9. if the child, the child’s parents or nursing staff became distressed by 
the microcirculatory image acquisition the procedure was 
abandoned. This did not happen at any point.
The adjustments to this methodology for the control groups of children are 
described in chapter 4.
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Figure 2.4. The Microscan - own image
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2.4. Echocardiography
Transthoracic echocardiographic examination took place with the patient in 
the supine position or in a left lateral semi-recumbency position. All studies 
were carried out by the Research Fellow using a GE™ (General Electrical) 
Vivid 7 Echocardiography machine within 30 minutes of microcirculatory 
visualisation. An electrocardiogram (EGG) tracing was recorded 
simultaneously with the echocardiogram. Standard parasternal, apical, and 
subcostal views were used to detect any cardiac abnormalities in the 
patients prior to obtaining functional studies. Transducer frequency was 3, 
5 or7 MHz depending on the size of the patient. At least three cardiac 
cycles were recorded for analysis for all measurements.
2.5.1. Systolic function
M-mode echocardiography was performed from the parasternal long axis 
view. On the M-mode echocardiography, the left ventricular (LV) fractional 
shortening (FS) was calculated from the LV end diastolic volume (LVEDV) 
and the LV end systolic volume (LVESV). The FS is 100 X (LVEDV- 
LVESV)/LVEDV
2.5.2. Diastolic function
Left ventricular diastolic function was estimated from the mitral inflow signal 
obtained by Doppler echocardiography. Transmitral flow velocity patterns 
were recorded from the apical 4-chamber view, with the pulsed doppler 
sample volume being positioned between the tips of the mitral valve 
leaflets. The early peak flow velocity (E) and atrial peak flow velocity (A)
were measured and the E/A ratio calculated.
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Tissue Doppler imaging (TDI) was obtained from an apical 4-chamber view 
to obtain longitudinal annular velocities at the lateral mitral wall annulus, 
adjacent to the atrioventricular valve hinge point. The maximal velocities of 
the E, A and S waves were recorded as was the E/Ea ratio. The E/Ea ratio 
was determined by dividing the peak E velocity from TDI imaging by the 
peak E wave measured by pulsed doppler readings of transmitral flow 
velocity patterns.
2.5.3. Global function
TheTei index, defined as the sum of isovolumic contraction and relaxation 
times divided by LV ejection time, was calculated via pulsed wave doppler 
and TDI for assessment of global systolic and diastolic left ventricular 
function.
2.6 Statistical Methods
Parametric tests were used if data followed a normal distribution when 
plotted as a histogram. Where data did not follow a normal distribution 
when plotted as a histogram, non-parametric tests were used. Standard 
statistical tests were used to calculate descriptive results of continuous data 
which were expressed as mean and standard deviation or median, 
interquartile range and range. Mann-Whitney U test or the t-test was used 
to determine rank, and Spearman’s correlation coefficient was used for 
correlations. A p value of less than 0.05 was considered significant. The 
Bonferroni correction was not utilised for correction of multiple testing on 
the advice of statistical support. Receiver operator characteristic curves 
were used to assess diagnostic test performance characteristics. Multiple
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logistic regression was used to account for confounding variables. 
Statistical analysis was performed using Statistical Package for Social 
Sciences (SPSS) for Windows, version 14.0, R (www.r-proiect.orcO. Excel 
with Analyse-it and Stats Direct software.
Longitudinal data analysis was performed by Gerwyn Green and Peter 
Diggle at the University of Lancaster. A joint model is postulated for a 
microcirculatory variable and another variable associating the two 
procedures via a correlated residual error structure using ‘R’ (www.r- 
proiect.orcO. As missing data was at random, the missingness can be 
ignored in the formulation of the likelihood.
A summary of which participants were included in each of the different
studies is in Table 2.4
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MCD ventilated MCD non 
ventilated
Presumed
Viral
Control 
(blood only)
Cardiac
control
Awake
control
Anaesthetised
control
Total
inter 3.
gnostic efficacy of
vated Partial
omboplastin Time
IT) waveform and
cafcitonin analysis in
diatric meningococcal
sis
15 9 12 20 0 0 0 56
joter 4.
! microcirculation in
mal children using
e Stream Dark Field
iging
0 0 0 0 0 20 20 40
aoter 5.
s Microcirculation in
lingococcal Disease
20 13 10 23 10 20 20 116
aoter 6.
ioactive mediators and
microcirculation in
ningococcal disease
20 13 10 23 0 0 0 66
aoter 7.
diac function in
ningococcai disease
20 (19 with 
longitudinal 
echocardiograohy)
13 10 23 0 0 0 66
Table 2.4, Details of included participants in each study. Due to amount of blood 
sample left from certain children after analysis or the method of sample collection or 
due to technical difficulties, not all of the children that were recruited are included in 
each study.
Chapter 3
Diagnostic efficacy of Activated Partial Thromboplastin Time (aPTT) 
waveform and Procalcitonin analysis in paediatric meningococcal
sepsis
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3.1 Introduction
Severe sepsis is a major cause of childhood morbidity and mortality and 
accounts for more than 10% of deaths in children aged 4 years or younger 
in the UK (Bryce, Boschi-Pinto et al. 2005; Hart and Thomson 2006). 
Meningococcal septicaemia is a rapidly progressive life-threatening 
infection and remains the most common cause of infection-related deaths 
in children (Heyderman, Ben-Shlomo et al. 2004). Early recognition and 
appropriate antibiotic treatment can significantly reduce the morbidity and 
mortality associated with MCD but diagnosis can be difficult in its early 
stages. One of the characteristic signs of MCD is a spreading petechial or 
non-blanching rash but 15% of cases can present with a blanching, 
maculopapular rash (Marzouk, Thomson et al. 1991). Paediatricians are 
often concerned that children who present with a non-blanching rash may 
have MCD, although 90% do not (Wells, Smith et al. 2001; Klinkhammer 
and Colletti 2008). The relatively well child who presents with fever and a 
rash can therefore be a diagnostic dilemma for the clinician. These children 
may be commenced on antibiotic therapy pending the definitive 
confirmation of MCD by blood culture or PCR. Biomarkers of sepsis, such 
as PCT, could be useful in this context, and PCT has been found to be 
sensitive and specific for MCD in children presenting with a fever and a 
rash (Carrol, Newland et al. 2002; Carrol, Newland et al. 2005). However 
this test is expensive and not widely available in the UK.
Over the past decade, there has been increasing interest in the biphasic 
waveform (BPW) abnormality of the aPTT assay as an early marker of 
sepsis and DIG in adults (Downey, Kazmi et al. 1997; Downey, Kazmi et al. 
1998; Fernandes and Giles 2003). The aPTT is a routinely performed test
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of intrinsic coagulation and its waveform is the optical profile generated 
from changes in light transmittance during the process of dot formation 
(Downey, Kazmi et al. 1997). The aPTT BPW, caused by immediate falls in 
light transmittance upon plasma recalcification, has been shown to be a 
sensitive indicator of sepsis and DIG in several studies in adults (Smith, 
Charles et al. 2004; Chopin, Floccard et ah 2006; Matsumoto, Wada et al. 
2006; Hussain, Hodson et al. 2008; Mair, Dunhill et al. 2008; Zakariah, 
Cozzi et al. 2008). Its diagnostic utility is independent of the aPTT clot time 
and the mechanism is mediated by complexes between CRP and very low 
density lipoprotein (VLDL) (Toh, Samis et al. 2002) induced by calcium 
within the aPTT reagent. These macroscopic complexes increase plasma 
turbidity to alter light transmittance when measured on the automated 
coagulation analyser, the MDA II. The aPTT BPW has been shown to be 
more accurate than either of its components; i.e. CRP and VLDL, for 
identifying adult patients with severe sepsis and septic shock (Chopin, 
Floccard et al. 2006).
Although PCT has been studied in children and neonates (Gendrel, Assicot 
et ah 1996; Carrol, Newland et al. 2002; Van der Kaay, De Kleijn et al. 
2002; Carrol, Newland et al. 2005) the aPTT waveform has not. Severe 
sepsis differs markedly between children and adults (Carcillo and Fields 
2002; Dellinger, Levy et al. 2008). Many adults have underlying co­
morbidities and there is a significantly higher mortality in adult sepsis 
(Carcillo and Fields 2002; Levy, Fink et al. 2003; Watson, Carcillo et al. 
2003; Dombrovskiy, Martin et al. 2007). The aim of this study is to 
determine whether an abnormal aPTT waveform is present in children with 
MCD and whether aPTT waveform analysis can distinguish children with 
presumed viral illnesses from those with MCD.
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3.2 Subjects and Methods
Patient recruitment, data collection, and blood sampling were carried out as 
detailed in Chapter 2. The aPTT waveform analysis and PCT were 
prospectively evaluated in all patients following informed consent. 
Clinicians performing the daily clinical assessment were blinded to the 
results of PCT and aPTT waveform analysis. Laboratory staff performing 
PCT and aPTT waveform analyses were blinded to the clinical information. 
Admission levels of PC, AT III, white cell count (WCC), platelet count, 
lactate and CRP were also determined. Analysis of the aPTT waveform, 
PC and AT III were possible whenever a coagulation specimen was taken 
for clinical purposes as it was retrieved from the Haematology laboratory at 
AH. However, PCT samples were only taken on admission and at 6, 12, 24 
and 72 hours post admission.
3.2.1 aPTT waveform and PCT analysis
For aPTT waveform analysis, PC and AT III estimation, plasma was 
derived from blood collected in 0.105 M trisodium citrate at a ratio of 1 part 
anticoagulant to 9 parts whole blood, which was separated within 30 
minutes and the plasma frozen at -70°C until analysed. The aPTT, including 
waveform analysis, was determined on the automated MDA II (Trinity 
Biotech, Ireland) analyzer using Platelin LS, as described in detail 
elsewhere (Downey, Kazmi et al. 1997; Downey, Kazmi et al. 1998). The 
MDA II uses a photo-optical detection system and quantifies changes in 
light transmittance at 580nm following plasma recalcification. Normal and 
biphasic aPTT waveforms are illustrated in Figure 1. To quantitate the 
waveform, light transmittance at time 0 is set at 100% and the value 
recorded 18 seconds later (TL18). This is then taken as the quantitative
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index of the abnormality, as previously described (Toh, Ticknor et ai. 2003). 
PC and AT III were quantified using chromogenic assays (bioMerieux, 
France) on the MDA II.
PCT was measured in plasma using an automated immunofluorescent 
assay using the BRAHMS PCT sensitive KRYPTOR kit designed for the 
BRAHMS KRYPTOR machine was utilised, according to the manufacturer’s 
instructions. The intra-assay coefficient of variation of the assay was <5% 
for values over 0.3 ng/ml and 10% for those around 0.2ng/ml.
3.2.2 Full blood count and CRP analysis
Full blood count and CRP analysis was performed as part of routine 
management. Whole blood was taken into EDTA for full blood count 
measurements on the Sysmex SE 9500 analyser (Global Medical 
Instrumentation Inc., Minnesota, USA). Whole blood was taken into a 
lithium heparin bottle for CRP estimation and analysed on the automated 
Architect cSOOO (Abbott Diagnostics, Illinois, USA) according to the
manufacturer’s instructions.
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Figure 3.1. Normal and Biphasic waveform profiles
A - Normal aPTT waveform. The first phase is a plateau that shows 100% 
transmittance. Once clot forms, light transmittance abruptly decreases. The 
number of seconds until the drop in light transmittance is the aPTT clot-time 
in seconds.
B - Biphasic aPTT waveform. There is decreasing light transmittance prior 
to clot formation.
Dashed lines denote the transmittance level at 18 s (TL18) as the 
quantitative index (In (A), TL18=100 and in (B), TL18=63).
Clot times (in seconds) are signified by arrows.
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3.2.3 Statistical analysis
Statistical differences between diagnostic groups were evaluated by 
Independent t-test or the Mann-Whitney U test depending on the 
distribution of data following evaluation of it from histograms. Correlations 
between the continuous variables were determined using Spearman’s 
correlation coefficient. Values for sensitivity, specificity, positive and 
negative predictive values (PPV and NPV) of aPTT BPW presence, PCI 
and CRP concentration for the diagnosis of sepsis were derived from a two- 
by-two table. Receiver operator characteristic (ROC) plots were used to 
calculate the area under the curve (AUC) to compare the performance of 
aPTT waveform analysis, PCI and CRP in detecting MCD. Statistical 
analyses were carried out using SPSS for Windows (version 14.0), R 
(www.r-project.org) and StatsDirect software. Logistic regression analysis 
was performed with binary values for PICU admission to examine for 
relationships with variables that may contribute to predicting the need for 
PICU admission. This analysis was carried out by the Medical Statistics 
Department at the University of Lancaster.
3.3 Results
Fifty six children were included in the study. Thirty six children were 
admitted with fever and a rash and there were 20 healthy control children. 
The median age for the children with fever and rash was 2.16 years [IQR 
0.89 - 4.53] and there were 13 males (33%). Twenty four of the 36 children 
(64%) had proven MCD whilst the other 12 (36%) had a presumed viral 
illness . Of the 24 children with MCD, 15 (71%) required PICU support. All 
the children survived but one required a limb amputation. The duration of 
hospital stay ranged from 1 to 30 days with a median of 5.5 days [IQR 3 to 
8 days]. Characteristics of the participants are shown in Table 3.1. Normal
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range determination on 20 healthy children attending for dental procedures 
under general anaesthetic showed a mean plasma TL18 value of 99.6% 
(99.0%-100.1%), with a mean coefficient of variation of 0.004%. The 
plasma PCT levels in these children were all found to be < 0.2 ng/ml.
3.3.1 Test performance in the diagnostic groups
There was a significant difference in aPTT TL18 between MCD patients 
and those with presumed viral illnesses (p<0.001) and controls (p<0.0005). 
There was no significant difference between children with a presumed viral 
illness and controls, p = 0.14 (Figure 3.2). There was also a significant 
difference in aPTT TL18 and PCT between children who required 
ventilation and those who did not (p<0.0001) as well as children with MCD 
presenting in septic shock and those who did not (p<0.0001). With regard 
to PC and ATI!I, there was a significant difference between the MCD group 
and both the presumed viral illness and control groups (p<0.05). Whilst 
there was a significant difference in ATIII between those children with MCD 
who required ventilation and those who did not (p<0.05)( no significance 
was seen with PC (p=0.06).
A significant inverse correlation was found between aPTT TL18 and PCT 
and length of PICU stay overall length of hospital stay, total duration of 
ventilation, time on inotropic support and resuscitation volume as well as 
CRP, PELOD, Maximum GMSPS and PRISM III scores. There was no 
correlation between TL18 and WCC and lactate. There was a positive 
correlation between PCT and lactate (Table 3.2).
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All MCD MCD
ventilated
MCD not 
ventilated
Presumed
viral
Control
otal number 24 15 9 12 20
ge at 2.98 2.16 3.96 1.58 2.16
dmission in 
ears [IQR]
[1.08 to 4.42] [0.69 to 4.75] [1.02 to 5.37] [0.67 to 2.5] [0.69 to 4.75]
ex 9 5 4 3 9
nale %] [39.1%] [33.3%] [44.4%] [25.0%] [45%]
aximum
MSPS
QR]
8
[3 to 12]
11
[9 to 12]
3
[2 to 3]
3
[2 to 3]
PIT TL18 (%) 93.8 91.9 98.0 99.4 99.7
QR]
lormal range 
98%)
[90.4 to 98.0] [90.1 to 95.7] [94.7 to 99.0] [99.3 to 99.9] [99.4 to 99.5]
CT (ng/ml) 61.8 169.5 23.5 0.1 0.04
QR]
lormal range 
5ng/ml)
[29.8 to 267.6] [47.5 to 371.9 [5.8 to 41.2] [0.2 to 0.4] [0.02 to 0.06]
RP (mg/I)
QR]
lormal range 
4mg/l)
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[70 to 174.6]
142.5
[107 to 200]
75.8
[50.8 to 122.4]
10.4
[4 to 37.1]
All <4
(CC(x106/l)
QR]
lormal range 
3-10.8 xWH)
21.3
[13.6 to 26.2]
20.7
[5.8 to 25.3]
23.7
[15.8 to 30.2]
15.9
[9.9 to 19.8]
latelet count 
k109/I)
QR]
tormal range
50 to 400
109/l)
226
[134 to 367]
182
[120 to 248]
322
[241 to 429]
301
[264 to 416]
rotein C 28.3 25.9 47.5 66.1 92.6
'o)[IQR] 
tormal range 
30%)
[21.4 to 41.3] [19.1 to 29.9] [29.5 to 67.5] [50.0 to 76.8] [84.1 to 104.7]
ntithrombin 55.8 51.6 91.9 101.8 109
(%)[IQR] 
tormal range 
30%)
[51.5 to 76.1] [46.9 to 54.8] [72.1 to 106.8] [80.3 to 114.6] [101.6 to 
114.9]
Table 3.1. Characteristics of included participants (results expressed as 
median IQR])
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p>0.05
Control MCD MCD Viral
Vent No Vent
Diagnostic group
Figure 3.2. Bar chart representing differences in aPTT waveforms, as 
quantified by the light transmittance level at 18 seconds (TL18) between 
the diagnostic groups. * p<0.05
MCD vent = Children with MCD who required ventilation; MCD No Vent = 
Children with MCD who did not require ventilation.
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Characteristics Admission aPTT TL18 Admission PCT
R P value R P value
Duration of Hospital Stay
(days)
-0.61 <0.0001 0.83 <0.0001
Duration of PICU stay (days) -0.65 <0.0001 0.8 <0.0001
Duration of ventilatory
requirement (hours)
-0.66 <0.0001 0.8 <0.0001
Duration of inotropic
requirement (hours)
-0.63 <0.0001 0.83 <0.0001
Resuscitation Volume (ml/kg) -0.78 <0.0001 0.79 <0.0001
CRP -0.7 < 0.0001 0.54 <0.005
White Cell Count -0.05 0.75 0.12 0.95
Lactate 0.16 0.53 0.68 <0.005
Maximum GMSPS -0.68 <0.0001 0.8 <0.0001
PRISM III -0.73 <0.0001 0.73 <0.0001
PELOD -0.68 <0.001 0.73 <0.0001
Table 3.2. Correlation between aPTT TL18 and PCT at admission and clinical and 
laboratory variables (r=Spearman Rank Correlation)
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False positive rate (1 - Specificity)
No discrimination
—a—pct
—o--- a pit waveform 
(TL18)
— a- - CRP
Figure 3.3. Receiver Operator Characteristic Curve for aPTT waveform 
TL18, PCT and CRP for detecting MCD at hospital admission.
AUC: PCT 0.99, TL18 0.96, CRP 0.91.
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In order to determine the discriminatory value of aPTT waveform, PCI and 
CRP levels for detecting MCD, a ROC curve of admission values was 
constructed {Figure 3.3). The optimum cut-off value of TL18 selected for 
detection of invasive meningococcal infection was 99.2%. This is 
equivalent to a slope 1 level of -0.08, another quantitative measure of the 
aPTT BPW that has been reported by others. Using this value, a BPW was 
present in 23 out of the 36 patients (64%) at the time of admission. Twenty 
two patients with a diagnosis of MCD had a TL18 below 99.2%; 
representing 96% of the total number of children diagnosed with MCD. 
One child with a diagnosis of MCD had a TL18 above 99.2% (99.81%) and 
one had a TL18 of exactly 99.2%. Neither child required mechanical 
ventilation and their length of hospital stays were 5 and 3 days, 
respectively. Neither had received intramuscular benzyl penicillin or any 
other antibiotic prior to hospital admission and GMSPS were 2 and 3 
respectively, indicating that they were at the less severe end of the MCD 
spectrum. Their PCT values were 32.6 ng/ml and 31.42 ng/ml respectively. 
One child who did not have a positive microbiological diagnosis had a BPW 
with a TL18 of 98.4%. This child’s admission CRP was 115mg/L and PCT 
was 0.02 ng/ml. Blood and throat cultures and PCR for Neisseria 
meningitidis, Haemophilus influenzae b and Streptococcus pneumoniae 
were negative. This child received 5 days of intravenous antibiotics. 
However there was no eventual confirmed diagnosis. The diagnosis in this 
child was that of a self-limiting illness. Virology investigations were 
negative. Two children were positive for HHV7, both had normal aPTT 
waveforms, PCT and CRP.
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The sensitivity and specificity for detecting MCD using aPTT TL18 were 
0.91 and 0.92 respectively with a NPV of 0.87 (Table 3.3). Table 3.3 
shows the comparative values for PCT and CRP. The cut-off value of PCT 
for a diagnosis of MCD using the ROC curve for this cohort was £11.5 
ng/ml. Using this threshold value, 23 patients had an abnormal PCT 
concentration on admission. Of these, 22 patients (96%) had a diagnosis 
of MCD. This gave a sensitivity of 0.96 and specificity of 1, with a NPV of 
0.92 (Table 3.3). if a cut-off value of <0.5ng/ml were used as in previous 
studies (Harbarth, Holeckova et al. 2001; Bugden, Coles et al. 2004), the 
result would be an increased sensitivity but reduced specificity (Table 3). 
Combining both the presence of a BPW and an abnormal PCT (defined as 
<0.5 ng/ml) minimally affected sensitivity and specificity.
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aPTT TL18 
(cut off 
99.2%)
PCT 
(cut off 
11.5ng/ml)
PCT 
(cut off 
0.5ng/ml)
CRP 
(cut off 
10g/dl)
a PIT TL18 
(cut off 99%) 
and PCT(cut 
off 0.5ng/ml)
AUC 
(95% Cl)
0.96
(0.31 to 1)
0.99
(0.8 to 1)
0.91
(0.82 to 0.99)
Sensitivity 
(95% Cl)
0.91
(0.72 to 0.99)
0.96
(0.78 to 0.99)
1
(0.86 to 1)
0.87
(0.66 to 0.97)
0.96
(0.85 to 0.99)
Specificity 
(95% Cl)
0.92
(0.64 to 1)
1
(0.73 to 1)
0.83
(0.52 to 0.98)
0.85
(0.55 to 0.98)
0.79
(0.58 to 0.93)
Positive 
predictive 
value 
(95% Cl)
1 (0.84 to 1) 1
(0.85 to 1)
0.92
(0.75 to 0.99)
0.91
(0.72 to 0.95)
0.9
(0.78 to 0.97)
Negative 
predictive 
value 
(95% Cl)
0.87
(0.6 to 0.98)
0.92
(0.64 to 0.99)
1
(0.69 to 1.0)
0.79
(0.49 to 0.95)
0.9
(0.69 to 0.99)
Likelihood 
ratio for 
positive 
test
(95% Cl]
3
(1.6 to 7.09)
Infinity 
(3.94 to 
infinity)
6
(2.18 to 20.9)
5.25 4.6
(2.36 to 10.38)
Likelihood 
ratio for 
negative 
test
(95% Cl)
0 0.04
(0 to 0.2)
0
(0 to 0.17)
0.15 0.05
(0.01 to 0.18)
Table 3.3. Performance characteristics of variables for detecting meningococcal disease 
in children presenting with a fever and a non-blanching rash.
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3.3.2 Probability of admission to PICU
Logistic regression analysis was undertaken to examine the relationship 
between PICU admission and aPTT TL18 with binary values for admission 
to PICU. Testing the null hypothesis of no association between the logit of 
requiring intensive care and aPTT TL18 gave a p-value of <0.01. Figure 3.4 
shows a 95% confidence band for the probability of a child being admitted 
to PICU given their TL18 value. This shows that the lower the admission 
aPTT TL18 (the more severe the BPW) the higher the probability of 
needing intensive care support.
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Figure 3.4. Pointwise 95% confidence band for the probability of a child 
requiring admission to PICU given their aPTT TL18 measurement.
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3.3.3 Serial monitoring
Figure 3.5 shows the serial aPTT TL18 changes in a 2 year old girl who 
was admitted to PICU with severe MOD. Admission GMSPS was 12, 
PRISM III was 22 and PELOD was 23, indicating a severe disease process 
with a high probability of mortality. She required inotropic support and 
haemodialysis due to renal failure. Widespread purpura fulminans 
developed within 24 hours and it was evident that she would have limb and 
tissue loss in the event of survival. The aPTT waveform was abnormal on 
admission (TL18=96.3%) and this progressively decreased until day 5 
(TL18=76.5%), whilst she remained in a critical state. After day 5, her 
ventilatory requirements began to fall and she was extubated on day 7. 
Improvement in the aPTT TL18 correlated with this progress. She required 
haemofiltration until day 13 and a left sided below knee amputation was 
carried out on day 14 due to dry gangrene. Following this, her clinical 
picture remained poor and her abnormal aPTT TL18s continued until day 
20. At this point she had to return to theatre for tissue debridement and a 
further skin graft. Subsequently she improved and was discharged home 
after a total hospital stay of 30 days. Her aPTT TL18 levels normalised from 
day 23 onwards. Her PCT values at admission and 6, 12, 24 and 72 hours 
post admission are shown in Figure 3.5. Serial PC and AT values over the 
same time frame are shown in Figure 3.6.
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Figure 3.5. Serial aPTT waveform changes as quantified by light 
transmittance levels at 18 seconds (TL18) on a child with severe MCD who 
required a below knee amputation.
Procalcitonin values: a=254.8 ng/ml at admission, b=914.8 ng/ml at 12 
hours, c=2584 ng/ml at 24 hours and d=985.3 ng/ml at 72 hours post
admission.
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Figure 3.6. Serial levels of protein C (normal range 70-130%) and 
antithrombin III (normal range 80-130%) in a child with severe MCD who 
had a below knee amputation on day 14.
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3.4 Discussion
This is the first study exploring aPTT waveform analysis in children with 
sepsis. We demonstrate that the aPTT waveform is abnormal in children 
with MCD, which is an example of serious bacterial sepsis. As has been 
shown in adults, aPTT waveform analysis could be a novel method for 
detecting sepsis in children. The presence of a biphasic aPTT waveform 
in the initial investigation of a child presenting with a fever and a spreading, 
non-blanching or petechial rash has a high sensitivity and specificity for the 
diagnosis of MCD at a level that is similar to PCT. Furthermore, the strong 
correlation between the extent of waveform abnormality and the likelihood 
of PICU admission indicates that the aPTT waveform analysis could be a 
useful adjunctive tool to identify children with MCD who are stable at 
admission but may deteriorate whilst on the ward and eventually require 
PICU support. This is in keeping with findings in adult studies (Smith, 
Charles et al. 2004; Hussain, Hodson et al. 2008; Mair, Dunhill et al. 2008), 
which have additionally highlighted the strong association of the BPW with 
mortality (Toh, Ticknor et al. 2003). We were unable to demonstrate this in 
children as there were fortunately no deaths in our study population.
In a disease with a rapidly progressive clinical course such as severe 
MCD (Thorburn and Baines 2002), it is important that diagnostic tests are 
not only accurate but also simple, rapid and inexpensive to perform. As 
waveform analysis is an adjunct to a standard test of coagulation, the aPTT 
test, it offers considerable practical advantage. Furthermore, studies in 
adult patients have demonstrated its ability to identify sepsis early in its 
clinical course. Zakariah et al reported that in 72% of patients, a BPW was 
present one day before or at the time of diagnosing sepsis (Zakariah, Cozzi 
et al. 2008) and Toh et al found that in 34% of 336 septic patients, the BPW
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preceded diagnosis by 18 hours (Toh, Ticknor et al. 2003). As early 
detection followed by prompt treatment of sepsis can significantly improve 
outcome, this could be important. Implicit in the translational value of any 
laboratory marker in sepsis is the ability to monitor response to treatment. 
The degree of aPTT waveform abnormality appears to correlate closely 
with the clinical condition in Figure 3.5. Even after amputation, the 
presence of the abnormal waveform appeared to be a harbinger of the 
need for further clinical intervention. Subsequent return to theatre for 
debridement of the amputation stump ultimately led to clinical recovery and 
normalisation of the aPTT waveform. This is a single case illustration and 
use of the aPTT waveform for clinical monitoring requires further testing. 
The changes in TL18 in this child may reflect changes in the underlying 
molecular mechanism, which is a calcium-dependent complex between 
CRP and VLDL. This complex has been identified in vivo in patients with 
sepsis (Toh, Samis et al. 2002) and whilst its pathogenic relevance remains 
to be fully elucidated, there is evidence of its ability to significantly enhance 
thrombin pro-coagulant activity (Dennis, Downey et al. 2004). The BPW 
provides a better predictor of sepsis than CRP alone, confirming findings in 
adult patients (Toh, Ticknor et al. 2003; Chopin, Floccard et al. 2006).
In this study, we also reconfirm the value of PCT as a useful diagnostic 
marker in MCD (Carrol, Newland et al. 2002; Leclerc, Leteurtre et al. 2002; 
Carrol, Newland et al. 2005; Casado-Flores, Blanco-Quiros et al. 2006; 
Mills, Lala et al. 2006). PCT is not commonly used as a diagnostic test in 
the UK as it is expensive and requires purchase of an additional analyser. 
A combination of PCT and the aPTT waveform analysis has increased 
specificity for the identification of sepsis in critically ill adults (Zakariah, 
Cozzi et al. 2008). This was not demonstrated here, possibly due to the
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sample size. A clear correlation between PCI changes and clinical events 
has yet to been demonstrated, although the mortality rate and multi-organ 
failure in adults on ICU has been shown to increase markedly when the 
PCT level increased day-to-day (Giamarellos-Bourboulis, Mega et al. 2002; 
Jensen, Hesiet et al. 2006). Most studies have concentrated on admission 
PCT levels for detecting sepsis in cohorts with known morbidities (Uzzan, 
Cohen et al. 2006; Jensen, Lundgren et al. 2007). In some non-survivors, 
PCT levels may actually decrease as the disease worsens (Claeys, Vinken 
et al. 2002; Gibot, Cravoisy et al. 2005).
The very high negative predictive values of the aPTT BPW and PCT for 
MCD, mean that they could be useful in ruling out sepsis in children 
presenting with fever and a spreading petechial rash or mixed spreading 
petechial and blanching rash. These children are often given parenteral 
antibiotics until meningococcal infection can be excluded. A diagnostic test 
that could reliably exclude serious bacterial infection could reduce hospital 
admissions and the associated clinical as well as financial costs of 
unnecessary antibiotic use. The aPTT waveform analysis could also be of 
use within the community for early detection of infection. However 
practically this would be difficult in terms of blood collection and processing 
and children may well be referred to hospital anyway due to their 
symptoms.
Our study has a number of limitations. It included only a small number of 
children and those with MCD mostly required PICU intervention. Although 
we only studied children with MCD, it is an excellent paradigm of sepsis as 
it is a clearly defined disease entity caused by a single organism. The 
samples that were taken on admission to PICU may not be representative
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of all admissions to the A&E department due to the different stages in the 
disease process at presentation. Before recommending aPTT waveform 
analysis as a screening tool studies of its relevance for sepsis detection in 
an A&E setting are required. Additionally, the aPTT waveform requires 
further study across the whole spectrum of childhood sepsis caused by 
other pathogens and alternative reasons for admission to PICU. Finally, 
whilst the aPTT waveform can be determined at no additional cost as part 
of the aPTT clot-time measurement, its availability requires the MDA ii 
analyser.
3.5 Conclusion
This study supports the value of aPTT waveform analysis and PCT as a 
simple, rapid and robust diagnostic marker of meningococcal sepsis. The 
BPW test has translational potential to facilitate prompt diagnosis and allow 
real-time monitoring of the patient.
Chapter 4
The microcirculation in normal children using 
Side Stream Dark Field Imaging
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4.1 Introduction
Clinicians have been unable to directly assess the microcirculation until 
relatively recently. It is now possible with Orthogonal polarisational spectral 
imaging (OPS) and Sidestream darkfield imaging (SDF) technology (Figure 
4.1). OPS was the first to be invented and was produced by Cytometrics 
(Philadelphia, United States of America). The instrument was called the 
CYTOSCAN™. The same company patented the HEMOSCAN™ which 
again used OPS technology but also incorporated a complex algorithmic 
analysis of the images produced. This enabled this particular device to 
calculate systemic haemoglobin concentrations. The purpose was to 
estimate a full blood count without the removal of blood from a patient 
(Nadeau 2000). The Cytoscan II was also produced but production ceased 
in 2003 when the company was sold to Rheologies Incorporated 
(Pennsylvania, United States of America) who discontinued production of 
both instruments.
These devices had been validated previously, mainly in comparison with 
‘gold standard’ devices such as intravital microscopy. They had also been 
used for the examination of the microcirculation in different structures such 
as the colon, pancreas and tumour surfaces in animals (Groner, Winkelman 
et al. 1999; Harris, Sinitsina et al. 2000; Biberthaler, Langer et al. 2001; 
Langer, Biberthaler et al. 2001; Langer, Harris et al. 2001; Harris, Sinitsina 
et al. 2002; Langer, Born et al. 2002; Pahernik, Harris et al. 2002; von 
Dobschuetz, Biberthaler et al. 2003; Heger M 2005). There were also 
validation studies in humans (Mathura, Vollebregt et al. 2001)
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These earlier devices were followed by the development of the Microscan™ 
by Microvision Medical (Amsterdam, Holland), This instrument uses SDF 
technology and provides real-time video images of the microcirculation 
using a 5x objective giving a screen magnification of x 326 (Ince 2005). It 
uses light emitting diodes instead of polarised light at a wavelength of 
530nm which is absorbed by red cells. A comparison of SDF and OPS, for 
the validation of SDF, showed that SDF is superior for visualising the 
microcirculation producing clear and easy to analyse images (Goedhart 
2007).
4.1.1 Outcome measures from microcirculation images 
Image attainment using OPS and SDF imaging gives a video recording of 
real time capillary and venular blood flow. For valid outcome 
measurements to be made from these recordings a robust process of 
image analysis must be developed. This process should be repeatable, 
easy to learn and carry out and quick to perform.
There are no fully automated computer software methods for analyzing the 
video images. Outcome measure methods have been developed and 
validated in adult studies by two independent groups. The group of De 
Backer, based in Brussels, developed a semi-quantitative analysis of OPS 
images. Three equidistant horizontal and three equidistant vertical lines 
were superimposed upon the moving image (De Backer, Creteur et al. 
2002). The vascular density of the area of tissue being observed could then 
be calculated as vessels per millimetre by counting the number of vessels 
crossing the lines. Flow categories were also assigned to each vessel type 
and from this measurements of capillary density (CD), the percentage of 
perfused vessels (PPV) and perfused vessel density (PVD) were
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calculated/derived. This method has is very time consuming and has an 
element of subjectivity in the assignment of flow categories.
Boerma and colleagues in Holland developed an alternative method of 
analysis, the Microvascular Flow Index (MFI) (Boerma, Mathura et al. 
2005). This is a semi-quantitative analysis in which the video image is 
divided into four quadrants and assigned flow categories per vessel 
diameter for the majority of vessels in the video sequence. The MFI can be 
calculated quickly and it is a much faster analysis that the method of De 
Backer et al. However it does not take into account functional capillary 
density and so misses a large amount of information that can be obtained 
from microcirculatory images.
De Backer's group developed software (Microvision Analysis Software, 
Microvision Medical, Amsterdam, Netherlands) that attempts to produce a 
more quantitative analysis of OPS and SDF derived flow images. This 
software has been designed for stabilisation of the image, vessel size 
identification and blood flow velocity determination which is carried out by 
constructing space-time diagrams from the centreline intensity of vessels in 
subsequent video frames. It allows the user to derive duration, width and 
blood velocity of individual vessel segments, so creating a detailed report of 
vascular variables. However this software is not user friendly, is time 
consuming and still involves a significant amount of user manipulation of 
the images. As it is not a fully automated process error can be introduced 
and there is no ‘normal’ data that has been produced from its use.
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Figure 4.1. A; Schematic to illustrate OPS imaging. B; Schematic to illustrate SDF imaging
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De Backer’s group have also developed a heterogeneity score of 
microvascular blood flow (De Backer, Creteur et al. 2002). Five areas of 
sublingual tissue are visualised. Between the five areas, the coefficient of 
variation of blood flow is calculated as the standard deviation of the five 
values of blood flow divided by their mean value. A heterogeneity index 
(HI) has also been used by an American group led by Trzeciak (Trzeciak, 
Dellinger et al. 2007). Five images are taken at the same time point and 
the lowest site flow velocity score is subtracted from the highest site flow 
velocity score. This value is then divided by the mean of the flow velocity 
scores of all of the sublingual sites. The higher the value the more 
heterogeneous the blood flow is between the images.
Trzeciak’s group was the first to incorporate all of the microvascular 
analysis methods in their study of septic adults. This led to a round table 
conference and a consensus statement advising that all of the methods 
described be used in the assessment of the microcirculation using OPS 
and SDF (De Backer, Hollenberg et al. 2007).
4.1.2 Histology and anatomy of the tongue
OPS and SDF imaging is undertaken by placing the probe sublingually. 
Although this is for convenience there are other reasons why this is 
appropriate. The tongue begins to form at approximately the same time as 
the palate and is mainly composed of skeletal muscle. The tongue extends 
past the posterior border of the mouth and travels into the oropharynx. The 
lingual artery, a branch of the external carotid artery, gives the blood supply 
to the tongue and the floor of the mouth. Blood supply to the tongue also 
comes from the tonsillar branch of the facial artery and the ascending
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pharyngeal artery (Snell 2003; Alan Stevens 2004). The sublingual area 
shares its’ embryological origin with the splachnic mucosa (Alan Stevens 
2004). Splachnic hypoperfusion is known to be an early indicator of 
systemic hypoperfusion (Povoas, Weil et al. 2001). Additionally the 
sublingual region of the oral mucosa is very thin which is why it is an ideal 
place for OPS images to be taken.
One previous study has used OPS imaging in children with sepsis. No 
normal control data was reported in this study (Top, Ince et al.). There 
have been no reported studies using SDF in the assessment of 
microcirculatory flow in children. No data therefore exists regarding 
microcirculatory variables in a paediatric population. This chapter 
examines the use of SDF imaging in normal, healthy children and reports 
the microcirculatory outcome measures found.
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4.2 Materials and Methods
4.2.1 Patients recruited
Two groups of children were eligible for inclusion in the study. The first 
group were children under the age of 6 yrs attending AH for routine surgery 
of a non-infective pathology, during a 12 month period. The second group 
were children over the age of 6 who were selected from a cohort of well 
children of colleagues from AH. All children had weight, blood pressure, 
heart rate, respiratory rate measured. Surface area was calculated from the 
weight as height was not always possible to measure (Sharkey, Boddy et 
al. 2001). Haematocrit was measured in anaesthetised patients on an 
arterial blood gas prior to SDF image acquisition.
4.2.2 Microcirculation visualisation
Microcirculatory real-time images were obtained in children under the age 
of 6 years once they had been anaesthetised. Children were anaesthetized 
using isoflurane, remifentanyl and propofol. Secretions were initially 
removed using gauze if necessary. The SDF images were obtained 
sublingually using the MicroScan™. The probe of the MicroScan™ was 
covered with a sterilized disposable cap to prevent direct contact between 
the instrument and the patient, and a different cap was used for each 
patient. The covered probe was placed under the tongue and manoeuvred 
until the microcirculation was visible. The MicroScan™ was then focused 
to give a clear image. In order to minimise the effect of pressure, once an 
adequate view of the microcirculation had been achieved the probe was 
advanced in the same area until the red cell flow was partially or completely 
occluded. The probe was then retracted from the mucosal surface until 
contact with the tissue was lost. The probe was then gently advanced to 
make contact with the mucosal surface, re-focused if necessary, and the
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image recorded. Video output was visualized on a monitor and images 
stored as described in Chapter 2.
Two different investigators obtained the images on each anesthetised child. 
At least five areas of sublingual tissue were chosen for analysis by each 
investigator and a continuous image lasting for 15-20 seconds each was 
recorded. The images were taken over a 10-15 minute period prior to the 
child’s surgery once a stable anaesthetic state was reached. The 10-15 
minute time period was adopted so that any technical difficulties (for 
example excessive saliva) could be overcome without affecting the time 
frame for preparation for surgery.
The investigator explained the principles of obtaining the images and 
minimising the effect of pressure to the group of children aged over 6.
They were then allowed to hold the MicroScan™ themselves and obtain 
images. Again, at least five tissue areas were selected by the children 
themselves under the guidance of the investigator and a continuous image 
lasting for 20 seconds was recorded.
4.2.3 SDF image analysis
Video clips were coded and then analysed by observers blinded to the 
clinical condition of the child (whether they were anaesthetised or not). 
Each video clip was analysed by two observers independently, off line to 
determine the interobserver agreement. For the intraobserver agreement 
of image analysis, video clips were duplicated, recoded and again analysed 
off line. When the two observers had analysed all images, if there was 
disagreement the images were discussed between the observers to agree
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a final consensus assessment of that particular image for use in statistical 
analysis.
The Microvision Analysis Software (MAS) software was used to stabilise 
the images prior to analysis. Where movement within the image was 
excessive and MAS could not stabilise the image, a shortened loop of video 
image was used for analysis without stabilisation. The MAS software was 
also used to analyse the size of vessels so that the correct vessel diameter 
was chosen for the calculation of capillary density and the assignment of 
flow categories.
CD, PPV and PVD were calculated by applying a Perspex sheet with three 
equidistant horizontal and three equidistant vertical lines superimposed 
upon it across the video sequence displayed on the computer screen 
(Figure 4.2). The three horizontal lines represented 1 mm of tissue surface 
each, the three vertical lines represented 0.7 mm each. Capillary density 
was calculated as the number of vessels less than 20 microns in diameter 
crossing these lines divided by the total length of the lines (5.1 mm). This 
gave the number of capillaries per millimetre of tissue. Flow categories 
were then assigned to each vessel type and defined as continuous, 
intermittent (this included flow that was stopping and starting and reversed 
blood flow), or absent for more than 50% of the video sequence. The PPV 
was calculated as the number of capillaries with continuous flow divided by 
the total number of capillaries per mm. The PVD was calculated by 
multiplying the CD by the PPV and gives a representation of total functional 
vessel density. The mean of all images was used for analysis.
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The MFI was ascertained for each image by first dividing the image into 4 
quadrants using MAS. Flow scores were assigned per quadrant for each 
vessel diameter (Figure 3.3). The vessel size cut-offs were: small, less 
than 25 microns; medium, 26 to 50 microns and large, 51 to 100 microns. 
The flow categories are 0 for no flow, 1 for intermittent flow, 2 for sluggish 
flow and 3 for continuous flow. The MF! is assigned by visualisation of 
each quadrant and assigning flow categories per vessel size for the 
majority of that group of vessels. The flow category assigned per vessel 
diameter is then totalled for the 4 quadrants and divided by the number of 
quadrants in which the vessel type is present. An MFI value can be 
determined for each vessel type and for the overall image with a score in 
the range 0-3.
The HI was calculated by subtracting the lowest site flow velocity score 
from the highest site flow velocity score of all of the images taken at the 
same time point. This value was divided by the mean flow velocity 
calculated from all of the images.
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Figure 4.2. The superimposition of lines upon the SDF image to determine 
capillary density, proportion of perfused vessels and perfused vessel density in 
accordance with the scoring system by De Backer (De Backer, Creteur et al. 
2002). Taken from How to evaluate the microcirculation: report of a round table 
conference. Crit Care. 2007;11(5):R101.
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Figure 4.3. Quadrant division of an image to determine the Microvascular flow 
index (MFI) score in accordance with Boerma et al (Boerma, Mathura et al. 2005). 
Taken from: How to evaluate the microcirculation: report of a round table 
conference. Grit Care. 2007;11(5):R101.
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4.2.4 Statistical analysis
intra- and interobserver agreement was determined by Bland-Altman plots 
and the repeatability coefficient for continuous variables and by kappa (k) 
cross tables for categorical variables. These analyses were performed for 
both image attainment (obtaining the video image) and image analysis 
(analysing the video image). Statistical analyses were performed using 
Analyse-lt Software v.1.62 for Microsoft Excel (Analyse-lt Software, Leeds, 
UK) and SPSS v. 14.0 (SPSS Inc., Chicago, IL, USA). Spearman’s rank 
correlation coefficient, multiple linear regression and univariate analysis 
were used to investigate the relationship between explanatory and outcome 
variables.
4.3 Results
Forty children were studied, twenty anaesthetised children and twenty 
awake children. None of the awake children had any previous medical 
history and the anaesthetised children had no co-morbidity other than the 
condition for which they were requiring surgery. There were 10 males 
(50%) and 10 females (50%) in each group. Demographics for the groups 
are shown in Table 4.1. All of the children had normal blood pressures, 
heart rate and respiratory rate for their age. The anaesthetised children all 
had a normal haematocrit and oxygen saturation level at time of image 
acquisition.
The mean number of capillaries per millimetre of tissue was 5.59 capillaries 
for awake children (standard deviation 0.76) and 6.56 per mm of tissue for 
anaesthetised children (standard deviation 0.78). There was a significant 
difference between the two groups (p<0.01, mean difference 0.97 (Cl -1.46 
to -0.47)) Independent t-test (Figure 4.4).
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Diagnosis Age
range in 
years
Median Age 
in years [IQR]
Median 
weight in 
kilograms 
[IQR]
Median 
Surface 
area in 
meters2 
[IQR]
Diagnoses in 
anaesthetised 
patients
Total
Awake 6.5 to 16 10.7
[5.8 to 15.6]
29.6
[19.6 to 39.6]
1.05
[0.7 to 1.8]
20
Anaesthetised 0.4 to 5.9 2.5
[0.75 to 4.5]
11.5
[3.2 to 19.8]
0.5
[0.2 to 0.8]
Spinal cord 
untethering
10
Scaphocephaly
repair
4
Trigonocephaly
repair
3
Brachycephaly
repair
3
Table 4.1. Demographic data for 40 control children used 
to determine normal microcirculatory values using SDF
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Figure 4.4. Box and whisker plot demonstrating the difference in capillary 
density between awake children and anaesthetised children.
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Figure 4.5. Scatter plot demonstrating the relationship between capillary 
density and weight in all control children. Blue= anaesthetised; Red= awake 
children.
R= -0.61, p<0.0001
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There were significant correlations between capillary density and age, sex, 
weight and body surface area (Table 4.2). Step-wise multiple linear 
regression showed that only weight was an independent factor affecting 
capillary density (Table 4.3). Univariate analysis of variance accounting for 
anaesthetic agent found the relationship between weight and capillary 
densitiy remained significant (p<0.05)
As this study investigated normal microcirculation in children it was 
unsurprising that the mean MFI for all images for large and small vessels 
was 3, the highest score possible and the heterogeneity index was 0 for all 
participants. The mean PPV from all images was 1 (or 100%), however 11 
participants (28%) - 6 anaesthetised and 5 awake, had a PPV of 0.99. As 
the PVD is calculated by multiplying the CD by the PPV, the results for CD 
and PVD will be identical in this healthy population with normal 
microcirculatory blood flow. The following analysis will therefore be based 
upon CD.
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Spearman rank
correlation coefficient
P value
Table 4,2 Correlation coefficients between capillary density and weight, age and 
body surface area
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Predictor variable B
coefficient
P value 95% Cl
Weight (Kilograms) -0.61 <0.001 -0.07 to -0.03
Sex 0.03 0.83 -0.14 to 0.9
Age (years) -0.18 0.75 -0.01 to 0.12
Body surface Area 0.36 0.78 -0.05 to 0.76
Table 4.3. Multiple Linear Regression Analysis of factors 
affecting capillary density Adjusted R Square= 0.36, F=22.8, 
p<0.0001 (using stepwise model)
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4.3.1. Inter- and Intraobserver repeatability
4.3.1.1 Image attainment.
Intraobserver agreement
Observer 1 obtained at least 5 images from each of the 20 anaesthetised 
patients. The four best images were chosen for analysis. A Bland-Altman 
plot of the two pairs of images taken by observer 1 show the limits of 
agreement (Figure 4.8). The 95% confidence interval for the lower limit is - 
2.3 to -1.2 and for the upper is 1.7 to 2.8. The 95% repeatability coefficient 
was 2.8 capillaries per mm. This means that the value within which the 
differences between two images attained by observer 1 is expected to be 
2.8 capillaries per mm for 95% of subjects.
Interobserver agreement
For the 20 anaesthetised patients, four images were chosen that had each 
been obtained by observer 1 and observer 2 from each participant. A 
Bland-Altman plot of the 80 images shows the limits of agreement (Figure 
4.9). The 95% confidence interval for the lower limit was -2.3 to -1.5 and 
for the upper is 2.0 to 2.9. The 95% repeatability coefficient was 3 
capillaries per mm. This means that the value within which the differences 
between two images attained by two observers is expected to be 3 
capillaries per mm for 95% of subjects.
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Figure 4.6 Bland Altman plot for intraobserver repeatability in obtaining 
SDF images
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Figure 4.7 Bland Altman plot for interobserver repeatability in obtaining SDF
images
141
4.3.1.2 Image analysis
The four best images in terms of focus and stability were chosen for image 
analysis from each participant. Kappa analysis of agreement for categorical 
variables for both inter- and intraobserver repeatability was 1 for both 
awake and anaesthetised images as all vessel sizes in all quadrants had 
continuous flow and therefore scored '3'.
Intraobserver agreement
The mean baseline CD from 4 images from all 40 subjects (160 images) 
measured by observer 1 was 6.08 capillaries per mm (95% Cl 5.9 to 6.3). 
For the second measurement by observer 1, from the duplicated images, 
this was 6.06 capillaries per mm (95% Cl 5.9 to 6.3). The mean difference 
between the first and second measurements was 0.2 capillaries per mm 
(95% Cl -0.25 to 0.29). A Bland-Altman plot constructed from the data 
shows that the limits of agreement are narrow with respect to the mean CD 
and there is no evidence of bias within the graph (Figure 3.7). The 95% 
confidence interval for the lower limit is -0.51 to -0.39 and for the upper is 
0.35 to 0.47. The narrow 95% limits indicate good intraobserver 
agreement. To further assess the agreement, the 95% repeatability 
coefficient was calculated and found to be 0.6. This means that the value 
within which the differences between two replicated images analysed by 
the same person is expected to be 0.6 capillaries for 95% of subjects.
Interobserver agreement
Four possible paired comparisons could be made between observer 1 and 
observer 2 from the 4 images taken from each participant. The mean 
baseline CD from 4 images from all 40 subjects (160 images) measured by
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observer 1 was 6.08 capillaries per mm (95% Cl 5.9 to 6.3). The mean 
baseline CD from 4 images from all images measured by observer 2 was 
6.12 capillaries per mm (95% Cl 5.9 to 6.3). The mean difference between 
the measurement between observer 1 and observer 2 was -0.04 capillaries 
per mm (95% Ci -0.31 to 0.23). A Bland-Altman plot of the data shows that 
the limits of agreement are narrow with respect to the mean CD and there 
is no evidence of bias within the graph (Figure 3.8). The 95% confidence 
interval for the lower limit is -1.13 to -0.85 and for the upper is 0.92 to 1.2 
and indicates good interobserver agreement. The 95% repeatability 
coefficient was 1.45 capillaries per mm. This means that the value within 
which the differences between two replicated images analysed by two 
observers is expected to be 1.45 capillaries per mm for 95% of subjects.
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Difference Plot
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-1.5 ■
Identity
Bias (-0.019)
-------- - 95% Limits of
agreement 
(-0.447 to 0.409)
Figure 4.8.Bland Altman plot for intraobserver agreement in the calculation of 
capillary density in healthy children.
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Difference Plot
Identity
Bias (0.038)
-------- 95% Limits of
agreement 
(-0.987 to 1.063)
Figure 4.9. Bland Altman plot for interobserver agreement in the calculation of 
capillary density in healthy children.
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4.4 Discussion
In this chapter the normal values for the manual assessment of 
microcirculation variables in children have been documented and shown 
good intra- and interobserver agreement. The values for image analysis are 
good with narrow 95% Cl limits of agreement. The values for image 
attainment were not as good with wider 95% Cl limits of agreement.
To ensure a wide spectrum of ages for the determination of normal 
microcirculation variables, it was necessary to recruit children who were 
anaesthetised. SDF imaging results in a video image representing a 1mm 
by 0.7 mm area of sublingual tissue. A significant degree of cooperation is 
required to obtain clear, focused images that are steady for 20 second on 
multiple occasions. This would not be possible in a young child as there 
would be significant movement in the tissue area being visualised and 
obstructions of view of the microcirculation due to saliva. The younger 
children (under 6 years of age) were therefore under the influence of 
anaesthetic agents whilst the older children were able to cooperate with the 
procedure.
Anaesthetic agents can cause significant haemodynamic alterations. 
Studies of propofol in animals (Goodchild and Serrao 1989) and humans 
(Claeys, Gepts et al. 1988) have shown minor degrees of hypotension and 
depression of cardiac contractility. Animal studies, using intravital 
microscopy have shown that anaesthetic agents such as propofol, 
thiopental and etomidate have a vasodilatory effect on the microcirculation 
(Holzmann, Schmidt et al. 1995; Bazin, Dureuil et al. 1998; Brookes, Reilly 
et al. 2004) but some agents, like isoflurane and ketamine, can cause
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vasoconstriction (Grundmann, Zissis et al. 1997; Brookes, Reilly et al. 
2004). Propofol has also been shown to reduce the oxygen extraction 
capabilities in dogs (Walley 1996)
De Backer et al conducted a prospective study of 15 women anaesthetised 
with propofol. (Koch, De Backer et al. 2008). They assessed the sublingual 
microcirculation before, during, and after propofol infusion using orthogonal 
polarization spectral imaging. They found that during propofol 
administration, systemic haemodynamic and oxygenation variables were 
unchanged, but that the CD and the PVD were significantly reduced by 
17%. These microcirculatory alterations resolved three hours after the 
completion of the propofol infusion. It was not possible to determine a 
baseline CD measurement in children prior to the anaesthetic, this type of 
analysis was not possible. However, a large number of capillaries with 
poor perfusion were not observed when analysing the images taken from 
anaesthetised children with a minimum PPV of 0.99. Propofol was used in 
these children but it may be that they respond differently to the anaesthetic 
agent or that the microcirculation changes require prolonged anaesthetic 
exposure. The results in adults suggest that the CD found in the younger 
age group might underestimate the values in awake infants and young 
children.
The relationship between weight and CD is not surprising. The need to 
consider size in children of different ages is well illustrated by the example 
of drug prescribing. Drug dose calculations are most commonly based on 
weight in kilograms (BNF 2005) although body surface area is a more 
satisfactory index of drug requirements than body weight or age, 
particularly during infancy and childhood (Lack and Stuart-Taylor 1997). A
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“third size modei” using an exponent of weight is weight3/4. This is called 
the allometric 3/4 power model (Kleiber and Rogers 1961) and has been 
found useful in normalizing a iarge number of physiological parameters 
including basal metabolic rate (BMR) and oxygen consumption (Dawson 
2005; Weibel and Hoppeler 2005).
It is possible to show that in almost all species including humans, the log of 
BMR and resting oxygen consumption plotted against the log of body 
weight produces a straight line with a slope of 3A (Weibel and Hoppeler 
2005). This exponential function remains the same between a 7 gram 
mammal and a horse of over 500 kilograms (Weibel and Hoppeler 2005). 
Explanations for this model vary and are still debated. Kleiber’s explanation 
is based on changes in body composition with size and concludes that the 
concentration of 'active protoplasm' declines with size (Kleiber and Rogers 
1961). Another theory is a structural explanation as the cross sectional area 
of an animal increases as a 3/4 power function of weight (McMahon 1973). 
The maximum power a muscle can produce depends on its cross-sectional 
area. Thus, if the metabolic rate of an organism is proportional to the power 
production of its muscles, then metabolic rate rises with muscle cross- 
sectional area and weight3/4. West et al. attempted to use fractal geometry 
to mathematically explain this relationship and by using the distributive 
nature of vascular networks in animals again arrived at the % power scaling 
rule (West, Brown et al. 1999). Recently others have argued that this 
relationship changes between rest and exercise and that no single power 
law relationship between metabolic rate and body size is appropriate 
(Darveau, Suarez et al. 2002).
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One of the most important roles of the capillary is oxygen transfer to 
tissues. If the oxygen consumption rate of mammals follows the % power 
law as has been suggested (Bishop 1999; Dodds, Rothman et al. 2001) , 
then the smaller the body mass, per area of muscle mass, more capillaries 
and a higher concentration of intracellular mitochondria will be needed to 
meet oxygen demand. A study involving muscle dissection of various 
mammals found that capillary density was proportional to the size of the 
mammal, corroborating this point (Schmidt-Nielsen and Pennycuik 1961).
4.4.1 Limitations
This technology has limitations, particularly the possible effects of contact 
pressure. Excessive pressure of the SDF probe upon the tissue can affect 
blood flow and may have contributed to a slight reduction of PPV that was 
seen in both control groups. This small reduction was however slight and 
may in fact be the norm in healthy children. This limitation can be overcome 
by experience. Lateral movement of tissue (or probe) will affect the video 
image and a smooth, continuous video sequence may not be possible. To 
visualise capillary and venular flow patterns and density effectively a static 
piece of tissue area is the ideal. This is difficult due to the small area of 
tissue examined by the SDF probe. A further limitation of this study is that, 
for the purposes of comparison with children with MCD, age matched 
controls were not possible for non anaesthetised children. Although 
preferable to assess the microcirculation in healthy unanaesthetised 
children , the level of co-operation needed to obtain high quality sublingual 
images is lacking in a child less than 6 years of age.
4.4.2. An approach to automated microcirculation image analysis
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Future work should aim for fully automated image analysis. Ideally the 
velocity of red cells should be calculated in a manner that removes any 
user manipulation Microcirculation image analysis is not yet available, 
although there have been attempts to solve the difficulties.
The videos to be analysed are recorded at 25 frames per second and are 
about 500 frames in length. In each frame red blood cells may appear as 
isolated objects or as collections of blood cells. Blood vessel walls cannot 
be visualised with this technology and are defined by the movement of red 
cells through them. In order to determine the speed of blood flow in a 
vessel, a cell (or group of cells) must be followed from frame to frame and 
the capillaries should be in an orthogonal plane to the lens, which is not 
always the case. Knowing the spatial scale of the image and the time 
interval between frames, the displacement of a cell in pixels per frame can 
be converted to a speed in micrometers per second. Video images may 
seem stable to the naked eye but when there is a significant amount of 
tissue or probe movement, it is difficult to identify each individual red blood 
cell in successive frames. There are tissue movements with respiration and 
vascular pulsations, which may be increased by mechanical ventilation and 
administration of inotropes in sick ICU patients. It is therefore important to 
stabilise each frame so that the capillary networks appears to be static over 
the duration of the video. Quantification of blood flow velocity requires a 
sequence of stable video images.
Following the motion of all cells over all frames allows the vessel network to 
be mapped out. This network is broken into separate segments as the 
speed of blood flow cannot be defined at a junction between vessels. The 
diameter of each segment is noted so that blood flow values can be
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categorised later into capillaries (diameter < 10 pm), venules and veins. 
Each non-linear vessel segment needs to be straightened to make 
subsequent speed analysis possible. For each vessel in turn, the cells 
visible in each frame are displayed in a 'space-time' diagram. If the cells are 
imaged clearly, this diagram exhibits features whose orientation is related 
to flow speed. If the cells are static then the features are aligned with the 
time axis of the diagram. Cells with higher speeds produce features at 
larger angles with respect to the time axis. The speed can be calculated 
every two seconds (giving approximately 10 values for a 20-second video). 
If the vessel segment is long then speeds can be calculated at different 
positions along the vessel length.
The result of the analysis is speed data for each vessel and is therefore a 
function of time and the position of an individual red blood cell along the 
vessel. This data can be reduced to a 'score' that can be compared with 
that produced by the manual analysis that has been carried out here. This 
software development is ongoing and the hope is that it will generate a 
quick, reliable set of microcirculatory values at the bedside, that aid clinical 
decision making.
4.5 Conclusion
Side stream dark field imaging can be used in healthy awake and 
anaesthetised children to obtain high quality images of the microcirculation 
and normal values for children have been established. Manual analysis of 
the images produced has good inter- and intra-observer agreement but a 
fully automated and user-friendly image analysis software system would be 
a superior and faster method of evaluation. Its use in critically ill children 
would therefore be appropriate.
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Chapter 5
The Microcirculation in Meningococcal Disease
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5.1 Introduction
Severe sepsis is characterized by systemic inflammation and widespread 
tissue injury. It involves widespread vasodilatation, increased microvascular 
permeability, and leukocyte attraction to affected tissue areas. Organ 
dysfunction can vary from mild impairment to complete organ failure 
(Dellinger, Levy et al. 2008). One reason for this variation is the extent to 
which the microcirculation has been affected by the inflammatory process. 
Normal blood flow in capillaries ensures the delivery of oxygen to cells, 
appropriate tissue oxygenation and the removal of waste products. The 
microcirculation is defined as a network of blood vessels less than 100 jL/m 
in diameter. These blood vessels consist of venules, capillaries and 
arterioles. Oxygen, nutrients and waste products are exchanged between 
the circulating blood and cells of various tissue types under normal 
circumstances. In severe sepsis poor tissue perfusion is attributable to 
abnormal capillary blood flow (Ince 1999; Ince and Sinaasappel 1999). 
Surrogate measures of tissue perfusion have been used to assess the 
degree of microcirculatory dysfunction. These include blood lactate, arterial 
blood base deficit, gastric and sublingual capnography and urine output (De 
Backer 2003).
Intravitai microscopy in animal models has given a large amount of 
information about the microcirculatory response to sepsis including 
evidence of major alterations in microvascular vessel density and flow 
patterns (Ellis, Bateman et al. 2002; Bateman and Waliey 2005). In most 
circumstances intravitai imaging technology cannot be used in humans. 
OPS and SDF technology, however, can be used to visualise some areas 
of the microcirculation in humans (Groner, Winkelman et al. 1999; De 
Backer and Dubois 2001; De Backer, Creteur et al. 2002; Spronk, Ince et
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al. 2002). Although still a research tool, microcirculatory imaging can 
provide real time, bedside images in the investigation of human sepsis and 
has been utilised in studies of severe sepsis in adults and children (Top, 
Inceetal.).
5.1.2 The microcirculation in childhood sepsis
This chapter examines the use of SDF imaging in children with severe 
MCD and describes the microcirculatory measures used and the 
abnormalities found.
5.2 Method
5.2.1 Patients
Patient recruitment, data collection, sublingual microvascular visualisation, 
echocardiography and blood sampling and analysis were carried out as 
detailed in Chapter 2. Control subjects were children who had blood taken 
during routine surgery. The 40 children from the previous chapter were 
controls for the microcirculatory variables. As an additional comparative 
group, the sublingual microcirculation was visualised on 10 children pre and 
post cardiac surgery. The sublingual microcirculation was visualised using 
SDF in these children white they were anaesthetised, approximately 10-15 
minutes prior to cardiac surgery, within one hour of completion of surgery 
and three hourly until extubation. Echocardiography was not performed on 
these children and blood was not taken from them. Analysis of SDF 
images was carried out as described in Chapter 4.
5.2.2 Echocardiography
Systolic and diastolic cardiac function measurements, cardiac output and 
index were calculated using the methods described in Chapter 2.
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5.2.3 Statistics
Data are presented as median and IQR or mean and standard deviation 
where appropriate. Correlations between variables were determined using 
Spearman rank correlation coefficient. A p value of <0.05 was considered 
statistically significant. Inter- and intraobserver agreement for 
measurements of SDF images by two independent observers is expressed 
as Kappa coefficients and Bland-Altman piots. Statistical analyses were 
carried out using SPSS for Windows (version 14.0), (SPSS,Inc., Chicago, 
Illinois) and Analyse-lt Software v.1.62 for Microsoft Excel (Analyse-lt 
Software, Leeds, UK). Longitudinal analysis was carried out by the Medical 
Statistic Department at the University of Lancaster.
5.3 Results
After informed consent, admission plasma samples were obtained from 43 
children who were reported to the research fellow as ‘suspected MCD’. This 
included 33 children subsequently confirmed to have MCD and 10 with 
presumed viral illness. Sequential plasma samples were available from 20 
of the 33 MCD children. Twenty-three children had blood taken during 
routine surgery to act as controls. Demographic details for these children 
are shown in Tables 5.1 and results of investigations in Table 5.2. There 
was no mortality and 2 children required limb amputations. One child 
required haemofiltration.
155
MCD
ventilated
MCD not 
ventilated
Presumed
viral
Control
Total number 20 13 10 23
Age at 2.16 3.1 1.58 2.5
admission in 
years [IQR]
[0.69 to 4.75] [1.02 to 5.37] [0.67 to 2.5] [0.74 to 4.5]
Sex 5 4 3 9
[male %] [25%] [30.7%] [30%] [39.1%]
Maximum 11 3 3
—
GMSPS
[IQR]
[9 to 12] [2 to 3] [2 to 3]
Admission
PELOD
[IQR]
11
[5.1 to 16.8]
0 0
Admission 20 3 3
—
PRISM III
[IQR] 
[17.2 to 22.5] [0 to 3] [0 to 3]
Admission 
Inotrope score 
[IQR]
17.5
[6 to 77.5]
0 0
Duration of 10 5 3
—
hospital stay 
(days)
[IQR]
[7.3 to 15.5] [3 to 7] [2 to 5]
Duration of 2 1 4.5
-
rash (hours) 
[IQR]
[1-7] [1-5.5] [2-7.5]
Table 5.1. Demographic data for the study population.
156
MCD ventilated MCD
not ventilated
Presumed
viral
Control p value
Total number 20 13 10 23
CRP (mg/I) [IQR] 
[normal range 
<4mg/l)
142.5
[107 to 200]
75.8
[50.8 to 122.4]
10.4
[4 to 37.1]
All <4 *NS
t<0.05
4<0.05
WBC (x106/l)
[IQR]
[normal range 
4.3-10.8 x107l)
20.7
[5.8 to 25.3]
23.7
[15.8 to 30.2]
15.9
[9.9 to 19.8]
* NS 
t NS 
TN/A
Platelet count 
(x109/l)
[IQR]
(normal range
150 to 400 x109/l)
182
[120 to 248]
322
[241 to 429]
301
[264 to 416]
*<0.001
fNS
JN/A
aPTT
[IQR]
(normal range 
22-34 seconds)
44.1
[39.3 to 55.7]
39.5
[34.1 to 39.6]
33.4
[31.4 to 35.1]
30.4
[29.1 to 34.2]
*<0.05 
t NS 
t NS
PCI (ng/ml)
[IQR]
(normal range 
<5ng/ml)
169.5
[47.5 to 371.9]
23.5
[5.8 to 41.2]
0.1
[0.2 to 0.4]
0.04
[0.02 to 0.06]
*<0.0001
t<0.005
t<0.05
IL-1Ra
(pg/ml) [IQR]
5107
[683 to 8388]
245.5
[76 to 1115.8]
86.2
[68 to 308.1]
39.6
[12.9 to 56.5]
*<0.005
fNS
$<0,001
IL-6
(pg/ml) [IQR]
3771
[1651 to 11140]
523.5
[100.8 to 2838.9]
61.0
[12.9 to 73.4]
34.0
[24 to 59.9]
*<0.05
t<0.05
$NS
IL-8
(pg/ml)
[IQR]
643.0
[137.5 to 1434.0]
328.5
[76.1 to 619.8]
26.6
[5.1 to 74]
44.0
[34.3 to 73.7]
*NS
f<0.05
$NS
IL-10
(pg/ml)
[IQR]
187
[70 to 519]
146.9
[28.2 to 1562.5]
33.0
[14.6 to 162.2]
47.8
[23.8 to 66]
*NS 
t NS 
t NS
TNF
(pg/ml)
[IQR]
316
[193 to 373]
66.8
[43.8 to 115.9]
26.0
[19.5 to 40.8]
43.9
[28.8 to 57.6]
*<0.0001 
t<0.005 
t NS
Bacterial load in 
copies per ml 
[IQR]
320,000 
[61,000 to 
1,020,000]
7800
[3000 to 32000]
*<0.05
fN/A
$N/A
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5.3.1 Agreement
There were 618 video images available for the assessment of agreement 
from the 20 children with MCD who required ventilation. The Kappa 
coefficients and weighted Kappa coefficients for intra- and inter-observer 
repeatability are shown in Table 5.3, indicating excellent agreement.
For the 20 children with MCD four images were chosen that had each been 
analysed by observer 1 and observer 2 for each time point. A Bland- 
Altman plot constructed from the image analysis (Figure 5.1) shows the 
limits of agreement. The 95% limit of agreement for the lower limit is -2.1 
(95% confidence interval -2.2 to -1.8). The 95% limit of agreement for the 
upper limit is 1.8 (95% confidence interval 1.6 to 1.9). The 95% 
repeatability coefficient was 2.6 capillaries per mm. This means that the 
value within which the differences between two images attained by two 
observers is expected to be 2.6 capillaries per mm for 95% of subjects.
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Kappa
coefficient
Cl Weighted
Kappa
coefficient
Cl
MFI for capillaries (MFIc)
Interobserver 0.83 0.80 to 0.86 0.80 0.70 to 0.83
Intraobserver 0.88 0.86 to 0.89 0.80 0.72 to 0.85
MFI for all vessels (MFI)
Interobserver 0.85 0.83 to 0.87 0.88 0.86 to 0.89
Intraobserver 0.88 0.86 to 0.89 0.80 0.72 to 0.85
Table 5.3. Inter- and intraobserver agreement for flow scoring for 
calculation of MFIc and MFI
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Figure 5.1. Bland-Altman plot of assessment of capillary density by two 
independent observers in children with MCD
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5.3.2 Microcirculatory variables
Table 5.4 shows the relationship between microcirculation measurements 
taken from each of the 618 video sequences. There are strong positive 
correlations between MFI and MFIc, PPV, PVD and a strong negative 
correlation between MFI and HI. There is a significant but weaker positive 
correlation between MFI and CD and PPV. As PPV is a function of CD this 
relationship is not surprising. Almost identical correlation coefficients were 
found when MFIc was used instead of MFI for the analyses (Table 5.4)
A significant reduction in admission MFI, MFIc, PPV, CD, and PVD were 
found in children with severe MCD when compared to both anaesthetised 
(p<0.05) and healthy awake controls (p<0.005) (Figures 5.2, 5.3, 5.4, 5.5 
and 5.6). These differences were no longer significant pre-extubation 
showing that microcirculatory recovery occurred alongside clinical recovery.
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Microcirculatory
outcome
variable
MFIc MFI CD PPV PVD HI
MFIc 1
MFI 1
p<0.0001
1
CD 0.5
p<0.0001
0.49
p<0.0001
1
PPV 0.76
p<0.0001
0.75
p<0.0001
0.45
p<0.0001
1
PVD 0.77
p<0.0001
0.67
p<0.0001
0.91
p<0.0001
0.63
p<0.0001
1
HI
U
p
o 
oo
b o o
-0.85
p<0.0001
-0.24
NS
-0.68
p<0.0001
-0.21
NS
1
Table 5.4. Spearman Rank Correlation coefficients between all microcirculatory 
outcome variables measured.
HI - Heterogeneity index, NS - not significant
M
FI
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Figure 5.2. Bar chart showing change in mean MFI and MFIc in children with MCD over 
time (with standard error bars)
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Figure 5.3. Bar chart showing change in mean percentage of perfused vessels (PPV) in 
children with MCD over time (with standard error bars).
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Figure 5.4. Bar chart showing change in mean capillary density (CD) in children 
with MCD over time (with standard error bars). Mean values for PVD in awake and 
anaesthetised control children are also included.
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Time post admission to PICU in hours (axis includes normal controls)
Figure 5.5. Bar chart showing change in mean perfused vessel density (PVD) 
in children with MCD over time (with standard error bars). Mean values for 
PVD in awake and anaesthetised control children are also included.
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Figure 5.6. Bar chart showing change in mean heterogeneity index (HI) in 
children with MCD over time (with standard error bars)
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5.3.3 Predicting outcome
Table 5.5 show the relationship between admission microcirculation 
measurements and assessments of illness severity. It shows a significant 
negative correlation between MFI and MFIc and volume of fluid 
resuscitation needed, total duration of time the child was ventilated and 
required inotropic support, admission inotrope score and the PELOD score.
To account for children presenting to PICU at different points in their illness, 
multiple linear regression analysis was used to assess the independent 
predictive ability of MFIc for the duration of ventilation in hours after 
adjustment for duration of illness, defined as the duration of rash prior to 
PICU admission and the duration of ventilation prior to PICU admission. 
MFIc was chosen for use in the analysis as was deemed to be the most 
pertinent microcirculatory variable due to its ease of ascertainment and 
analysis from an SDF image. The results show that MFIc predicts the 
duration of ventilatory requirement, irrespective of the stage of illness at the 
time of admission to PICU (Table 5.6).
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^ovariate MFI MFIc CD PPV PVD HI
Duration of Hospital stay 
days)
r=-0.28
NS
r=-0.3
NS
r=-0.4
NS
r=-0.15
NS
r=-0.3
NS
r=0.4
NS
Duration of PICU stay 
days)
r=0.39
NS
r=0.39
NS
r=-0.25
NS
r=-0.24
NS
r=-0.11
NS
r=0.4
NS
Bacterial load r=-0.31
NS
r=-0.31
NS
r=-0.2
NS
r=0.06
NS
r=0.03
NS
r=0.3
NS
t/olume of resuscitation
Fluid p<0.05
= -0.54' 
p<0.05
r= -0.2
NS
r=-0.46
p<0.05
r= -0.19
NS
r= 0.35
NS
Duration of ventilation 
hours) p<0.05 p<0.05
r= 0.06
NS
r= -0.27 
NS
r=-0.08
NS p<0.05
Duration of inotropic 
support (hours)
=-0.56
p<0.05
-0.49
p<0.05
r= -0.19
NS
r= -0.16 
NS
r=0.15
NS
r= 0.36
NS
PELOD r=-0.58
p<0.05
r=-0.5
p<0.05
r= -0.04 
NS
r= -0.15 
NS
r= 0.1
NS p<0.05
PRISM III r= -0.18
NS
r= -0.12
NS
r= -0.19 
NS
r= -0.19 
NS
r= -0.19
NS
r= 0.01
NS
Peak GMSPS
p<0.05 p<0.05
r=0.01
NS
r=-0.15
NS
r=0.13
NS
r=0.4
NS
notrope score
r= -0.75
p<0.001
= -0.74
p<0.001
r=-0.1
NS
r=-0.62
p<0.05
r=0.001
NS
r=0.67
p<0.01
Table 5.5. Correlations between admission microcirculation variables and markers of 
illness severity
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Predictor variable B
coefficient
P value 95% Cl
Total Duration of ventilation -0.56 <0.05 -0.01 to -0.15
Duration of rash prior to
hospitalisation
0.41 0.9 -0.04 to 0.5
Duration of ventilation prior to
admission
0.21 0.9 -0.01 to 0.002
Table 5.6. Multiple linear regression analysis was used to assess the 
independent predictor ability of MFIc for the duration of ventilation in hours
Adjusted R Square= 0.34, F=9.7, p<0.01 (using stepwise model)
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5.3.4 Longitudinal Data Analysis
The longitudinal data analysis for microcirculation variables is shown in 
Table 5.7 and reports the estimated correlation parameter p between each 
time-varying covariate and the measured microcirculation (MFIc was the 
microcirculation parameter used for the analysis). All microcirculation 
variables changed over time alongside MFIc when MFIc was used as the 
comparative variable. This relationship is strongest with MFI, PPV and HI.
Table 5.8 shows admission correlations and longitudinal analysis 
comparing changes in clinical and biochemical measurements of tissue 
perfusion in the 20 children with MFIc over time. It demonstrates that as 
MFIc improves over time lactate, pC02 and Fi02 all decrease. Base 
excess, pH and urine output all correlate with an increase in MFIc over 
time. Table 5.9 shows that aPTT, INR and PCT all decreased over time 
alongside MFIc. Haemodynamic variables are shown in Table 5.10 and 
although the inotrope score decreased over time in relation to MFIc, there 
was no change in cardiac systolic function, as assessed by FS, or cardiac 
index.
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Covariate
/\
P Cl
MR 0.91 0.69 to 1.1
CD 0.29 0.03 to 0.55
PPV 0.66 0.43 to 0.88
PVD 0.34 0.1 to 0.58
Heterogeneity index -0.75 -0.53 to -0.97
Table 5.7. Longitudinal analysis comparing changes in microcirculation variables with 
MFIc over time. p=estimated correlation parameter
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Covariate MFIc
/\
P Cl
Table 5.8. Admission correlations between clinical and biochemical measurements of 
tissue perfusion and MFIc and Longitudinal analysis comparing changes clinical and 
biochemical measurements of tissue perfusion with MFIc overtime. p=estimated
correlation parameter
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Covariate MFIc
/\
P Cl
aPTT r=-0.23
NS
-0.46 -0.69 to -0.23
INR r=-0.57
p<0.05
-0.37 -0.59 to -0.15
Fibrinogen r=0.39
NS
-0.001 -0.76 to 0.76
Haemoglobin r=-0.13
NS
-0.21 -0.4 to 0.01
Haematocrit r=-0.3
NS
-0.1 -0.68 to 0.24
WCC r=0.36
NS
0.002 -0.36 to 0.36
Neutrophil r=0.33
NS
0.04 -0.22 to 0.29
Platelet r=0.22
NS
-0.07 -0.35 to 0.21
CRP r=0.58
p<0.05
0.2 -0.60 to 0.03
PCI r=-0.36
NS
-0.37 -0.6 to -0.14
Glucose r=0.11
NS
0.25 -0.03 to 0.53
Table 5.9. Admission correlations between laboratory markers and MFIc and
Longitudinal analysis comparing changes in laboratory markers with MFIc over time.
/\
p = estimated correlation parameter
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Covariate MFIc P Cl
Inotrope Score r=-0.74
p<0.01
-0.46 -0.71 to -0.21
MAP r=0.05
NS
-0.14 -0.4 to 0.14
CVP r=-0.02
NS
-0.08 -0.3 to 0.13
Fractional shortening r=0.08
NS
0.17 -0.07 to 0.41
Cardiac Index r=-0.23
NS
-0.2 -0.44 to 0.04
SVR r=0.15
NS
-0.04 -0.26 to 0.18
Table 5.10. Admission correlations between haemodynamic variables and MFIc and 
Longitudinal analysis comparing changes in haemodynamic variables with MFIc over 
time, p = estimated correlation parameter
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5.4 Cardiac comparative group
Of the 10 children undergoing cardiac surgery, 4 children had ventricular 
septal defects, 4 had completion of Fontan circulation from complex 
congenital cyanotic cardiac defects and 2 had supravalvular aortic stenosis 
repair. The median age of the children was 2.1 years (IQR 0.7 to 2.6), 50% 
were male. The median time to extubation from the completion of surgery 
was 52 hours (interquartile range 3.8 to 68 hours).
There was no significant difference between pre-surgical microcirculatory 
findings and those taken from anaesthetised controls. A significant 
reduction of CD, MFI, PPV and PVD were found in all children 1 hour 
following surgery when compared to anaesthetised (p<0.05) and awake 
controls (p<0.05). These differences were no longer significant 3 hours 
after this time point. There were significant correlations between 
cardiopulmonary bypass time and MFI (r= -0.73, p<0.05) and PPV (r= - 
0.62, p<0.05) and aortic cross clamp time and MFI (r= -0.78, p<0.01) and 
PPV (r= -0.76, p<0.05). Two of these children were not receiving any 
inotropic support when microvascular abnormalities were seen. The other 
8 were receiving milrinone at the time in image acquisition.
No significant difference was found between admission values for MFIc 
(p=0.23), MFI (p=0.23), CD (p=0.5), PPV (p=0.4) and PVD (p=0.4) for 
children with MCD and the same microcirculatory values for children who 
were 1 hours post cardiac surgery. A significant reduction in admission CD 
(p<0.05), MFI (p<0.05), PPV (p<0.05) and PVD (p<0,05) was seen in 
children with MCD when compared to children 3 hours post cardiac surgery 
in the 6 children that remained ventilated 3 hours post operatively.
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5.5 Discussion
These results confirm excellent intraobserver and interobserver agreement 
in the assessment of microcirculation SDF images from children with MCD. 
This chapter demonstrates that microcirculation variables can predict the 
duration of ventilatory requirement, irrespective of the stage of illness at the 
time of admission to PICU and that the microcirculatory dysfunction present 
in children with severe MCD recovers alongside clinical recovery. As a 
useful comparative group this study has also shown that the systemic 
inflammatory response seen in children post operatively from cardiac 
surgery requiring cardiopulmonary bypass produces similar sublingual 
microcirculatory changes to children with MCD. These changes were 
shown to be shorter in duration when compared to children with severe 
sepsis indicating more severe microcirculatory disruption in children with 
MCD.
De Backer et al. showed a significant decrease in CD and PPV in adults 
with severe sepsis with the most severe changes being associated with 
mortality (De Backer, Creteur et al. 2002). Sakr et al. used OPS to assess 
the microcirculation in adults and showed that PPV that did not improve 
over time in non-survivors (Sakr, Dubois et al. 2004). The findings here 
show a clear relationship between microcirculatory dysfunction and severity 
of illness in children. Sakr et al. stated that the persistence of significant 
microcirculatory dysfunction was the most accurate haemodynamic 
predictor of mortality when compared with commonly used methods of 
global hemodynamic assessment. They concluded that poor tissue 
perfusion of organs could be identified using OPS imaging and this would 
allow for more targeted therapy to improve microcirculatory blood flow and
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reduce mortality (Sakr, Dubois et al. 2004). Trzeciak et al. found 
microcirculatory abnormalities in patients with severe sepsis treated with 
early goal directed therapy (EGDT) which were more severe in non­
survivors than in survivors and in patients with cardiovascular dysfunction 
(Trzeciak, Dellinger et al. 2007). EGDT is a technique used in adult and 
some paediatric critical care, involving early monitoring of superior vena 
cava oxygen saturation (Scv02) and a treatment algorithm. Adjustments 
of cardiac preload, afterload, and contractility are made to within tight target 
ranges in order to balance oxygen delivery with oxygen demand in patients 
with a high risk of morbidity and mortality (Rivers, Nguyen et al. 2001; 
Rivers, Nguyen et al. 2004; Rivers 2006). The only paediatric study to date 
used OPS imaging to examine the microcirculation of 21 children with 
sepsis from a variety of aetiologies. This study demonstrated that in 
children with septic shock the persistence of microcirculation abnormalities 
was associated with a poor outcome. This was despite adequate 
resuscitation and support of systemic haemodynamics (Top, Ince et al.). 
The buccal mucosa was examined in this study which is not a common 
place to obtain microcirculation images as detailed in the majority of the 
adult literature.
The reasons for the occurrence of microcirculation abnormalities in severe 
sepsis are complex and the precise mechanisms remains unclear. 
Multiorgan dysfunction is associated with endothelial cell injury leading to 
tissue hypoxia. A disruption in global oxygen delivery alters the metabolic 
regulation of tissue oxygen delivery contributing to organ dysfunction 
leading to a cycle of tissue destruction. The profound hypotension seen in 
septic shock will lead to vascular shutdown contributing to the 
microcirculation problems. Hypotension is in part a result of the
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microvascular changes, including increased permeability and the shunting 
of blood. Reactive oxygen species and vasoactive substances including 
NO cause damage to red blood cells, affecting their normally smooth 
journey through the vessels of the microcirculation (Lominadze and 
McHedlishviii 1999). Red blood cells are able to change their shape as 
they move through narrow capillaries. If this ability to change shape is lost, 
red blood cells become rigid resulting in impaired perfusion and oxygen 
delivery in peripheral tissues. Rigid red blood cells can be caused by NO 
release and may block microvessels directly (Parthasarathi and Lipowsky 
1999).
This study has shown correction of coagulopathy alongside microcirculatory 
recovery. A large randomised study called the RESOLVE (REsearching 
severe Sepsis and Organ dysfunction in children: a global perspectiVE) 
trial to investigate the efficacy and safety of Drotrecogin alfa (activated PC) 
was published in 2007 (Nadel, Goldstein et al. 2007). 477 patients were
enrolled; 237 received placebo, and 240 Drotrecogin alfa. No significant 
difference was found between the groups in 28-day mortality and serious 
bleeding events were similar between groups. This study however enrolled 
a wide spectrum of paediatric patients with sepsis. With a more specific 
criterion for trial entry, such as using an MFI cut off of 2 in conjunction with 
other entry criteria, a positive effect of Drotrecogin alfa may have been 
seen.
Vasopressors have a vasoconstrictor effect which may have an effect on 
capillary function. An increase in systemic vascular resistance would 
increase blood pressure but at the expense of poor blood flow through 
capillaries. The inverse relationship shown here between microcirculation
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variables and inotrope score could be explained by this. Alternatively it 
may be because the sicker the patient is the worse the microcirculatory flow 
is and hence the need for more inotropes. Cardiopulmonary bypass (CPB) 
induces a systemic inflammatory response. Studies in adults have shown 
microcirculatory abnormalities after cardiac surgery. Our study confirms 
this. Microcirculatory dysfunction was seen in children following cardiac 
surgery both in children who were and children who were not on inotropes. 
This would indicate that inotropic agents play a minor part, if at all in 
microcirculation abnormalities in children with MCD.
A limitation of this work is that there are insufficient time points to compare 
cardiac patients with children with MCD in longitudinal analysis. This also 
highlights the speed at which the microcirculation recovered in the cardiac 
comparison group indicating that the nature of the insult and the effect of 
the inflammatory cascade is more potent in sepsis. However, eight of the 
children in the cardiac comparison group were receiving milrinone at the 
time of image acquisition, an agent that has been shown in a small case 
series of MCD to be of benefit (Rich, West et al. 2003). Milrinone is an 
inodilator that improves left ventricular diastolic relaxation by selectively 
inhibiting III phosphodiesterase isoenzyme in both cardiac and vascular 
muscle which increases myocardial contractility. A different response is 
seen in vascular smooth muscle where vasodilation occurs due to a 
reduced sensitivity of the muscle to calcium influx (Shipley, Tolman et al. 
1996; Duggal, Pratap et al. 2005). These influences on the microcirculation 
may also contribute to improved microcirculatory blood flow in the children 
in the cardiac comparison group.
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Another cellular entity to consider is the endothelial cell glycocalyx. This is 
a surface matrix that lines the luminal surface of all blood vessels and 
consists of glycolipids, glycoproteins, and proteoglycans (Taylor and Gallo 
2006). The glycocalyx plays a protective role for the capillary wall. Studies 
have shown that the haematocrit, flow resistance, permeability, 
coagulation, and leukocyte adhesion may all be regulated by the glycocalyx 
(Vink and Duling 1996; Pries and Kuebler 2006). Marechal et al. 
demonstrated that administration of intravenous LPS into rats induced 
microvascular dysfunction due to loss of the endothelial glycocalyx which 
improved when activated protein C was administered, limiting degradation 
of the glycocalyx (Marechal, Favory et ai. 2008). It is highly likely that a 
mechanism such as this will be fundamental in the pathogenesis of 
microvascular dysfunction associated with severe sepsis in humans.
A limitation of this work is that the image analysis is manual and time 
consuming if all microcirculation variables are computed. A recent study 
has found that MFI can be reasonably quickly estimated at the bedside by a 
suitably experienced individual. For microcirculation measurements from 
SDF to be used to maximse clinical care and as an endpoint for 
resuscitation, the outcome measures derived from the images must be 
assessed quickly
5.6 Conclusion
These results have shown that the assessment of the microcirculation in 
children is possible and interpretation of images is repeatable. The findings 
are pertinent to the diagnosis, management and prognosis of septic shock 
in children. A new part of the circulation has been visualised in children for
the first time.
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Chapter 6
Soluble mediators and the microcirculation in meningococcal disease
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6.1 Introduction
6.1.2 Vasoactive mediators
A normally functioning endothelium is a requirement for efficient tissue 
perfusion. Sepsis is a process of intravascular inflammation. The normal 
response to this is a complex immunologic cascade that ensures a rapid 
response to neutralise the bacterial invasion. An inadequate immunologic 
defence may allow infection to become established. Alternatively an 
excessive or poorly regulated response may harm the host by an 
exaggerated release of inflammatory mediators. Cytokines and immune 
modulators mediate the clinical manifestations of sepsis leading to 
continued activation of leukocytes, macrophages, and lymphocytes. All of 
these processes can create a destructive immunologic imbalance.
6.1.2.1 Cell Adhesion Molecules
The attraction of activated leucocytes to areas of tissue damage and 
infection is a vital part of the host immune response to eradicate infection. 
It involves a three stage process. Leucocytes initially roll along the 
vascular endothelium. They then adhere to the endothelium and migrate 
across it. Leucocyte rolling is mediated through the expression of selectins 
on the surfaces of leucocytes and the endothelium. This is regulated by 
pro-inflammatory cytokines. The selectins are three proteins which are 
designated by their prefixes P (platelet), E (endothelial) and L (leucocyte). 
The roiling of leucocytes along the endothelium is mediated by P-selectin 
and E-selectin (both expressed on the endothelium) and L-selectin which is 
present on the surfaces of leucocytes (Carlos and Harlan 1994; Tedder, 
Steeber et al. 1995; Frenette and Wagner 1996; Frenette and Wagner 
1996). Activation is triggered by factors, including IL-8, and causes the
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adhesion of leucocytes to the endothelium surface through the binding of 
(32 integrins to ICAM-1 (Xu, Gonzalo et al. 1994). IL-8 is a powerful 
chemoattractant and activator of neutrophils. Strong adherence of 
leucocytes to the endothelium causes migration into tissue between 
endothelial tight junctions.
Adult studies have demonstrated that disease severity in sepsis is related 
to an increase in the expression of adhesion molecules. Cowley et ai found 
that E-selectin, ICAM-1 and VCAM-1 were all raised with the highest levels 
found in patients with multi-organ failure (Cowley, Heney et al. 1994). 
Gando et al demonstrated that levels of E-selectin, ICAM-1 and VCAM-1 
were higher in adults with sepsis related DIG than those with sepsis but no 
evidence of DIG. They found no difference in P-selectin levels between the 
two groups (Gando, Kameue et al. 2005). These findings have also been 
documented in paediatric studies (Whalen, Doughty et al. 2000; Krueger, 
Heinzmann et al. 2007). In one study, tCAM-1 and E-selectin were found 
to be raised in children with MCD when compared to children who 
presented to hospital with a fever and a rash with no eventual diagnosis of 
MCD. The highest levels were found in children with severe MCD as 
assessed by the GMSPS. P-selectin was not raised and was lower in 
children who died. VCAM-1 was not measured in this study (Baines, 
Marzouk et al. 1999).
6.1.2.2 Nitric oxide
Vascular endothelium and smooth muscle cells produce nitric oxide (NO) 
from inducible nitric oxide synthase (INOS). This is mediated by pro- 
inflammatory mediators including endotoxin, TNF and IL-1. NO has been 
shown, in experimental models, to have a key role in the fall in systemic
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vascular resistance underlying the hypotension and myocardial dysfunction 
in septic shock (Umans, Wylam et ai. 1993; Wang, Ba et al. 1995; Rees, 
Monkhouse et al. 1998). Refractory hypotension is a prominent feature of 
severe MCD with children unresponsive to treatment with fluids, inotropes 
and conventional vasoconstrictors. NO synthesis requires the presence of 
L-arginine. Theoretically administration of an analogue of L-arginine (L-N 
monomethylarginine) should block production of NO and restore vascular 
tone in septic shock. A multi-centre, randomised, placebo-controlled, 
double-blind study in adult septic shock showed increased mortality in 
human septic shock in those given L-N monomethylarginine (Lopez, 
Lorente et al. 2004). There was an increased proportion of deaths due to 
refractory shock in the L-N monomethylarginine treatment group. This 
implied that in some patients, treatment with L-N monomethylarginine 
provoked a paradoxical worsening of the circulatory failure or myocardial 
dysfunction. The authors attributed the increased mortality in the L-N 
monomethylarginine treated group to a possible overcorrection of vascular 
tone resulting in an excessive increase in ventricular afterload compounded 
by inadequate inotropic support. Additionally a previously unrecognized 
primary effect of L-N monomethylarginine of worsening myocardial 
performance may have been present. NO depresses cardiac contractility 
and the ability of the myocardium to relax, thus maximising end diastolic 
filling and coronary artery perfusion. Nitric oxide also reduces 
responsiveness to (E-adrenergic agents (Balligand, Kelly et al. 1993; 
Balligand, Ungureanu et al. 1993; Brady 1993; Brady and Poole-Wilson 
1993; Brady, Warren et al. 1993; Grocott-Mason and Shah 1998).
Nitric oxide is a highly labile molecule and cannot easily be measured 
directly. The metabolites nitrite and nitrate can be measured in plasma as
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an index of nitric oxide concentrations. High nitrate and nitrite levels have 
been reported in hypotensive children with septic shock (Wong, Carcillo et 
al. 1996). In a study specific to MCD peak and admission nitrate and nitrite 
levels were highest in the children with severe meningococcal disease 
when compared to those with less severe disease (Baines, Stanford et al. 
1999).
There have been no studies investigating the relationship between the 
microcirculation and vasoactive mediators in sepsis.
6.2 Method
Patient recruitment, data collection, sublingual microvascular visualisation 
and blood sampling and analysis were carried out as detailed in Chapter 2.
6.2.1 Statistics
Data are presented as median and IQR and mean and standard deviation 
where appropriate. Correlations between variables were determined using 
Spearman rank correlation coefficient. Comparison between diagnostic 
groups was carried out using the Mann Whitney U test. A p value of <0.05 
was considered statistically significant. Statistical analyses were carried 
out using SPSS for Windows (version 14.0), (SPSS,Inc., Chicago, Illinois). 
Longitudinal analysis was carried out by the Medical Statistic Department at 
the University of Lancaster using the MFI for capillaries (MFIc) as the factor 
that other variables are related to as described in Chapter 2. As the 
findings in Chapter 5 demonstrated a close relationship between MFI and 
MFIc, only MFIc is used in statistical analysis in this chapter.
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6.3 Results
After informed consent, admission plasma samples were obtained from 43 
children who were reported to the research fellow as ‘suspected MCD’. 
MCD was confirmed in 33 and 10 had a presumed viral illness. Sequential 
plasma samples were available from 20 of the children with MCD. Twenty- 
three children who had blood taken during routine surgery were controls, 
the demographic features of these children are as described in Chapter 5.
6.3.1 ICAM-1
The median admission ICAM-1 levels per diagnostic group were: 273.9 
ng/ml for controls (IQR 255.9 to 352.8); 246 ng/ml for presumed viral illness 
(IQR 146 to 473.9); 594.7 ng/ml for MCD non-ventilated (IQR 363.5 to 
697.4) and 890.6 ng/ml for children with MCD requiring ventilation (IQR 
816.7 to 986) (Figure 6.4). The admission ICAM-1 levels were significantly 
higher in children with MCD than those with a presumed viral illness 
(p<0.01) and controls (p<0.01). Children ventilated with MCD had higher 
admission ICAM-1 levels than those who did not (p<0.05). There were 
negative correlations between admission ICAM-1 levels and admission 
MFIc and PPV. There were positive correlations between ICAM-1 and HI 
(Table 6.1). Table 6.2 shows that there was a weak reduction of ICAM-1 
overtime in parallel with MFIc.
I
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i
MCD no vent MC D ve nt
Diagnostic Group
Figure 6.1. Admission ICAM-1 levels per diagnostic group
Viral - presumed viral illness
MCD no vent - children with MCD who did not require ventilation at admission to hospital 
MCD Vent- children with MCD did not require ventilation at admission to hospital
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6.3.2 VCAM-1
The median admission VCAM-1 levels per diagnostic group were: 406 
ng/ml for controls (IQR 251.9 to 694.7); 1177.2 ng/ml for presumed viral 
illness (IQR 791 to 1517.4); 1465 ng/ml for MOD non-ventilated (IQR 
1331.9 to 1662.6) and 1930 ng/ml for children with MCD requiring 
ventilation (IQR 1664 to 2023.6) (Figure 6.5). The admission VCAM-1 
levels were significantly higher in children with MCD than those with a 
presumed viral illness (p<0.01) and controls (p<0.01). Children ventilated 
with MCD had higher admission VCAM-1 levels than those who did not 
(p<0.05). There were negative correlations between admission VCAM-1 
levels and MFIc and PPV. There was a positive correlation between 
VCAM-1 and HI (Table 6.1). Table 6.2 shows that there was no relationship 
between VCAM-1 and MFIc over time.
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Figure 6.2. Admission VCAM-1 levels per diagnostic group 
Viral - presumed viral illness
MCD no vent - children with MCD who did not require ventilation at admission to hospital 
MCD Vent- children with MCD did not require ventilation at admission to hospital
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6.3.3 P-Selectin
The median admission P-Seiectin levels per group were: 62.8 ng/ml for 
controls (IQR 47.3 to 77.4); 61.7 ng/ml for presumed viral illness (IQR 30.8 
to 107.9); 117.6 ng/ml for MCD non-ventilated (IQR 56.6 to 130.5) and 92.9 
ng/ml for children with MCD requiring ventilation (IQR 68.9 to 98.9) (Figure 
6.6). There was no significant difference in admission P-Selectin values 
between the diagnostic groups. There were no correlations between 
admission P-Selectin levels and the microcirculatory variables (Table 6.1). 
Table 6.2 shows that there was no relationship between P-Selectin and 
MFIc overtime.
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Figure 6.3. Admission P-Selectin levels per diagnostic group 
Viral - presumed viral illness
MCD no vent - children with MCD who did not require ventilation at admission to hospital 
MCD Vent- children with MCD did not require ventilation at admission to hospital
192
6.3.4 E-Selectin
The median admission E-Seiectin levels per group were: 102 ng/mi for 
controls (IQR 91.3 to 118.5); 94.5 ng/ml for presumed viral illness (IQR 
50.7 to 113.3); 202 ng/ml for MCD non-ventilated (IQR 160.5 to 298.3) and 
397.6 ng/ml for children with MCD requiring ventilation (IQR 300 to 450.8) 
(Figure 6.7). The admission E-Selectin levels were significantly higher in 
children with MCD than those with a presumed viral illness (p<0.001) and 
controls (p<0.001). Children ventilated with MCD had higher admission E- 
Selectin levels than those who did not (p<0.001). There were strong 
negative correlations between admission E-Selectin levels and MFIc and 
PPV. There was a strong positive correlation between E-Selectin and HI 
(Table 6.1). Table 6.2 shows that there was no relationship between E- 
Selectin and MFIc over time.
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Figure 6.4. Admission E-Selectin levels per diagnostic group
Viral - presumed viral illness
MCD no vent - children with MCD who did not require ventilation at admission to hospital 
MCD Vent- children with MCD did not require ventilation at admission to hospital
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MFIc CD PPV PVD HI
ICAM-1 r= -0.78 r= -0.1 r= -0.59 r= -0.1 r= 0.67
p<0.01 NS p<0.01 NS p<0.01
VCAM-1 r= -0.75 r= -0.1 r= -0.52 r=0 r= 0.64
p<0.01 NS p<0.05 NS p<0.01
E selectin r= -0.92 r= 0.02 r= -0.66 r=0.01 -i ii o bo
p<0.01 NS p<0.01 NS p<0.01
P selectin r= 0.14 r= -0.2 r= 0.05 ii ■ o w r= 0.1
NS NS NS NS NS
NO r=-0.56 r=-0.36 r=-0.38 r=-0.23 r=0.67
p<0.05 NS NS NS p<0.001
IL-6 r= -0.61
C
O
o
1
II r= -0.42 r= -0.21 r= 0.51
p<0.01 NS NS NS p<0.05
IL-8 r= -0.31 r= -0.47 r= -0.48 r= -0.33 r=-0.45
NS p<0.05 p<0.05 NS p<0.05
IL-1ra r= -0.24 r= 0.06 i~r=^0.2 r= 0.16 r= 0.06
NS NS NS NS NS
IL-10 r= -0.39 r= -0.43 r= -0.56 r= -0.34 r= -0.52
NS NS p<0.05 NS p<0.05
INF
t—CDiII ii i o Kj r= -0.2 -i ii ■ o r= 0.06
NS NS NS NS NS
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6.3.5 Nitric oxide
The median admission NO levels per group were: 41.8 nmol/ml for controls 
(IQR 25.6 to 62.8); 29.7 nmoi/ml for presumed viral illness (IQR 24.8 to 
37.2); 32.4 nmol/ml for MOD non-ventilated (IQR 19.7 to 41.6) and 70.7 
nmol/ml for children with MOD requiring ventilation (IQR 59.9 to 94.3). The 
admission NO levels were significantly higher in children with MOD than 
those with a presumed viral illness (p<0.001) and controls (p<0.001). 
Children ventilated with MCD had higher admission NO levels than those 
who did not (p<0.0001). There was a negative correlation between 
admission NO levels and MFIc and a positive correlation between NO and 
HI (Figures 6.8 and 6.9). Table 6.2 shows that there was a weak reduction 
of NO over time in parallel with MFIc.
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Figure 6.5. MFI for capillaries and NO at admission 
Spearman rank correlation r= -0.56, p<0.05
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Figure 6.6 Heterogeneity index and NO at admission 
Spearman rank correlation r= 0.67, p<0.001
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/\
P Cl
Table 6.2. Longitudinal analysis comparing changes of laboratory variables with
MFIc over time
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6.3.6 Cytokines
The relationship between admission levels of IL-1Ra, IL-6, IL-8, IL-10 and 
INF and microcirculation variables and their changes over time in relation 
to MFIc are shown in Table 6.1 and 6.2 respectively. There were negative 
correlations between MFIc and IL-6 and also PPV and HI with IL-8 and IL- 
10.
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6.4 Discussion
This study has demonstrated elevated levels of VCAM-1, ICAM-1, E- 
selectin and NO in children with MOD with the highest levels in ventilated 
patients. This study has also demonstrated a relationship between the 
microcirculation and vasoactive mediators in children with MOD.
Sepsis related tissue injury that leads to organ dysfunction and failure 
cannot be attributed to a single inflammatory mediator. IL-1b, IL-6, lL-8, IL- 
1Ra, 1L-10, TNF, IL-4 and IL-13 have all been shown to be associated with 
morbidity and mortality in adults and children with sepsis. (Casey, Balk et 
al. 1993; Koj 1996; Bjerre, Brusletto et al. 2004; Carrol, Thomson et al. 
2005). Endotoxin stimulation causes neutrophils to produce TNF and IL-lb 
which in turn stimulates the production of IL-6, IL-8 and IL-10. TNF and IL- 
1b induce fever, activates coagulation and trigger the expression of 
adhesion molecules.
Studies in adults with severe sepsis have shown that the expression of 
adhesion molecules is associated with disease severity with levels being 
highest in those patients with multiple organ failure. Cowley et al. 
demonstrated a relationship between mortality and high E-Selectin levels in 
adult sepsis (Cowley, Heney et al. 1994). Boldt et al. found that E- 
Selectin, ICAM-1 and VCAM-1 were all markedly higher in non-surviving 
than in surviving critically ill patients (Boldt, Wollbruck et al. 1995). The 
same group demonstrated that adult trauma patients showed lower plasma 
levels of E-Selectin, ICAM-1 and VCAM-1 than did sepsis patients 
indicating a more pronounced inflammatory related endothelial activation or 
damage in sepsis (Boldt, Muller etal. 1996).
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These finding have been corroborated by paediatric studies. Whaien et al. 
showed that piasma VCAM-1 (but not 1CAM-1 or E-selectin) was increased 
in children with sepsis and multi organ failure when compared to children 
with sepsis and no evidence of multi organ failure. They also demonstrated 
that ICAM-1 and VCAM-1 concentrations independently predicted multi 
organ failure. ICAM-1 and VCAM-1 also predicted mortality (Whalen, 
Doughty et al. 2000). A study specific to MCD recruited 67 children, 40 of 
whom had mild disease as defined by a GMSPS below 8. The E selectin 
values in those with severe disease were higher than in those with mild 
disease. P selectin concentrations were not altered in meningococcal 
disease, but those who died had lower concentrations. (Baines, Marzouk et 
al. 1999). More recently Krueger et al. studied VCAM-1, ICAM-1 and E- 
selectin in ventilated neonatal and paediatric intensive care patients with 
varying severity of multiorgan dysfunction. Dysfunction of three or more 
organ systems was associated with a significant increase in VCAM-1 
levels. A significant difference in E-selectin serum levels was found 
between patients with organ failure due to an infectious cause when 
compared to those with organ failure of non-infectious origin. This study 
found no relationship between adhesion molecules and mortality although 
the sample size was much smaller than that of Whalen et al. (Krueger, 
Heinzmann et al. 2007).
The data as presented here confirms the findings of these studies with the 
highest values of VCAM-1, ICAM-1 and E-selectin in ventilated patients 
with MCD. This study also adds new data about the pathophysiological 
process with the visualisation of the microcirculation. For the first time it 
has been possible to obtain a real time view of the microvascular
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dysfunction in severe childhood sepsis. The data demonstrates a 
relationship between dysfunctional tissue perfusion and endothelial 
activation. P-Selectin levels have not been observed to rise in previous 
studies investigating cell adhesion molecules in sepsis and this is 
confirmed here. There were also no correlations of P-$electin with 
microcirculation variables. This may be because P selectin is stored in 
Weibel-Palade bodies as a presynthesised molecule within endothelial cells 
and so is released rapidly in the inflammatory process. Possibly the peak 
concentration of P-Selectin is missed so that no correlations between it and 
microcirculation variables are detectable. In comparison E-selectin reaches 
a maximum at 6 h and returns to baseline at 24 hours post cell line 
stimulation with endotoxin. Levels of ICAM-1 and VCAIVM peak between 
12 and 24 hours and remain elevated for at least 48 hours (Springer 1994).
The reasons for this relationship between vasoactive mediators and 
microcircuiatory variables are likely to be complex. Truhan et al. examined 
17 adult patients with angiographically proven normal coronary arteries and 
slow coronary flow in all three coronary vessels. They found increased 
levels of ICAM-1, VCAM-1, and E-selectin in patients with slow coronary 
flow. They concluded that this may be an indicator of endothelial activation 
and was likely to be in the causa! pathway leading to slow coronary flow 
(Turhan, Erbay et al. 2005).
A clear relationship between NO and microcirculation variables has been 
documented in this study. This is consistent with a previous study in 19 
children with MCD in which higher levels of nitrates and nitrites (the 
composite measures of NO) were seen in the more severely affected 
children and there was a strong positive correlation with PRISM scores
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(Baines, Stanford et al. 1999). There are clear alterations in haemodynamic 
regulation in MCD producing maldistribution of oxygen delivery and 
arteriovenous shunting. Both processes result in the tissue hypoxia and 
lactic acidosis seen in severe sepsis. This cellular hypoxia is confounded 
due to impaired cellular oxygen extraction. In an animal model it is 
suggested that this occurs via mitochondrial disruption mediated by NO 
(Loke, McConnell et al. 1999). Mitochondria are the energy suppliers of 
cells. They are also involved in oxygen sensing and cell death. NO is 
thought to block the mitochondrial electron transfer chain at its terminal 
receptor. This then causes cellular hypoxia and an increase in 
mitochondrial derived reactive oxygen species concentrations (Poderoso, 
Carreras et al. 1996).
The exact mechanism causing the abnormal capillary blood flow observed 
using SDF in severe sepsis remains unknown. Hypoxia and hypovolaemia 
will inevitably play a role. This is the first study to show a relationship 
between the endothelial activation seen in MCD with abnormal blood flow. 
Direct endothelial destruction is likely to contribute to the microcirculation 
abnormalities seen in this study.
6.5 Conclusion
This study has demonstrated that children with severe MCD release cell 
adhesion molecules and NO into the bloodstream. It has also shown a 
relationship between these substances and the microcirculation as 
assessed using SDF imaging. Future work should be directed at 
elucidating the effects that cell adhesion molecules and NO have upon the
endothelium in childhood MCD.
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Chapter 7
Cardiac function in meningococcal disease
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7.1 Introduction
There are several complex interacting components contributing to the 
pathophysiology of the haemodynamic instability seen in MCD. Endothelial 
activation and damage leads to capillary leakage and a reduction in the 
circulating vascular volume. The inflammatory response to endotoxin 
released by the meningococcus results in peripheral vasodilatation. Healthy 
adults injected with endotoxin intravenously, had lower systemic vascular 
resistance and arterial pressure (Suffredini, Fromm et al. 1989). This study 
also showed that the cardiac output in these volunteers was high as a 
result of a reduced afterload, or did not change from baseline readings.
Myocardial dysfunction has been shown to be present and persistent 
despite the correction of the common physiological disturbances in children 
with MCD, such as acidosis, electrolyte derangements and hypovolaemia 
(Mercier, Beaufils et al. 1988). There is evidence of biventricular dilation, 
reduced ejection fraction and fractional shortening, and a requirement for 
high infusion rates of inotropes to maintain cardiac output within the normal 
range (Boucek, Boerth et al. 1984; Mercier, Beaufils et al. 1988; Hagmolen 
often Have, Wiegman et al. 2000; Briassoulis, Narlioglou et al. 2001).
The cause of this dysfunction is unclear (Boucek, Boerth et al. 1984; 
Mercier, Beaufils et al. 1988; Tavernier, Li et al. 2001). Explanations range 
from factors influencing cardiac contractility (Krown, Page et al. 1996; 
Comstock, Krown et al. 1998) to myocyte damage and death (Herbertson, 
Werner et al. 1996; Pathan, Sandiford et al. 2002). Cytokine production 
and release of intracellular mediators are likely to play a role, but this has 
not been fully elucidated.
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Pathan et al have shown that that myocardial depression was mediated in 
part by circulating factors and that the contractility of rat myocytes was 
suppressed by serum taken from patients with proven MCD. They also 
showed that myocardial depressant factors were released when whole 
blood or peripheral blood mononuclear cells of healthy donors are exposed 
to heat-killed meningococci (Pathan, Sandiford et al. 2002). This group 
went on to show that elevated IL-6 levels significantly reduced myocyte 
contractility and was associated with disease severity and myocardial 
dysfunction in patients with severe MCD (Pathan, Hemingway et al. 2004).
7.1.1 Assessment of cardiac function in sepsis
7.1.1.1 Biomarkers
The release of cTn into blood signifies myocardial necrosis (Katus, 
Remppis et al. 1991). An elevation of both cTnT and cTnl have been found 
in sepsis and are associated with a poorer prognosis (Swaanenburg et al. 
1998, Turner et ai. 1999b, ver Elst et al. 2000, Gunnewiek et al. 2004, 
Roongsritong et al. 2004, van Bockel et al. 2005). cTnT levels are 
associated with mortality, cardiac dysfunction and correlate with TNF, IL-6 
and sTNFR levels (Turner et al. 1999a, Ammann et al. 2003) and the inter­
cellular adhesion marker ICAM-1 in septic adults (Spies, Haude et al. 
1998). cTnl levels have been shown to be elevated in children with sepsis 
and correlate with disease severity scores, the level of inotropic support 
and evidence of ischaemia on EGG (Thiru, Pathan et al. 2000; Briassoulis, 
Narlioglou et al. 2001; Gurkan, Alkaya et ai. 2004). Release of cTn has 
been attributed to inflammatory myocardial damage and not ischaemia 
(Cunnion, Schaer et al. 1986). However, if a dysfunctional microcirculation 
is present in septic patients, ischaemia may be present in various organs, 
including the heart (Hersch, Gnidec et al. 1990).
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With the discovery that the infusion of myocardial tissue into rats caused 
diuresis, ANP was the first of the natriuretic peptides to be isolated and is 
released from cardiac atria (de Bold, Borenstein et al. 1981), Brain 
natriuretic peptide (BNP) was isolated initially from porcine brains (Sudoh, 
Kangawa et al. 1988) and subsequently from the ventricles of the heart 
(Suga, Nakao et al. 1992). The natriuretic peptides lower blood pressure by 
diuresis and vasodilation, inhibit the renin-angiotensin system, sympathetic 
outflow, vascular smooth muscle and endothelial cell proliferation (Hunt, 
Espiner et al. 1996). Both ANP and BNP are released in response to 
myocyte stretching and are therefore markers of myocardial wall stress 
(Magga, Marttila et al. 1994). They improve myocardial performance on 
their release due to their natriuretic properties. NT-Pro BNP is an 
established biomarker for the diagnosis of heart failure in adults and is 
considered a (first line) diagnostic tool for congestive heart failure in acute 
settings and in primary care (Wright, Doughty et al. 2003; Januzzi, 
Camargo et al. 2005; Januzzi, van Kimmenade et al. 2006).
NT-Pro BNP is a useful laboratory marker in the identification of systolic 
dysfunction in adults (Charpentier, Luyt et al. 2004; Roch, Allardet-Servent 
et al. 2005; Tang, Huang et al. 2007; Varpula, Puikki et al. 2007) and 
survival in sepsis (Brueckmann, Huhie et al. 2005). Two recent studies 
found that NT-Pro BNP discriminated between sepsis and non-sepsis 
related left ventricular failure in children (Domico, Liao et al. 2008) and is a 
useful tool in predicting septic shock (Fried, Bar-Oz et ai. 2006).
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7.1.1.2 Cardiac systolic, diastolic and global function assessment
Systolic function
Conventional two-dimensional M-mode echocardiography has been used in 
paediatric studies to evaluate sepsis related cardiac systolic dysfunction. 
(Boucek, Boerth et al. 1984; Hagmolen often Have, Wiegman et al. 2000; 
Briassoulis, Narlioglou et al. 2001; Gurkan, Alkaya et al. 2004). These 
studies have used either fractional shortening (FS) or the ejection fraction 
(EF) of the left ventricle.
FS measures the difference in left ventricular (LV) diameter during the 
cardiac cycle. It is calculated using the following formula:
LV end-diastolic diameter- LV end-systolic diameter 
LV end-diastolic diameter
Figure 7.1 shows the measurement of FS. Systolic dysfunction is classified 
as mild in the range of 27% to 30% and more severe below 27% 
(Gutgesell, Paquetetal. 1977; Snider AR 1990).
EF measures the volume changes during the cardiac cycle and is 
determined from the formula:
LV diastolic volume - LV systolic volume 
LV diastolic volume
A value of less than 50% represents systolic dysfunction (Snider AR 1990).
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Figure 7.1 Echocardiographic M-mode recording to measure Fractional Shortening. 
(Own image).
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Diastolic function.
Left ventricular filling pressure and diastolic function variables can be 
derived from flow measurements across the mitral valve at the level of the 
tips of the mitral valve leaflets. The early mitral peak flow velocity (E wave), 
atrial peak flow velocity (A wave), and the early mitral to atrial peak flow 
velocity ratio (E/A) are all methods of LV diastolic function assessment. 
There are several important factors in Doppler evaluation including sample 
volume and placement, recording speed, beam alignment and 
echocardiography machine settings (Appleton, Jensen et al. 1997). The 
initial abnormality in diastolic dysfunction is loss of the elastic recoil in early 
diastole. Diastolic dysfunction manifests as abnormal relaxation and there 
is a lower than normal E/A ratio. If this dysfunction progresses then active 
myocardial relaxation reduces and ventricular compliance becomes 
abnormal. In this state mitral inflow Doppler patterns are mildly abnormal. 
As diastolic dysfunction progresses, the E wave increases and the A wave 
becomes smaller. This is called the restrictive pattern and if it persists 
despite manipulation of filling pressure, then it is irreversible and is called 
stage IV LV diastolic dysfunction. These later changes are chronic and will 
not be seen in the acute setting such as severe sepsis. (Appleton, Hatle et 
al. 1988; Appleton, Jensen et al. 1997; Ommen and Nishimura 2003). 
Different loading conditions have effects on transmitral flow velocity (Wood 
and Picard 2004). Acute decrease in preload lowers E and A waves. 
Increase in preload has an opposite effect. The E wave decreases and the 
A wave increases if afterload is increased (Yamamoto, Redfield et al. 
1996).
Tissue doppler imaging (TDl) measures the velocity of the inter-ventricular 
septum and lateral mitral annulus during the cardiac cycle and provides an
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estimate of LV diastolic function {Ommen 2001). Conventional Doppler 
echocardiography measures biood flow at low amplitude and high 
frequency. Myocardial tissue velocities, however, have a higher amplitude 
and lower frequency. The TDI values recorded are a peak systolic annular 
velocity (Sa), a peak annular velocity during early diastole (Ea) and a peak 
annular velocity during atrial contraction (Aa) (Hiarada, Orino et al. 2000). 
These three distinct waveforms can be easily identified. (Figure 7.2).
Several time intervals can be obtained from the mitral annular TDI tracing. 
The isovolumic relaxation time (IRT) is defined as the time from the end of 
the systolic waveform to the beginning of the early diastolic velocity (wave). 
The isovolumic contraction time (ICT) is defined as the time from the end of 
the diastolic waveform with atrial contraction to start of the systolic velocity 
(wave). (Figure 7.2). Peak early diastolic myocardial velocity (Ea) is 
measured at the lateral corner of the mitral valve annuius and is a more 
reproducible measurement than the septal annular velocity (Sohn, Chai et 
al. 1997). Ea is a good index of LV relaxation and appears to be less 
sensitive to alterations in preload (Nagueh, Middleton et al. 1997; Oki, 
Tabata et al. 1997). These values are age and heart rate specific but 
normal values to account for this in children have been reported as Z score 
tables (Roberson, Cui et al. 2007). In combination with pulsed-wave 
Doppler echocardiography, Nageuh and colleagues showed that the E/Ea 
ratio (when the Ea is recorded at the lateral mitral annulus) correlates with 
invasively measured LV filling pressures in adults (Nagueh, Middleton et al. 
1997; Nagueh, Mikati et al. 1998). This relationship has been confirmed in 
children, where patients with an E/Ea ratio of >9.8 have high LV end 
diastolic pressures (Oyamada, Toyono et al. 2008).
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Diastolic dysfunction in septic adults has been investigated in four studies. 
Three studies used pulsed wave Doppler flow across the mitral valve to 
assess left ventricular inflow patterns and showed diastolic dysfunction. 
(Jafri, Lavine et al. 1990; Poelaert, Declerck et al. 1997; Munt, Jue et al. 
1998). A recent study used TDI to assess the LV diastolic function of 
adults with severe sepsis. (Bouhemad, Nicolas-Robin et al. 2008). it 
confirmed the findings of the previous three studies and showed that the 
impairment of left ventricular relaxation was reversible but associated with 
transient increases in cTnl, TNF, IL-8, and IL-10.
No previous studies have evaluated diastolic dysfunction in children with 
sepsis.
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Figure 7.2. Tissue Doppler velocity curve in a healthy volunteer. Apical 4-chamber view. 
The pulsed wave Doppler sample volume is positioned in the basal interventricular 
septum. The initial positive excursion represents the isovolaemic contraction time (ICT), 
Peak systole (Sa) is followed by a positive excursion represents the isovolaemic 
contraction time (]RJ) followed. The negative waves represent early (Ea) and late (Aa) 
diastole. (Own image).
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Global function -Tei index
Systolic and diastolic LV dysfunction can be, and often are, present 
simultaneously. The indices of cardiac function discussed here were 
designed to assess either systolic or diastolic function alone. The Tei index 
evaluates systolic and diastolic function and is also known as the 
myocardial performance index (Figure 7.3.). The calculation is made from 
the respective times from the start to the end of transmitral blood flow 
(interval a) and from the start to the end of aortic ejection (interval b) (Tei 
1995; Tei, Ling et al. 1995). interval a is the sum of the ICT, ejection time 
(ET), and IRT, and a - b is the sum of ICT and IRT, The ICT is the time 
interval from the mitral valve closing to the aortic valve opening and IRT is 
the time from aortic valve closure to mitral valve opening. They are indices 
of systolic and diastolic function respectively and become prolonged as 
function deteriorates. The ICT and IRT are both dependent on the heart 
rate. The ET measurement is determined by stroke volume. It too can be 
shortened by systolic or diastolic dysfunction. It is also dependent on heart 
rate. When the ICT is divided by the ET it becomes independent of heart 
rate and a decrease in systolic function can be identified more clearly. 
Similarly the IRT also becomes independent of the heart rate when divided 
by the ET. The sum of the ICT/ET and IRT/ET is the Tei index and 
increases when there is impairment of either systolic or diastolic function 
(Pellett, Tolar et al. 2004).
The Tei index was initially measured by pulsed wave Doppler ultrasound. A 
limitation of using pulsed Doppler is that the interval between the end and 
onset of mitral inflow and ejection time are measured sequentially and not 
in the same cardiac cycle. Heart rate variability can therefore affect the
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findings. TDI enables the simultaneous measurement of both the systolic 
and diastolic components of the cardiac cycle and in therefore a superior 
method of evaluating the Tei index. Studies have shown good 
reproducibility using this method (Harada, Tamura et al. 2002; Cui and 
Roberson 2006). Normal values have been established for the left ventricle 
in children and are 0.35 ± 0.03. A value of 0.40 or higher in the left ventricle 
is abnormal (Eidem, Tei et al. 1998).
No studies in adults or children have evaluated the Tei index in sepsis.
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Tei index a-bb
Figure 7.3
Schematic of Doppler flow velocity to represent the time intervals necessary to derive the left 
ventricular Tei index. Time interval ‘a’ is the end of mitral inflow to the start of mitral inflow (of the 
next cycle), it includes the isovolumic contraction time (ICT), ejection time and the isovolumic 
relaxation time (IRT). Time interval ‘b’ is the duration of the ejection time (the left ventricular 
outflow).
Taken from Pellett, A. et al. (2004). "The Tei index: methodology and disease state values. 
Echocardiography 21(7): 669-72.(Pellett, Tolar et al. 2004)
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7.1.1,3 Cardiac output measurement
Cardiac output (CO) can be measured non-invasively, using Doppler 
ultrasound. The measurements needed are the blood velocity in the 
ascending aorta and the cross sectional area of the aortic valve. The 
calculation (below) gives the stroke volume and when this value is 
multiplied by the heart rate gives the CO. This method of evaluating CO 
has been well validated in adult and child studies (Chew and Poeiaert 
2003; Brueckmann, Huhle et al.). However CO varies with size and is 
indexed for body surface area (CO/BSA) to give the cardiac index (Cl). The 
normal (resting) value for cardiac index is between 3 l/min/meter2 to 5 
l/min/meter2 (Ceneviva, Paschall et al. 1998). Ceneviva et al showed that 
60% of a group of children with septic shock had a low cardiac index.
To calculate the volume of blood coming into the ascending aorta from the 
left ventricle the temporal mean velocity is measured but certain 
assumptions need to be made. These are that the flow across the aortic 
valve is laminar, the ultrasound probe is placed in the suprasternal notch 
such that the Doppler beam is parallel to the flow in the ascending aorta to 
ensure that maximal velocities are recorded. The mean velocity is 
calculated from the area under the Doppler curve also known as the 
velocity time integral (VTl). This is repeated over several cardiac cycles to 
obtain a mean value. The area under the Doppler curve can be calculated 
using software incorporated into the echocardiographic machine and is 
shown in Figure 7.4. The systolic aortic diameter (DAo) then has to be 
measured using M mode.
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From this measurement the aortic cross sectional area can be determined 
using the formula:
Aortic cross sectional area x DAo2
Stroke volume is then calculated as follows:
VTI x Aortic cross sectional area.
CO is calculated by SV x heart rate.
The systemic vascular resistance can be calculated once cardiac output is 
known using the following formula:
Systemic vascular resistance (SVR) = MAP-CVP
CO
Normal values lie between 11 to 15 Woods units.
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Figure 7.4. Principles of cardiac output calculation using echocardiography.
A. The pulsed wave doppler gate is placed in the ascending aorta. The velocity recording is 
shown beneath. The velocity recording's outline is traced (red line). The area under the red 
line indicates the velocity time interval (VTI)
B. Schematic representing the area under the maximum aortic velocity represent the stroke
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7.2 Method
7.2.1 Patients
Patient recruitment, data collection and blood sampling are detailed in 
Chapter 2. Forty three children were recruited due to the diagnosis of 
‘suspected MCD’. After informed consent, admission and sequential 
plasma samples were obtained from 23 and 20 children respectively. The 
20 children in whom sequential biood sampling was possible were all 
ventilated and admitted to PICU. in one of these children repeated 
echocardiography for longitudinal analysis and any measurement of TDI 
velocities (including admission) were not possible - only an admission 
echocardiogram was possible. This was due to an acute clinical 
deterioration during initial echocardiography which was therefore not 
repeated. Twenty-three children undergoing routine surgery formed the 
control group.
Sixteen of the 20 children admitted to PICU were ventilated using controlled 
mechanical ventilation. Tidal volume was set between 6 and 9 ml/kg, and 
respiratory rate was adjusted by the clinician in charge of the patient to 
achieve acceptable PaC02 values. Inspiratory time was between 0.3 and 
0.6 seconds, according to the age of the child, set by the treating physician. 
Fi02 and positive end expiratory pressure (PEEP) were adjusted to 
maintain arterial oxygen saturation Sa02 at £ 90% throughout the study 
period. The remaining 4 children were ventilated using high frequency 
oscillation. Inspiratory time was fixed at 33% and Fi02 adjusted to maintain 
arterial oxygen saturation Sao2 at >=90% throughout the study period. The 
mean airway pressure and frequency were adjusted to achieve acceptable 
Pa02 and PaC02 values respectively. All patients were sedated with 
morphine and midazolam initially. Mean arterial pressure was measured
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using an indwelling arterial catheter (Hewlett Packard Hp monitors). CVP 
was assessed from an indwelling central venous line (Hewlett Packard Hp 
monitors).
7.2.2 Echocardiography
Systolic and diastolic cardiac function measurements, cardiac output and 
the Tel index were assessed using the methods described in Chapter 2 and 
this chapter. An abnormal FS was defined as < 27%. Tissue Doppler 
values were abnormal if they were 1.5 standard deviations (Z-scores) from 
the mean as per published results for normal children (Roberson, Cui et al. 
2007). Cardiac output was calculated and analysed as described in section 
7.1.1.3.
7.2.3 Troponin
cTnl and cTnT were measured by an automated Troponin i and T STAT 
(Short Turn Around Time) assay, using Eiecsys 10:10 apparatus, Roche 
Diagnostics GmbH, Mannheim. This involves an Eiectro-Chemical- 
Luminescence ImmunoAssay (ECLIA). An abnormal result was defined as 
>0.2 ng/ml for cTnl and >0.01 ng/ml for cTnT.
7.2.4 NT-Pro BNP
Plasma NT ProBNP concentrations were determined using a commercially 
produced ELISA kit, 96 well plate, Biomedica Gruppe, Austria, according to 
the manufacturer’s instructions.
Samples and Controls were diluted 1:10 in assay buffer before being 
assayed (10 pi sample + 90 pi assay buffer). The samples were defrosted 
once only for the assay having been frozen since collection.
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7.2.4a Reconstitution
Wash buffer: Diluted with the wash concentrate 1:20 i.e. 50 ml wash buffer 
+ 950 ml distilled water.
Standard: 3 mis of assay buffer was pipetted into the vial and left at room 
temperature (18-26°C) for 30 min. The reconstituted standard has a 
concentration of 1,000 fmol/ml. Control: 250 pi of distilled water was 
pipetted into the vial and left at room temperature for 30 min.
A 1:2 dilution series with the reconstituted standard and Assay buffer was 
prepared as follows:
Standardl = reconstituted standard (1.000 fmol/ml)
500 pi Standardl + 500 pi Assay buffer - Standard2 (500 fmol/ml)
500 pi Standard2 + 500 pi Assay buffer = Standards (250 fmol/ml)
500 pi Standards + 500 pi Assay buffer = Standard4 (125 fmol/ml)
500 pi Standard4 + 500 pi Assay buffer = Standards (62.5 fmol/ml)
500 pi Standards + 500 pi Assay buffer = Standards (31.25 fmol/ml)
7.2.4b Method
200 pi Assay buffer was placed into the wells marked as blank in duplicate. 
200 pi diluted standard, diluted sample or diluted control were placed in 
duplicate into their respective wells leaving the blank.
50 pi Conjugate was placed into each well, except the blank.
The plate was covered with a plate cover and incubated overnight at 4°C in 
the dark.
The plate was washed five times with 300pl of diluted wash buffer using an 
automated plate washer. Any remaining wash buffer was removed by 
hitting the inverted plate against paper towel after the last wash.
200 pi of substrate was pipetted into each well.
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The plate was covered with a plate cover and incubated for 20 min at room 
temperature in the dark.
50 pi of Stop solution was pipetted into each well.
The absorbance at 450 nm was read immediately, subtracting the blank 
well absorbance from all other values. A standard curve was constructed 
from the standard values using commercially available software and 
sample concentrations were obtained from this standard curve. The 
concentration of a sample was taken from the mean of the two wells
7.2.4c Performance characteristics of the assay
The minimum detectable concentration of the assay was 5 fmol/ml with an 
inter-assay coefficient of variation of 4-6.5 % and an intra-assay coefficient 
of variation of 3.8-4.4 %. A panel of blood donors (n=110) showed a 
median of 208 fmoi/ml (95th percentile 300 fmol/ml).
7.2.5 Cytokine determination
Cytokines were measured using Luminex technology as described in 
Chapter 5.
7.2.6 Statistics
Data are presented as median and IQR and mean and standard deviation 
where appropriate. Correlations between variables were determined using 
Spearman rank correlation coefficient. A p value of <0.05 was considered 
statistically significant. Receiver operator characteristic (ROC) plots were 
used to calculate the area under the curve (AUC) to compare the 
performance of NT-Pro BNP, PCT and CRP in the identification of septic 
shock in MCD. Inter- and intraobserver agreement for measurements of 
FS was obtained by selecting 10 random images for two independent
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observers to assess. Agreement is expressed as Bland-Altman plots. 
Statistical analyses were carried out using SPSS for Windows (version 
14.0), (SPSS, Inc., Chicago, Illinois) and Analyse-lt Software v.1.62 for 
Microsoft Excel (Analyse-lt Software, Leeds, UK).
7.3 Results
Sixty six children were included in this study. Twenty children had severe 
MCD requiring ventilation and admission to PICU. All of these children had 
septic shock. Two children required limb amputations but there were no 
deaths. Thirteen children with MCD did not require intensive care 
admission, 10 children had a presumed viral illness and there were 23 
controls (See Chapter 2).
7.3.1 Cardiac Troponin and systolic function
Among the 43 patients recruited at admission to hospital due to possible 
diagnosis of MCD, 12 (29%) had an increase in cTnl and cTnT within 24 
hours of admission to hospital. cTnT and cTnl were both elevated in these 
12 cases, and were highly correlated. (Spearman rank r-0.98, p<0.001).
All of the children with abnormal cTn values were confirmed MCD cases, 
receiving ventilatory respiratory support. They represented 60% of the 20 
children admitted to PICU with severe MCD. The clinical characteristics of 
these 20 patients are summarized in Table 7.1. None of the children with a 
presumed viral illness or those with a confirmed diagnosis of MCD who did 
not require admission to PICU had an elevated cTnT or cTnl. In patients 
with a raised cTn the peak concentrations (median, IQR) were 1.0 ng/ml 
(0.32-2.3 ng/ml) for cTnl and 0.38 ng/ml (0.19-1.0 ng/ml) for cTnT as 
shown in Figure 7.5.
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An increased cTn within 24 hours of admission was seen in 12 children 
(60%). 10 of the 20 children admitted to PICU had systolic dysfunction and 
a rise in cTn. Two of the ventilated children had raised cTn values but 
normal cardiac systolic function. Two children had persistent systolic 
dysfunction at 6 hours post admission, both with elevated cTn. All children 
had normal systolic function at 12 hours after admission. The correlations 
between systolic function, measured by FS, at admission and the peak in 
cTnT and cTnl were -0.68 (p<0.001) and -0.73 (p<0.005) respectively.
The demographic, clinical, and biological markers of children admitted to 
PICU with raised cTn! and cTnT were compared to the PICU patients with 
normal concentrations (Table 7.1). The two groups differed in the duration 
and type (inotrope score) of inotropic support administered, duration of 
ventilatory support, systolic function and the values of cytokine 
measurements (Table 7.1). The male-to-female ratio did not differ 
according to cTn status. Patients with elevated cTn values had higher 
GMSPS scores at admission but not PRISM III or the PELOD scores (Table
7.1) . Significant positive correlations were found between peak cTn 
concentrations and length of hospital and PICU stay, length of ventilatory 
and inotropic requirement whilst on PICU, disease severity assessments 
scores, resuscitation volume required, and admission lactate value. (Table
7.2)
Tr
op
on
in
 le
ve
l in
 n
g/
m
l
226
Hours past admission
Figure 7.5 Median peak clnl and cTnT per time point with interquartile ranges in 20
children with severe MCD.
227
Raised Troponin Normal Troponin p value
Total number 12 8 -
Age in months (range) 2.54
(0.83 to 15.2)
1.42
(0.5 to 15.3)
NS
Sex (male %) 4 (33%) 4 (50%) NS
GMSPS at admission (IQR) 12
(10 to 14)
9
(3.5 to 12.5)
<0.05
PELOD at admission (IQR) 19
(15 to 22)
12.5
(7 to 17.5)
NS
PRISM III at admission (IQR) 19
(6.3 to 31)
20
(15.5 to 25.5)
NS
Duration of ventilation in hours
(IQR)
57
(18 to 96)
30
(17.5 to 42.5)
<0.01
Duration of inotropic
requirement in hours (IQR)
40
(23 to 57)
18
(8 to 28.5)
<0.01
Inotrope score at admission 39
(6 to 82)
10
(6 to 22)
<0.01
Resuscitation volume in ml/kg
(IQR)
110
(50 to 162)
80
(50 to 110)
NS
FS% at admission (IQR) 22
(15 to 29)
35
(27.5 to 42.5)
<0.001
Cardiac index in litres/m2/min at
admission (IQR)
6.5
(3.5 to 10)
5.9
(3.1 to 8.8)
NS
Peak IL-6 in pg/ml (IQR) 6821.5
(2082.8 to 16242.3)
446.5
(48.3 to 2170.1)
<0.001
Peak IL-10 in pg/ml (IQR) 740.5
(280.5 to 4661.8)
146.9
(38.1 to 834.5)
NS
Peak IL-8 in pg/ml (IQR) 1148.5
(563 to 12158.5)
220
(47.1 to 1456)
<0.01
Peak INF in pg/ml (IQR) 292.5
(200.8 to 398.6)
68.5
(33.3 to 314)
<0.01
Table 7.1. Demographic table of 20 children admitted to PICU with severe 
MCD. Results are expressed as medians and interquartile ranges.
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Peak cTnl Peak cTnl
R P value R P value
Duration of Hospital Stay
(days)
0.65 <0.0001 0.65 <0.0001
Duration of PICU stay (days) 0.72 <0.0001 0.72 <0.0001
Duration of ventilatory
requirement (hours)
0.76 <0.0001 0.76 <0.0001
Duration of inotropic
requirement (hours)
0.75 <0.0001 0.75 <0.0001
Resuscitation Volume (ml/kg) 0.67 <0.0001 0.66 <0.01
Lactate 0.63 < 0.0001 0.57 <0.005
Maximum GMSPS 0.67 < 0.0001 0.67 < 0.0001
PRISM III 0.46 <0.01 0.48 <0.005
PELOD 0.6 <0.0001 0.62 <0.0001
Peak Inotrope score 0.6 <0.0001 0.61 <0.01
Table 7.2. Multiple Linear Regression Analysis of factors affecting peak Troponin T 
Adjusted R Square= 0.23, F=7.57, p<0.05 (using stepwise model)
229
The cTnl and cTnT concentrations were normalised by logarithmic 
transformation and then entered into a multiple linear regression analysis to 
assess the independent predictor ability of cTnl and cTnT for duration of 
ventilatory requirement after adjustment for the following independent 
variables: age, gender and length of illness. Step-wise multiple linear 
regression showed that peak cTnT and cTnl were independent factors 
associated with the duration of ventilation. Excluded from the model were 
age, sex and length of time of illness (and rash) prior to hospitalisation. 
The regression model gives the following equation for the estimation of 
ventilatory time:
Duration of ventilation in hours - 18.6 + 68.3 x (peak cTnT) - 1.36 x (peak 
cTnl)
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Predictor variable B
coefficient
P value 95% Cl
Peak cTnT 68.3 <0.001 32 to 104.6
Sex 0.65 0.62 NA
Age (years) -0.15 0.32 NA
Duration of illness
prior to
hospitalisation
0.07 0.6 NA
Duration of rash prior
to hospitalisation
0.15 0.27 NA
Table 7.3. Multiple Linear Regression Analysis of factors affecting peak Troponin T 
Adjusted R Square= 0.23, F=7.57, p<0.05 (using stepwise model)
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7.3.2 NT-Pro BNP and Diastolic function
NT-proBNP analysis was carried out on plasma samples taken from 66 
children at the time of admission to hospital and 12 and 24 hours post 
admission where possible. Levels of NT-proBNP were significantly higher 
in all children with MCD compared to those with a presumed viral illness 
(Mann Whitney U, p<0.01) and controls (Mann Whitney U, p<0.01) at 
admission. There was also a significant difference in NT-proBNP between 
children with MCD who required mechanical ventilation at admission and 
those that did not as shown in Figure 7.7 (Mann Whitney U, p<0.05). 
Median admission NT-proBNP per group and demographic data are shown 
in Table 7.4. At 24 hours after admission, levels of NT-Pro BNP in children 
with MCD who required mechanical ventilation were no longer significantly 
higher than in those that did not (Mann Whitney U, p=0.19).
Two (10%) children of the 20 children with MCD receiving mechanical 
ventilation had abnormal left ventricular filling pressure patterns with an E/A 
ratio less than 1 as assessed by pulsed wave Doppler. There was no 
significant difference in admission and pre-extubation E/A ratios (Table 
7.5).
Seven of the 19 children had abnormal diastolic function at admission as 
assessed by the Ea wave of the TDI tracing being 2 Z-scores below the 
mean when accounting for heart rate and age. This represented 37% of 
the children receiving mechanical ventilation. The same 7 children had an 
E/Ea ratio above 10 indicating abnormally raised LV filling pressure. The 
two children with an abnormal E/A ratio were included in this group. All of 
the children who had evidence of diastolic dysfunction also had systolic
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dysfunction with an FS of below 27%. A significant difference between 
admission and pre-extubation values found for Ea velocity and the E/Ea 
ratio (Table 7.5). Figure 7.9 shows the development of these changes over 
time.
Both the Ea velocity and the E/Ea ratio correlated with the total duration of 
inotropic support (r=-0.71, p<0.01 and r=0.53, p<0.05 respectively). There 
was no correlation found with inotrope scores.
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All MCD MCD
ventilated
MCD
not ventilated
Presumed
viral
Control
Total number 33 20 13 10 23
Sex [male] 13
[39.4%]
8
[40%]
5
[38.5%]
3
[30%]
13
[56.5%]
Age at 2.25 2.16 2.25 1.25 2.5
admission in
years [IQR]
[0.98 to 4.6] [0.6 to 4.38] [0.84 to 4.8] [0.57 to 2.8] [0.75 to 4.5]
Admission NT- 1606 2578 587 381.5 461.8
proBNP in
fmol/m [IQR]
[600.0 to 2926.0] [1715 to 5315.9] [509.3-615.0] [184.3-511.0] [365.0 to 537.4]
Admission
CRP in mg/I
[IQR]
88.8
[45.5 to 148.6]
126.5
[62.6 to 156.2]
60.6
[26.7 to 94.1]
4.7
[4 to 21]
All <4
Maximum
GMSPS [IQR]
8 [3 to 12] 11 [9 to 12] 3 [2 to 3] 3 [2 to 3]
Table 7.4 Characteristics of included participants (results expressed as median [IQR])
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Figure 7.6 Box and whisker plot indicating NT-Pro BNP levels at 
admission between the diagnostic groups.
MCD no vent = children with confirmed MCD who did not require 
ventilation. MCD vent = children with confirmed MCD who did require
ventilation.
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Figure 7.7. Box and whisker plot showing changed in NT-Pro BNP 
levels overtime in children with severe MCD.
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Admission
Mean ± SD
Range Pre-extubation
Mean ± SD
Range p value
Heart rate
(beats/min)
153.8±35.8 100-200 130.8122.7 90-140 0.54
E (cm/sec) 120.7H6.5 88-158 123117.9 92-169 0.63
A (cm/sec) 71128 20-130 78.2121.6 39-135 0.23
E/A 1.5210.5 0.8-2.7 1.4810.3 1.2-2.8 0.76
Ea (cm/sec) 10.213.8 3-16 12.912.6 8-18 <0.05
Aa (cm/sec) 71128 20-130 72127 30-150 0.95
Ea/Aa 1.5710.6 0.4-2.5 2.110.9 0.6-4.3 <0.05
E/Ea 9.913.7 4-18 7.911.5 7-9 <0.05
Table 7.5. Diastolic echocardiographic measurements in children with severe MCD 
at admission to PICU.
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Figure 7.8. Changes in mean TDI Ea wave and E/Ea ratio in children with 
severe MCD over time (with standard error bars)
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There were negative correlations between admission NT-proBNP and FS 
(r—0.45, p<0.05), and Ea (r"-0.57, p<0.05). These relationships were no 
longer significant at 24 hours post admission. There was a positive 
correlation between NT-proBNP and E/Ea (r^O./l, p<0.05). The 
relationship is shown in Figure 7.10. There were also positive correlations 
between admission and peak NT-proBNP and duration of hospital stay, 
GMSPS and PRISM III, duration of inotropic requirement and resuscitation 
volume (Table 7.6). 36 of 43 children had peak levels at the time of first 
measurement. Three children had peak levels at 12 and three at 24 hours 
post admission.
To account for children presenting to PICU at different points of their 
illness, multiple linear regression analysis was used to assess the 
independent predictor ability of NT-Pro BNP for the E/Ea ratio after 
adjustment for the duration of illness, including the duration of a rash and 
the duration of time that the child was ventilated prior to PICU admission. 
The results show that even when accounting for children presenting at 
different times in their illness admission NT-Pro BNP levels still predict left 
ventricular filling pressure as assessed by the E/Ea ratio (Table 7.7)
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Characteristics Admission
NT-Pro BNP
Peak
NT-Pro BNP
R P value R P value
Duration of Hospital Stay (days) 0.72 <0.0001 0.78 <0.0001
Duration of PICU stay (days) 0.8 <0.0001 0.79 <0.0001
Duration of ventilatory requirement
(hours)
0.82 <0.0001 0.82 <0.0001
Duration of inotropic requirement
(hours)
0.82 <0.0001 0.82 <0.0001
Resuscitation Volume (ml/kg) 0.84 <0.0001 0.84 <0.0001
Lactate 0.19 NS 0.17 NS
Admission GMSPS 0.83 <0.0001 0.82 <0.0001
Maximum GMSPS 0.80 < 0.0001 0.80 < 0.0001
PRISM III 0.78 <0.0001 0.79 <0.0001
PELOD 0.76 <0.0001 0.76 <0.0001
Admission Inotrope score 0.27 NS 0.25 NS
Peak Inotrope score 0.30 NS 0.3 NS
Fractional shortening -0.45 <0.05 -0.44 <0.05
Ea -0.57 <0.05 -0.6 r<0.05
E/Ea 0.71 <0.05 0.7 <0.05
Table 7.6 Correlation table for admission and peak NT-Pro BNP levels.
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Predictor variable B
coefficient
P value 95% Cl
Admission NT-Pro BNP 0.66 <0.001 0.001 to 0.002
Duration of ventilation prior to -0.2 0.29 -0.3 to 0.99
PICU admission
Duration of rash prior to 0.4 0.051 -0.006 to 1.52
hospitalisation
Table 7.7. Multiple Linear Regression Analysis of factors affecting the 
relationship between admission NT-Pro BNP levels and the E/Ea ratio. 
Adjusted R Square= 0.58, F=9.2, p<0.01 (using stepwise model)
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Figure 7.9. Scatter plot showing the relationship between NT-Pro BNP and 
left ventricular pressure as evaluated by the E/Ea ratio. r=0.71, p<0.05. 
Blue circles represent patients in septic shock. Red circles represent 
patients not in septic shock
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7.3.3 Global function
The Tel index was greater than 0.40 at the time of admission in 10 children, 
including the 10 children that had systolic dysfunction and the 7 with 
diastolic dysfunction. There was a significant difference in the admission 
and pre-extubation Tei index value for the 19 children (p<0.05). Figure 
7.12 shows the change in the mean Tei index over time.
There was a negative correlation between the Tei index and FS on 
admission. (r=“0.47, p<0.05). Positive correlations were found between the 
admission Tei index and total durations of ventilation, inotropic support and 
PICU admission (r=0.62, p<0.05, r=0.48, p<0.05 and r=0.77, p<0.05 
respectively). No correlations were found with the Tei index and IL6 
(p=0.38), IL8 (p=0.12), IL10 (p=0.52) or TNF (p=0.39).
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Figure 7.10. Changes in mean Tei index in children with severe MCD 
over time (with standard error bars)
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7.3.4 Cardiac output and index
Seven out of the 20 children (35%) admitted to PICU had a low cardiac 
output at the time of admission (less than 3.3 litres per minute). When 
indexed to take into account BSA only one child (5%) had a low cardiac 
index (less than 3 I/m in/meter2). Five of the 20 (25%) children had a high 
cardiac output (more than 5 litres per minute). When indexed to take into 
account BSA, 13 children (65%) had a high cardiac index (more than 5 
l/min/meter2). One of the two children who subsequently had limb 
amputations had a high Cl and the other a low Cl at the time of admission. 
One of these children did not have any further echocardiography carried 
out. The Ci of the children who did had serial echocardiography 
normalised alongside clinical recovery.
No correlation were found between admission Cl with peak cTnl (p=0.08, 
p=0.85 respectively), clnT (p-0.08, p=0.9 respectively) or peak NT-Pro 
BNP levels (p=0.42, p=0.9 respectively). There was a statistically 
significant difference found between the admission and pre-extubation 
values for cardiac output and index for the 19 children (p<0.05), with values 
being high and returning to the normal range. There was also a statistically 
significant difference found in the admission cardiac output and cardiac 
index between children with an admission GMSPS above 8 and those 
below 8 (p<0.05 and p<0.005 respectively) with higher values being seen in 
the group with a GMSPS above 8.
Negative correlations were found between admission SVR and CO and Cl 
(Figure 7.15 and Figure 7.16)
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r=-0.84
p<0.0001
SVR in Woods units
Figure 7.11. Scatter plot to display relationship between admission cardiac 
output and systemic vascular resistance in 20 children with severe MCD
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r=-0.55
p<0.05
SVR in Woods units
Figure 7.12. Scatter plot to display relationship between admission cardiac index 
and systemic vascular resistance in 20 children with severe MCD
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7,3.5 Agreement
From the 20 ventilated patients ten echocardiographic M-mode images 
were chosen from a convenient sample and the FS measured by observer 
1 and observer 2 independently. A Bland-Altman plot constructed from the 
10 images (Figure 7.13) shows the limits of agreement. The 95% 
confidence interval for the lower limit is -5.1 to -1.3 and for the upper is 2.6 
to 4.5. The 95% repeatability coefficient was 1.3%. This means that the 
value within which the differences between two images analysed by two 
observers is expected to be 1.3% for 95% of subjects.
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Figure 7.13. Bland Altman plot to show agreement between two independent 
observers in the assessment of fractional shortening
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7.4 Discussion
7.4.1 Cardiac Troponin and systolic function
This study has shown abnormal cardiac systolic function in children with 
severe MCD which improves alongside clinical recovery and is associated 
with cTnl and cTnT release. It has also shown significant positive 
correlations between peak cTn levels and indicators of disease severity 
including severity assessment scores, duration of inotropic and ventilatory 
support and hospital stay. These results confirm the finding from other 
paediatric septic shock and MCD specific studies (Thiru, Pathan et al. 
2000; Briassoulis, Narlioglou et al. 2001; Fenton, Sable et al. 2004; Gurkan, 
Alkaya et al. 2004; Lodha, Arun et al. 2009). None of these studies 
described how many children had abnormal cTn levels but normal cardiac 
function. This occurred in two children in this study, who were both 
transferred from other regional hospitals. Echocardiography may have been 
performed after the earlier introduction of cardiovascular support had 
corrected any detectable cardiac dysfunction.
The relationship between myocardial injury and dysfunction and MCD is 
complex, has not been fully elucidated and may well not be applicable to all 
forms of bacterial sepsis. Endotoxin stimulates the release of TNF, IL-1(3, 
other pro-inflammatory cytokines and reactive oxygen species, which 
reduce myocyte contractility (Balligand, Kelly et al. 1993; Balligand, 
Ungureanu et al. 1993; Kumar, Thota et al. 1996). Studies in rats have 
demonstrated that sustained infusions of TNF leads to contractile 
dysfunction and LV dilatation. This was partially reversed by stopping the 
infusion or by treatment with a TNF antagonist (Bozkurt, Kribbs et al. 1998). 
Human volunteers demonstrate similar responses when given TNF
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infusions (Van der Poll, Romijn et al. 1991; van der Poll, van Deventer et al. 
1992). INF works synergisticaily with IL-6 in causing an increase in 
myocyte cell membrane permeability. An intracellular rise of free calcium is 
the event that couples myocyte electrical excitation with contraction. 
Calcium ions also play a role in the excitation process itself. Total and 
ionised calcium has been shown to be reduced in 70% of children with 
MCD, with a negative correlation between calcium concentration and 
disease severity (Baines, Thomson et al. 2000). Pathan et al used gene- 
expression profiling to identify a serum factor causing cardiac dysfunction in 
MCD. IL-6 was found to cause significant myocardial depression in vitro. 
When IL-6 was removed from serum samples of patients with MCD and 
from supernatants of inflammatory cells stimulated by meningococci in 
vitro, the negative inotropic activity was eliminated. The relationship 
between IL-6 and myocyte contractility was dose dependent (Pathan, 
Hemingway et al. 2004).
Aggressive fluid management could lead to left ventricular strain and thus 
myocyte damage. Alternatively those with most myocyte damage may 
have the worst cardiac function and therefore need more fluid resuscitation. 
Children with the most severe meningococcal disease tend to receive the 
highest fluid volumes during resuscitation. Could fluid therapy contribute to 
the pathogenesis of myocardial dysfunction? Weisel et al showed that 
once circulating volume has been restored cardiac damage can continue, 
suggesting that fluid related damage is unlikely (Weisel, Vito et al. 1977). A 
dysfunctional microcirculation may contribute to the abnormal cardiac 
behaviour described in this chapter. Chapters 5 and 6 have shown that the 
endothelial activation that occurs in MCD results in grossly abnormal 
microcirculatory blood flow, with the worst seen in the children with the
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most severe disease. Regional flow disturbances and abnormal tissue 
oxygenation associated with septic shock may cause ischaemia in multiple 
organs, including the heart.
7.4.2 NT-Pro BNP, Diastolic function and Global function 
This is the first study to report NT-Pro BNP levels in children with MCD and 
has shown that NT-Pro BNP levels correlate with disease severity and 
declines as clinical recovery occurs in children with severe MCD. It is also 
the first study that has examined diastolic function in children with sepsis 
and shown a relationship between diastolic dysfunction and NT-Pro BNP 
levels. The Tei index revealed abnormal global cardiac function, reflecting 
systolic and diastolic dysfunction in the same subjects on admission. All 
measures of cardiac function returned to normal values in parallel with 
clinical recovery. There are no previous studies assessing global function 
in sepsis.
Few studies have examined diastolic function in sepsis. Jafri et al carried 
out echocardiography within 24 hours of the onset of septic shock or blood 
culture positivity in adults (Jafri, Lavine et al. 1990). Systolic function was 
normal but, using mitral inflow by pulsed wave Doppler, abnormal 
ventricular filling patterns typical of diastolic dysfunction were shown. 
Poelaert et al confirmed these findings (Poelaert, Declerck et al. 1997). 
Munt et al found that in non-survivors compared with survivors of severe 
sepsis, abnormal left ventricular relaxation occurred (assessed by pulsed- 
wave Doppler measurement of the left ventricular inflow pattern) (Munt, Jue 
et al. 1998). Bouhemad et al (Bouhemad, Nicolas-Robin et al. 2008) 
incorporated TDI into their assessment of adults with septic shock. 
Patients with septic shock who had systolic dysfunction and cTnl release at
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admission had significantly lower Ea values at the mitral annulus than those 
without these abnormalities. This resolved over time and 7 days after 
admission there was no difference between the groups. Diastolic 
dysfunction had not been assessed over time previously. These findings 
have been confirmed in the current study population. A strong relationship 
has been shown between NT-Pro BNP levels and LV filling pressure, 
estimated by the E/Ea ratio. Whether these diastolic abnormalities are a 
direct consequence of bacteraemia, or represent a compensatory 
mechanism of the ventricle to allow a larger diastolic volume without a 
pressure increase that would produce pulmonary oedema, has not been 
determined.
There have only been two studies where NT-Pro BNP has been measured 
in children with sepsis. The first compared 10 children with septic shock 
and 10 children with LV failure on PICU (Fried, Bar-Oz et al. 2006). Both 
groups underwent echocardiography within the first 24 hours of admission 
to assess systolic but not diastolic function. The group with LV failure had 
significantly higher levels of NT-Pro BNP when compared with the group 
with sepsis. The group with sepsis had higher levels of NT-Pro BNP when 
compared with 20 children who were admitted to hospital with a febrile 
illness. Dominico et al. found that children with septic shock had an 
elevated NT-Pro BNP level at admission when compared to critically ill 
children without sepsis (Domico, Liao et al. 2008). NT-Pro BNP levels at 
12 hrs correlated positively with PRISM ill and negatively with FS. The 
findings presented here support these two paediatric studies. Although 
elevated NT-Pro BNP levels in MCD might be attributed to the underlying 
myocardial dysfunction it has also been shown here that NT-Pro BNP
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levels are raised in septic patients without shock. This finding has been 
shown before (Nikolaou, Goritsas et al. 2007) and indicates a direct effect 
on NT-Pro BNP release due to sepsis alone. In support of this concept 
LPS and pro-inflammatory cytokines have a direct effect on BNP 
transcription and translation in cardiomyocytes in vitro, (Tomaru Ki, Arai et 
al. 2002; Ma, Ogawa et al. 2004). Animal studies of severe sepsis have 
indicated that tissue hypoxia also induces BNP gene transcription (Toth, 
Vuorinen et al. 1994). An increase in plasma NT-proBNP was seen when 
Escherichia coli endotoxin (LPS) was administered intravenously to 10 
healthy adults, aged 20-40 years, with normal medical history, clinical 
examination, EGG, echocardiography (Vila, Resl et al. 2008). A rise in NT- 
Pro BNP occurred after LPS administration, peaked at 6 hours and was 
absent after saline infusion. The NT-proBNP levels correlated with changes 
in body temperature, heart and GRP, but not blood pressure. This model of 
systemic infection showed that NT-Pro BNP can be released without 
cardiac involvement.
It is possible that the volume resuscitation received by children with severe 
MCD could cause BNP release, by the elevation of both left-sided and 
right-sided filling pressures. Roch et al however found, in a multivariate 
analysis, that fluid loading was not a significant predictor of a high NT- 
proBNP level (Roch, Allardet-Servent et ai. 2005).
7.4.3 Cardiac output and index
A higher cardiac output is a consequence of the reduced afterload 
(Suffredini, Fromm et al. 1989) and in this study has been shown to be 
strongly correlated with SVR and CO and Cl. The cardiac index was found 
to be high in the majority of children with MCD. This is contrary to the
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findings of Monsalve, who recruited adults and children with MCD to a 
study that evaluated CO with a pulmonary artery catheter using a 
thermodilution method. They showed a lower CO in patients with MCD 
despite higher cardiac filling pressures when compared to patients with 
other forms of Gram-negative sepsis. The study went on to demonstrate 
that the non-MCD patients were able to increase their Cl with an increase 
in filling pressure, but this response was not seen in the MCD group and 
suggesting that MCD related cardiac dysfunction is more severe 
(Monsalve, Rucabado et al. 1984). The discrepancy may have been due to 
the fact that numbers are smaller in this study or to the use of a non- 
invasive method of CO measurement as pulmonary artery thermodilution 
catheters are not routinely used in paediatric critical care. Transthoracic 
echocardiography is operator dependent and suboptimal alignment with the 
ascending aorta can affect the CO calculation although would probably not 
over-estimate it because angle variation would reduce the Doppler signal 
size.
Another possible source of error is the indexing of CO by dividing by BSA 
to obtain the Cl. This allows comparisons to be made between children of 
different sizes. However large changes in the Cl are seen in the smallest of 
children and may result in overestimation of the Cl. A more appropriate 
method of adjustment may be that of the allometric scaling as discussed in 
Chapter 4. This would entail dividing the cardiovascular variable by a body 
size variable that is raised to a scalar component. So for CO this would be 
CI=CO/BSAx where x is the scaling component. A study examining the 
allometric relationship between body size and stroke volume and cardiac 
output in 970 normotensive adults and children has confirmed this. The 
study revealed that indexing stroke volume and cardiac output for the first
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power of body surface area was acceptable in adults, because the 
allometric powers detected were close to 1. However this same index 
calculation in children introduced a significant error, because the power 
detected by allometric regression was below 1, especially for cardiac 
output. It recommended that in children, body surface area needs to be 
raised to the appropriate power, which, for cardiac output, is approximately 
its square root function (de Simone, Devereux et al. 1997):
When this calculation is applied to the relationship between SVR and this 
method of cardiac scaling for the current study population, the relationship 
remains significant with a stronger correlation coefficient (r=-0,75, p<0.001). 
Normal ranges for children using this allometric scaling method for critical 
illness have not however been established.
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7.5 Conclusion
This study has found that children with severe MCD and septic shock have 
myocardial cell injury, which is related to echocardiographic findings of 
systolic and diastolic dysfunction. The measurement of cTns, NT-proBNP 
and the transthoracic echocardiographic evaluations made in this group of 
children has given new information into the haemodynamic changes seen 
in MCD.
Chapter 8
Conclusions
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This thesis describes a series of studies of the haemodynamic responses in 
the host to invasive meningococcal disease in children. The aims of this 
thesis were: 1) To determine whether activated Partial Thromboplastin 
Time waveform analysis and Procalcitonin could be used as early 
diagnostic markers in sepsis. 2) To assess the microcirculation of normal 
healthy children using side-stream dark-field imaging to validate its use in 
children. 3) To visualise the microcirculation in children with severe 
meningococcal disease using side-stream dark-field imaging. 4) To 
correlate microcirculatory variables of children with severe MCD with 
disease severity, cardiac function and plasma vasoactive endothelial 
mediators and cytokines.5) To study cardiac function using 
echocardiography and determine the relationship between plasma cardiac 
troponin and NT Pro-BNP with cardiac function in children with severe 
MCD.
8.1 Summary of conclusions from the studies
1) This study supports the value of aPTT waveform analysis as a simple, 
rapid and robust diagnostic marker in the detection of meningococcal 
sepsis that has translational potential in facilitating prompt diagnosis 
and real-time monitoring of patients with critical illnesses.
2) This study demonstrated that side stream dark field imaging can be 
used in healthy awake and anaesthetised children to obtain high 
quality images of the microcirculation. Normal values for children have 
also been established. Manual analysis of the images produced has 
shown good inter- and intraobserver agreement. Automated and user
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friendly image analysis software would be a superior and faster method 
of evaluation. Its use in critically ill children would therefore be 
appropriate.
3} This study has shown that microcirculation dysfunction is present in 
children with MCD and that microcirculation outcome variables can be 
used to predict outcome.
4) This study demonstrated that in children with severe MCD there is 
release of cell adhesion molecules and NO. It has also shown that 
there is a relationship between these and microcirculation variables as 
assessed using SDF imaging.
5) This study found that children with severe MCD and septic shock had 
myocardial cell injury which was related to echocardiographic findings 
of systolic and diastolic dysfunction. The measurement of cTns, NT- 
proBNP and transthoracic echocardiographic evaluation of the 
haemodynamic effects of MCD could be helpful in guiding PICU 
interventions in these children.
8.2 Future research
8.2.1 Targeted anti-inflammatory therapy
Drotrecogin alfa (activated protein C; APC) is an endogenous protein 
that is not only an anticoagulant but also has an anti-inflammatory effect 
through the inhibition of E-selectin meditated leukocyte adhesion. It also 
has a role in anti-apoptosis in endothelial cells. These factors make
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Drotrecogin alfa a potential agent in the restoration of a healthy 
microcirculation during sepsis, it has been shown to reduce mortality in 
severe sepsis in adults (Bernard, Vincent et al. 2001; Ely, Bernard et al. 
2002; Ely, Laterre et al. 2003; Vincent, Angus et ai. 2003; Abraham, 
Laterre et al. 2005). A study using OPS imaging to monitor the effects of 
Drotrecogin alfa in adults with severe sepsis has been carried out. 
Images were taken at administration of Drotrecogin alfa, four hours later 
and then daily for a week. Patients receiving Drotrecogin alfa had an 
increase in the PPV 4 hours after administration (De Backer, Verdant et 
al. 2006). APC was not found to be beneficial in a large RCT in 
children with sepsis in the PICU setting. The reason for this may have 
been the wide inclusion criteria used for study entry (Nadel, Goldstein et 
al. 2007). If SDF imaging or if aPTT analysis were to be used as a tool 
to assess entry criteria in such a study a different outcome may be found 
in terms of mortality and morbidity in children with MCD.
8.2.2 Vasoactive agents
Agents that improve the microcirculation should improve organ function. 
Vasodiiatating agents can improve microcirculatory blood flow. Agents 
such as sublingual acetylcholine and early studies of intravenous 
nitroglycerin have been shown to improve microcirculatory blood flow 
when used together with adequate volume support, inotropes and 
steroids (De Backer, Creteur et al. 2002; Spronk, Ince et al. 2002). 
Intravenous nitroglycerin has however recently been shown to have no 
effect on sublingual microcirculatory blood flow in a randomised 
controlled trial of nitroglycerin use in early-phase severe sepsis or septic
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shock. Vasopressors such as adrenaline and nor-adrenaline could have 
a detrimental effect upon the microcirculation despite appearing to be 
beneficial in maintaining blood pressure.
This study has shown high levels of NO production in children with MOD. 
This is due to iNOS up regulation and can cause arterial hypotension. 
iNOS inhibition has been shown to cause microvascular dysfunction, by 
increasing leukocyte adhesion, microthrombosis, and microvascular 
leakage (Hollenberg, Broussard et al. 2000; Bateman, Sharpe et al. 
2008; Trzeciak, Cinel et al. 2008; Bruhn, Correa et al. 2009; Fortin, 
McDonald et al. 2009). Animal models have shown that exogenous NO 
may have a role in improving a dysfunctional microcirculation due to its 
vasodilatory effect and by modulation of leukocyte adhesion (Berger, 
Gibson et al. 1993; Gundersen, Corso et al. 1998; Chang, Kang et al. 
2006; Assadi, Desebbe et al. 2008). Further research in this area needs 
to be directed at investigating whether inhaled NO can reverse 
microvascular alterations whilst maintaining haemodynamic equilibrium 
in MCD.
8.2.3 Novel microcirculation therapies
Randomised trials are needed in children with MCD and severe sepsis 
of therapies demonstrated to improve microvascular perfusion in 
adults. The difficultly in undertaking randomised controlled trials in 
children with severe MCD is the spectrum of disease seen and children 
will present to a tertiary centre’s PICU at different stages of their
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illness. Also poor outcomes such as mortality and limb loss are 
fortunately becoming less common making it near impossible to use as 
comparative outcome measures. To overcome this, a national multi- 
centre study being carried out over several years would be needed. 
Multiple mechanisms lead to cellular dysfunction in sepsis and poor 
tissue perfusion. Microcirculatory failure is only one of these. 
Mitochondrial dysfunction plays an important role and can be 
counteracted by stimulating mitochondrial synthesis with insulin 
(Lambert, Wang et al. 2004; Remedi, Nichols et ai. 2006). It can also 
be counteracted by reducing the oxidative stress within the 
mitochondria using antioxidants (Kowluru 2001; Protti and Singer 
2006). These methods of therapy are purely investigational and not in 
clinical use.
8.2.4 Improvement of Cardiac function
This study has confirmed cardiac systolic dysfunction and damage in 
children with MCD and is the first study to demonstrate diastolic 
dysfunction. Milrinone is an inodilator, which also improves left 
ventricular diastolic relaxation. It is a phosphodiesterase isoenzyme 
inhibitor for both cardiac and vascular muscle. Phosphodiesterase 
isoenzyme is needed for S'S'-cyclic adenosine monophosphate (cAMP) 
breakdown and its inhibition leads to elevated cAMP levels. This 
results in increased myocardial contractility. Additionally in the vascular 
smooth muscle, vasodilation occurs due to a reduced sensitivity of the 
muscle to calcium (Shipley, Tolman et al. 1996). The use of milrinone 
in children with MCD has been studied in small case series with no 
improvement in outcome although the interpretation of these studies is
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limited by small sample size (Rich, West et al. 2003), No randomised 
controlled studies have been carried out in an adult or paediatric critical 
care sepsis setting.
Levosimendan, a drug receiving a large amount of interest, has a 
calcium sensitizing effects and interacts with potassium channels in the 
myocyte plasma membrane and in the mitochondria (Toller and Stranz 
2006). Levosimendan has been shown to be more effective than 
dobutamine or milrinone in improving cardiac performance (Pinto, 
Rehberg et al. 2008). It not only increases stroke volume and cardiac 
output but improves LV diastolic function and LV filling pressures 
(Barraud, Faivre et al. 2007; Osthaus, Boethig et al. 2009) . This study 
has found these parameters to be abnormal in children with MOD 
making Levosimendan an ideal inotrope to consider in the management 
of these children.
8.3 Conclusions
Despite improvements in the detection of sepsis and management of 
MCD, there is no doubt that prevention with appropriate vaccination 
would reduce mortality and morbidity. We do not fully understand why 
some children suffer death or disability due to invasive MCD. This 
thesis has shown new insights into the complex haemodynamic 
response within a host to invasive MCD. The relationship between 
microcirculatory and macrocircuiatory failure is complex and variable 
within patients. Macrocircuiatory dysfunction may be present without 
microcirculatory dysfunction and the contrary may also be true. The 
identification and monitoring of both is important in the management of
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these children. The incorporation of these new haemodynamic insights 
into a novel approach to paediatric critical illness is awaited alongside 
its impact upon the outcome in these children.
References
266
Abraham, E., P. F. Laterre, et al. (2005). "Drotrecogin alfa (activated) for 
adults with severe sepsis and a low risk of death." N Engl J Med 
353(13): 1332-41.
Alan Stevens, J. S. L. (2004). "Human Histology. Third Edition. Mosby.
Alpert, J. S., K. Thygesen, et al. (2000). "Myocardial infarction redefined—a 
consensus document of The Joint European Society of 
Cardiology/American College of Cardiology Committee for the 
redefinition of myocardial infarction." J Am Coll Cardiol 36(3): 959- 
69.
Ammann, P., T. Fehr, et al. (2001). "Elevation of troponin I in sepsis and 
septic shock." Intensive Care Med 27(6): 965-9.
Ammann, P., M. Maggiorini, et al. (2003). "Troponin as a risk factor for 
mortality in critically ill patients without acute coronary syndromes." 
J Am Coll Cardiol 41 (11): 2004-9.
Appleton, C. P., L. K. Hatle, et al. (1988). "Relation of transmitral flow 
velocity patterns to left ventricular diastolic function: new insights 
from a combined hemodynamic and Doppler echocardiographic 
study." J Am Coll Cardiol 12(2): 426-40.
Appleton, C. P., J. L. Jensen, et ai. (1997). "Doppler evaluation of left and 
right ventricular diastolic function: a technical guide for obtaining 
optimal flow velocity recordings," J Am Soc Echocardioar 10(3): 
271-92.
Arkader, R., E. J. Troster, et al. (2006). "Procalcitonin does discriminate 
between sepsis and systemic inflammatory response syndrome." 
Arch Pis Child 91(21: 117-20.
Assadi, A., O. Desebbe, et al. (2008). "Effects of sodium nitroprusside on 
splanchnic microcirculation in a resuscitated porcine model of septic 
shock." Br J Anaesth 100(1): 55-65.
Bache, C. E. and I. P. Torode (2006). "Orthopaedic sequelae of
meningococcal septicemia." J Pediatr Orthoc 26(1^: 135-9.
Baggiolini, M., A. Walz, et al. (1989). "Neutrophil-activating peptide-
1/interleukin 8, a novel cytokine that activates neutrophils." 
JLCiinJnyest 84(4): 1045-1049.
Baines, P. B., O. Marzouk, et al. (1999). "Endothelial cell adhesion
molecules in meningococcal disease." Arch Pis Child 80(1): 74-6.
Baines, P. B., S. Stanford, et al. (1999). "Nitric oxide production in
meningococcal disease is directly related to disease severity." Grit 
Care Med 27(6): 1187-90.
Baines, P. B., A. P. Thomson, et al. (2000). "Hypocalcaemia in severe 
meningococcal infections." Arch Pis Child 83(6): 510-3.
Baines, P. T., APJ; Hart, CA (2001). "Cardiac function and tissue perfusion 
in children with severe meningococcal disease." Clinical Intensive 
Care 12((5,6)): 215-221.
Balligand, J. L, R. A. Kelly, et al. (1993). "Control of cardiac muscle cell 
function by an endogenous nitric oxide signaling system." Proc Natl 
Acad Sci U S A 90(1): 347-51.
Balligand, J. L, D. Ungureanu, et al. (1993). "Abnormal contractile function 
due to induction of nitric oxide synthesis in rat cardiac myocytes 
follows exposure to activated macrophage-conditioned medium." J 
Clin Invest 91(51: 2314-9.
Barraud, D., V. Faivre, et al. (2007). "Levosimendan restores both systolic 
and diastolic cardiac performance in lipopolysaccharide-treated
267
rabbits: comparison with dobutamine and milrinone." Grit Care Med 
35(5): 1376-82.
Bateman, R. M., M. D. Sharpe, et al. (2008). "Inhibiting nitric oxide 
overproduction during hypotensive sepsis increases local oxygen 
consumption in rat skeletal muscle." Grit Care Med 36(1): 225-31.
Bateman, R. M. and K. R. Walley (2005). "Microvascular resuscitation as a 
therapeutic goal in severe sepsis." Grit Care 9 Suppl 4: S27-32.
Bazin, J. E., B. Dureuil, et al. (1998). "Effects of etomidate, propofol and 
thiopental anaesthesia on arteriolar tone in the rat diaphragm." Br J 
Anaesth 81(3): 430-5.
Belthur, M. V., C. F. Bradish, et al. (2005). "Late orthopaedic sequelae 
following meningococcal septicaemia. A multicentre study." J Bone 
Joint Sura Br 87(2): 236-40.
Berger, J. I., R. L. Gibson, et al. (1993). "Effect of inhaled nitric oxide during 
group B streptococcal sepsis in piglets." Am Rev Resoir Pis 147(5): 
1080-6.
Bernard, G. R., J. L. Vincent, et al. (2001). "Efficacy and safety of
recombinant human activated protein C for severe sepsis."
N.Enal.J.Med. 344(401: 699-709.
Bernard, G. R., J. L. Vincent, et al. (2001). "Efficacy and safety of
recombinant human activated protein C for severe sepsis." N End J
Med 344(10): 699-709.
Berton, C. and B. Cholley (2002). "Equipment review: new techniques for 
cardiac output measurement-oesophageal Doppler, Pick principle 
using carbon dioxide, and pulse contour analysis." Grit Care 6(3): 
216-21.
Biberthaler, P., S. Langer, et al. (2001). "In vivo assessment of colon 
microcirculation: comparison of the new OPS imaging technique 
with intravital microscopy." Eur J Med Res 6(12): 525-34.
Bishop, C. M. (1999). "The maximum oxygen consumption and aerobic 
scope of birds and mammals: getting to the heart of the matter." 
Proc_Bioj_Sci 266(1435): 2275-81.
Bjerre, A., B. Brusletto, et al. (2004). "Plasma interferon-gamma and 
interleukin-10 concentrations in systemic meningococcal disease 
compared with severe systemic Gram-positive septic shock." Grit 
Care Med 32(2): 433-8.
Bjerre, A., B. Brusletto, et al. (2004). "Plasma interferon-gamma and 
interleukin-10 concentrations in systemic meningococcal disease 
compared with severe systemic Gram-positive septic shock." Grit 
Care Med. 32(2): 433-438.
BNF (2005). "The BNF for children." Drug Ther Bull 43(11): 84-5.
Bodor, G. S., L. Survant, et al. (1997). "Cardiac troponin T composition in 
normal and regenerating human skeletal muscle." Clin Chem 43(3): 
476-84.
Boerma, E. C., K. R. Mathura, et al. (2005). "Quantifying bedside-derived 
imaging of microcirculatory abnormalities in septic patients: a 
prospective validation study." Grit Care 9(6): R601-6.
Boerma, E. C., K. R. Mathura, et al. (2005). "Quantifying bedside-derived 
imaging of microcirculatory abnormalities in septic patients: a 
prospective validation study." Grit Care 9(61: R601-R606.
Bohuon, C., M. Assicot, et al. (1998). "[Procalcitonin, a marker of bacterial 
meningitis in children]." Bull Acad Natl Med 182(7): 1469-75; 
discussion 1475-7.
268
Bohuon, C. and D. Gendrel (1999). "[Procalcitonin: a new marker of 
bacterial infection. Importance and prospectsl." Arch Pediatr 6(2): 
141-4.
Boldt, J., M, Muller, et al. (1996). "Circulating adhesion molecules in the 
critically ill: a comparison between trauma and sepsis patients." 
Intensive Care Med 22(21: 122-8.
Boldt, J., M. Wollbruck, et al. (1996). "Do plasma levels of circulating 
soluble adhesion molecules differ between surviving and 
nonsurviving critically ill patients?" Chest 107(3): 787-92.
Bone, M., M. Diver, et al. (2002). "Assessment of adrenal function in the 
initial phase of meningococcal disease." Pediatrics 110(3): 563-9.
Bone, R. C. (1991). "The pathogenesis of sepsis." Ann.Intern.Med. 115(6): 
457-469.
Booy, R., P. Habibi, et al. (2001). "Reduction in case fatality rate from 
meningococcal disease associated with improved healthcare 
delivery." Arch.Dis.Child 85(5): 386-390.
Boswell, S. A. and T. M. Scalea (2003). "Sublingual capnometry: an 
alternative to gastric tonometry for the management of shock 
resuscitation." AACN Clin Issues 14(21: 176-84.
Boucek, M. M., R. C. Boerth, et al. (1984). "Myocardial dysfunction in 
children with acute meningococcemia." J Pediatr 105(4): 538-42.
Boucek, M. M., R. C. Boerth, et al. (1984). "Myocardial dysfunction in 
children with acute meningococcemia." J.Pediatr. 105(4): 538-542.
Bouhemad, B., A. Nicolas-Robin, et al. (2008). "Isolated and reversible 
impairment of ventricular relaxation in patients with septic shock." 
Crit Care Med 36(3): 766-74.
Bouskela, E. and G. M. Rubanyi (1995). "Effects of iloprost, a stable 
prostacyclin analog, and its combination with NW-nitro-L-arginine on 
early events following lipopolysaccharide injection: observations in 
the hamster cheek pouch microcirculation." Int J.Microcirc.Clin.Exp. 
15(4): 170-180.
Bozkurt, B., S. B. Kribbs, et al. (1998). "Pathophysiologicaily relevant 
concentrations of tumor necrosis factor-alpha promote progressive 
left ventricular dysfunction and remodeling in rats." Circulation 
97(14): 1382-91.
Brady, A. J. (1993). "Nitric oxide synthase activities in human myocardium." 
Lancet 341(8842): 448.
Brady, A. J. and P. A. Poote-Wilson (1993). "Circulatory failure in septic 
shock. Nitric oxide: too much of a good thing?" Br Heart J 70(2): 
103-5.
Brady, A. J., J. B. Warren, et al. (1993). "Nitric oxide attenuates cardiac 
myocyte contraction." Am J Physiol 265(1 Pt2): H176-82.
Brandt, R. R., K. Filzmaier, et al. (2001). "Circulating cardiac troponin I in 
acute pericarditis." Am J Cardiol 87(11): 1326-8.
Brandtzaeg, P., T. E. Mollnes, et al. (1989). "Complement activation and 
endotoxin levels in systemic meningococcal disease." J.Infect.Pis. 
160(1): 58-65.
Brandtzaeg, P., P. M. Sandset, et al. (1989). "The quantitative association 
of plasma endotoxin, antithrombin, protein C, extrinsic pathway 
inhibitor and fibrinopeptide A in systemic meningococcal disease." 
Thromb.Res. 55(4): 459-470.
Brazy, J. E., D. V. Lewis, et al. (1985). "Monitoring of cerebral oxygenation 
in the intensive care nursery." Adv Exp Med Biol 191: 843-8.
269
Brazy, J. E., D. V. Lewis, et al. (1985). "Noninvasive monitoring of cerebral 
oxygenation in preterm infants: preliminary observations." Pediatrics 
75(2): 217-25.
Briassoulis, G., M. Narlioglou, et al. (2001). "Myocardial injury in
meningococcus-induced purpura fulminans in children." Intensive 
Care Med. 27(61: 1073-1082.
Briassoulis, G., M. Narlioglou, et al. (2001). "Myocardial injury in
meningococcus-induced purpura fulminans in children." Intensive 
Care Med 27(61: 1073-82.
Brierley, J. and M. J. Peters (2008). "Distinct hemodynamic patterns of 
septic shock at presentation to pediatric intensive care." Pediatrics 
122(4): 752-9.
Britto, J., S. Nadel, et al. (1996). "Severity of illness scores and risk of 
complication during transfer." Intensive Care Med. 22(10): 1130- 
1131.
Brookes, Z. L., C. S. Reilly, et al. (2004). "Differential effects of propofol, 
ketamine, and thiopental anaesthesia on the skeletal muscle 
microcirculation of normotensive and hypertensive rats in vivo." Br J 
Anaesth 93f21: 249-56.
Brueckmann, M., G. Huhle, et al. (2005). "Prognostic value of plasma N- 
terminal pro-brain natriuretic peptide in patients with severe sepsis." 
Circulation 112(4): 527-34.
Bruhn, F. H., P. B. Correa, et al. (2009). "Blocking systemic nitric oxide 
production alters neuronal activation in brain structures involved in 
cardiovascular regulation during polymicrobial sepsis." Neurosci Lett 
453(3): 141-6.
Bruserud, O., P. E. Akselen, et al. (1995). "Serum concentrations of E- 
selectin, P-selectin, ICAM-1 and interleukin 6 in acute leukaemia 
patients with chemotherapy-induced leucopenia and bacterial 
infections." Br.J.Haematol. 91(2): 394-402.
Bryce, J., C. Boschi-Pinto, et al. (2005). "WHO estimates of the causes of 
death in children." Lancet 365(9465): 1147-52.
Bugden, S. A., C. Coles, et al. (2004). "The potential role of procalcitonin in 
the emergency department management of febrile young adults 
during a sustained meningococcal epidemic." Emerq Med Australas 
16(2): 114-9.
Callaghan, M. J., C. Buckee, et al. (2008). "Opa protein repertoires of 
disease-causing and carried meningococci." J Clin Microbiol 46(9): 
3033-41.
Carcillo, J. A., A. L. Davis, et al. (1991). "Role of early fluid resuscitation in 
pediatric septic shock." JAtVIA 266(9): 1242-1245.
Carcillo, J. A. and A. I. Fields (2002). "Clinical practice parameters for 
hemodynamic support of pediatric and neonatal patients in septic 
shock." Crit Care Med. 30(61: 1365-1378.
Carcillo, J. A. and A. I. Fields (2002). "Clinical practice parameters for 
hemodynamic support of pediatric and neonatal patients in septic 
shock." Crit Care Med 30(6): 1365-78.
Carlos, T. M. and J. M. Harlan (1994). "Leukocyte-endothelial adhesion 
molecules." Blood 84(7): 2068-2101.
Carrol, E. D., P. Newland, et al. (2002). "Procalcitonin as a diagnostic 
marker of meningococcal disease in children presenting with fever 
and a rash." Arch Pis Child 86(4): 282-5.
Carrol, E. D., P. Newland, et al. (2005). "Prognostic value of procalcitonin in 
children with meningococcal sepsis." Crit Care Med 33(1): 224-5.
270
Carroi, E. D.( A. P. Thomson, et al. (2005). "A predominantly anti­
inflammatory cytokine profile is associated with disease severity in 
meningococcal sepsis." Intensive Care Med 31(10): 1415-9.
Carrol, E. D., A. P. Thomson, et al. (2002). "Myositis in children with 
meningococcal disease: a role for tumour necrosis factor-alpha and 
interieukin-8?" J Infect 44(11: 17-21.
Carrol, E. D., A. P. Thomson, et al. (2000). "Performance characteristics of 
the polymerase chain reaction assay to confirm clinical 
meningococcal disease." Arch Pis Child 83(3): 271-3.
Casado-Flores, J., A. Blanco-Quiros, et al. (2006). "Prognostic utility of the 
semi-quantitative procalcitonin test, neutrophil count and C-reactive 
protein in meningococcal infection in children." Eur J Pediatr 165(1): 
26-9.
Casey, L. C., R. A. Balk, et al. (1993). "Plasma cytokine and endotoxin 
levels correlate with survival in patients with the sepsis syndrome." 
Ann.Intern.Med. 119(81: 771-778.
Casey, L. C., R. A. Balk, et al. (1993). "Plasma cytokine and endotoxin 
levels correlate with survival in patients with the sepsis syndrome." 
Ann Intern Med 119(8): 771-8.
Ceneviva, G., J. A. Paschall, et al. (1998). "Hemodynamic support in fluid- 
refractory pediatric septic shock." Pediatrics 102(2): e19.
Cerwinka, W. H., D. Cooper, et al. (2003). "Superoxide mediates endotoxin- 
induced platelet-endothelial cell adhesion in intestinal venules." 
Am.J.Physiol Heart Circ.Phvsiol 284(21: H535-H541.
Chalumeau, M., S. Leroy, et al. (2007). "[Procalcitonin bedside testing in 
the pediatric emergency department]." Arch Pediatr 14(6): 529-31.
Chang, Y. S., S. Kang, et al. (2006). "Pretreatment with N-nitro-L-arginine 
methyl ester improved oxygenation after inhalation of nitric oxide in 
newborn piglets with Escherichia coii pneumonia and sepsis." J 
Korean Med Sci 21 (6L 965-72.
Chappell, D., K. Hofmann-Kiefer, et al. (2008). "TNF-aipha induced 
shedding of the endothelial glycocalyx is prevented by 
hydrocortisone and antithrombin." Basic Res Cardiol.
Charpentier, J., C. E. Luyt, et al. (2004). "Brain natriuretic peptide: A marker 
of myocardial dysfunction and prognosis during severe sepsis." Crit 
Care Med 32(3): 660-5.
Chew, M. S. and J. Poelaert (2003). "Accuracy and repeatability of pediatric 
cardiac output measurement using Doppler: 20-year review of the 
literature." Intensive Care Med 29(11): 1889-94.
Chopin, N., B. Floccard, et al. (2006). "Activated partial thromboplastin time 
waveform analysis: a new tool to detect infection?" Crit Care Med 
34(6): 1654-60.
Chopin, N., B. Floccard, et al. (2006). "Activated partial thromboplastin time 
waveform analysis: a new tool to detect infection?" Crit Care Med. 
34(6): 1654-1660.
Chua, G. and L. Kang-Hoe (2004). "Marked elevations in N-terminal brain 
natriuretic peptide levels in septic shock." Crit Care 8(4): R248-50.
Claeys, M. A., E. Gepts, et al. (1988). "Haemodynamic changes during 
anaesthesia induced and maintained with propofol." Br J Anaesth 
60(1): 3-9.
Claeys, R., S. Vinken, et al. (2002). "Plasma procalcitonin and C-reactive 
protein in acute septic shock: clinical and biological correlates." Crit 
Care Med 30(4): 757-62.
Clark, P. K. a. M. L. (2002). "Clinical Medicine."
271
Collinson, P. O., S. C. Barnes, et ai. (2004). "Analytical performance of the 
N terminal pro B type natriuretic peptide (NT-proBNP) assay on the 
Elecsys 1010 and 2010 analysers." Eur J Heart Fail 6(3): 365-8.
Comstock, K. L, K. A. Krown, et al. (1998). "LPS-induced TNF-alpha 
release from and apoptosis in rat cardiomyocytes: obligatory role for 
CD14 in mediating the IPS response." J Mol Cell Cardiol 30(12): 
2761-75.
Cowley, H. C.t D. Heney, et al. (1994). "Increased circulating adhesion 
molecule concentrations in patients with the systemic inflammatory 
response syndrome: a prospective cohort study." Crit Care Med 
22(4): 651-7.
Creteur, J. (2006). "Gastric and sublingual capnometry." Curr Qpin Crit 
Care 12(3): 272-7.
Cui, W. and D. A. Roberson (2006). "Left ventricular Tel index in children: 
comparison of tissue Doppler imaging, pulsed wave Doppler, and 
M-mode echocardiography normal values." J Am Soc Echocardioar 
19(12): 1438-45.
Cunnion, R. E., G. L. Schaer, et al. (1986). "The coronary circulation in 
human septic shock." Circulation 73(4): 637-44.
Darveau, C. A., R. K. Suarez, et al. (2002). "Allometric cascade as a 
unifying principle of body mass effects on metabolism." Nature 
417(6885): 166-70.
Dawson, T. H. (2005). "Modeling of vascular networks." J Exp Biol 208(Pt 
9): 1687-94.
Day, K. M., N. Haub, et al. (2008). "Hyperglycemia is associated with 
morbidity in critically ill children with meningococcal sepsis." Pediatr 
Crit Care Med 9(6): 636-40.
De Backer, D. (2003). "Lactic acidosis." Minerva Anestesiol 69(4): 281-4.
De Backer, D., J. Creteur, et al. (2002). "Microvascular blood flow is altered 
in patients with sepsis." Am J Resoir Crit Care Med 166(1): 98-104.
De Backer, D. and M. J. Dubois (2001). "Assessment of the 
microcirculatory flow in patients in the intensive care unit." Curr Qpin 
Crit Care 7(3): 200-3.
De Backer, D., S. Hollenberg, et al. (2007). "How to evaluate the 
microcirculation: report of a round table conference." Crit Care 
11(5): R101.
De Backer, D., C. Verdant, et al. (2006). "Effects of drotrecogin alfa 
activated on microcirculatory alterations in patients with severe 
sepsis." Crit Care Med 34(71: 1918-24.
De, B. D., J. Creteur, et al. (2002). "Microvascular blood flow is altered in 
patients with sepsis." Am.J.Respir.Crit Care Med. 166(1): 98-104.
de Bold, A. J., H. B. Borenstein, et al. (1981). "A rapid and potent natriuretic 
response to intravenous injection of atrial myocardial extract in rats." 
Life Sci 28(11: 89-94.
de Oliveira, C. F., D. S. de Oliveira, et al. (2008). "ACCM/PALS 
haemodynamic support guidelines for paediatric septic shock: an 
outcomes comparison with and without monitoring central venous 
oxygen saturation." Intensive Care Med 34(6): 1065-75.
de Simone, G., R. B. Devereux, et ai. (1997). "Stroke volume and cardiac 
output in normotensive children and adults. Assessment of relations 
with body size and impact of overweight." Circulation 95(7): 1837- 
43.
Dec, G. W., Jr., H. Waldman, et al. (1992). "Viral myocarditis mimicking 
acute myocardial infarction." J Am Coll Cardiol 20(1^: 85-9.
272
Dellinger, R. P., M. M. Levy, et al. (2008), "Surviving Sepsis Campaign: 
international guidelines for management of severe sepsis and septic 
shock: 2008," Intensive Care Med 34(1): 17-60.
Dempfle, C. E., S, Lorenz, et al, (2004). "Utility of activated partial 
thromboplastin time waveform analysis for identification of sepsis 
and overt disseminated intravascular coagulation in patients 
admitted to a surgical intensive care unit." Crit Care Med 32(2): 520- 
4.
Dennis, M. W., C. Downey, et al. (2004). "Frothrombinase enhancement 
through quantitative and qualitative changes affecting very low 
density lipoprotein in complex with C-reactive protein." Thromb 
Haemost 91(31: 522-30.
Derkx, B., A. Marchant, et al. (1995). "High levels of interleukin-10 during 
the initial phase of fulminant meningococcal septic shock." 
J.Infect.Dis. 171(1): 229-232.
Derkx, B., J. Wittes, et al. (1999). "Randomized, placebo-controlled trial of 
HA-1 A, a human monoclonal antibody to endotoxin, in children with 
meningococcal septic shock. European Pediatric Meningococcal 
Septic Shock Trial Study Group." Clin.Infect.Dis. 28(4): 770-777.
Dodds, P. S., D. H. Rothman, et al. (2001). "Re-examination of the "3/4- 
law" of metabolism." J Theor Biol 209(1): 9-27.
Dombrovskiy, V. Y., A, A. Martin, et al. (2007). "Rapid increase in 
hospitalization and mortality rates for severe sepsis in the United 
States: a trend analysis from 1993 to 2003." Crit Care Med 35(5): 
1244-50,
Domico, M., P. Liao, et al. (2008). "Elevation of brain natriuretic peptide 
levels in children with septic shock." Pediatr Crit Care Med 9(5): 
478-83.
Downey, C., R. Kazmi, et al. (1997). "Novel and diagnostically applicable 
information from optical waveform analysis of blood coagulation in 
disseminated intravascular coagulation." Br J Haematol 98(1): 68- 
73.
Downey, C., R. Kazmi, et al. (1998), "Early identification and prognostic 
implications in disseminated intravascular coagulation through 
transmittance waveform analysis." Thromb Haemost 80(1): 65-9.
Duggal, B., U. Pratap, et al. (2005). "Milrinone and low cardiac output 
following cardiac surgery in infants: is there a direct myocardial 
effect?" Pediatr Cardiol 26(5): 642-5.
Eidem, B. W., C. Tei, et al. (1998). "Nongeometric quantitative assessment 
of right and left ventricular function: myocardial performance index 
in normal children and patients with Ebstein anomaly." J Am Soc 
Echocardioar 11(9): 849-56.
Eling, M., A. C. Stephens, et al. (2001). "Tissue factor pathway inhibitor 
(TFPI) levels in the plasma and urine of children with 
meningococcal disease." Thromb Haemost 85(2): 240-4.
Eilis, C, G., R, M. Bateman, et al. (2002). "Effect of a maldistribution of 
microvascular blood flow on capillary 0(2) extraction in sepsis." Am 
J Physiol Heart Circ Physiol 282(11: H156-64.
Ely, E. W., G. R. Bernard, et al. (2002). "Activated protein C for severe 
sepsis." N Engl J Med 347(131: 1035-6.
Ely, E. W., P. F. Laterre, et al. (2003). "Drotrecogin alfa (activated) 
administration across clinically important subgroups of patients with 
severe sepsis." Crit Care Med 31(1): 12-9.
Emonts, M., J. A. Hazelzet, et al. (2003). "Host genetic determinants of 
Neisseria meningitidis infections." Lancet Infect Pis 3(9): 565-77.
273
Fallon, P., I. G. Roberts, et al. (1994). "Cerebral blood volume response to 
changes in carbon dioxide tension before and during 
cardiopulmonary bypass in children, investigated by near infrared 
spectroscopy." Eur J Cardiothorac Sura 8(3): 130-4.
Faust, S. N., M. Levin, et al. (2001). "Dysfunction of endothelial protein C 
activation in severe meningococcal sepsis." N Enal J Med 345(6): 
408-16.
Feliick, J. M., J. A. Sills, et ai. (2001). "Neurodevelopmental outcome in 
meningococcal disease: a case-control study." Arch Pis Child 85(1): 
6-11.
Fenton, K. E., C. A. Sable, et al. (2004). "Increases in serum levels of 
troponin I are associated with cardiac dysfunction and disease 
severity in pediatric patients with septic shock." Pediatr Crit Care 
Med 5(6): 533-8.
Fernandes, B. and A. Giles (2003). "An abnormal activated partial 
thromboplastin time dotting waveform is associated with high 
mortality and a procoagulant state." Lab Hematol 9(3): 138-42.
Fernandes, C. J., Jr., N. Akamine, et al. (1999). "Cardiac troponin: a new 
serum marker of myocardial injury in sepsis." intensive Care Med 
25(10): 1165-8.
Finn, A., S. Naik, et al. (1993). "Interleukin-8 release and neutrophil 
degranulation after pediatric cardiopulmonary bypass." 
J.Thorac.Cardiovasc.Sura. 105(2): 234-241.
Fortin, C. F., P. P. McDonald, et al. (2009). "Sepsis, leukocytes and nitric 
oxide (NO): an intricate affair." Shock.
Fourrier, F., P. Lestavel, et al. (1990). "Meningococcemia and purpura 
fulminans in adults: acute deficiencies of proteins C and S and early 
treatment with antithrombin III concentrates." Intensive Care Med. 
16(2): 121-124.
Frenette, P. S. and D. D. Wagner (1996). "Adhesion molecules-Part 1." N 
Enal J Med 334(231: 1526-9.
Frenette, P. S. and D. D. Wagner (1996). "Adhesion molecules-Part II: 
Blood vessels and blood cells." N Enal J Med 335(1): 43-5.
Fried, I., B. Bar-Oz, et al. (2006). "Comparison of N-terminal pro-B-type 
natriuretic peptide levels in critically ill children with sepsis versus 
acute left ventricular dysfunction." Pediatrics 118(4): e1165-8.
Friedman, G., G. Berlot, et al. (1995). "Combined measurements of blood 
lactate concentrations and gastric intramucosal pH in patients with 
severe sepsis." Crit Care Med 23(7): 1184-93.
Fries, M., M. H. Weil, et al. (2006). "Increases in tissue Pco2 during 
circulatory shock reflect selective decreases in capillary blood flow." 
Crit Care Med 34(2): 446-52.
Gando, S., T. Kameue, et al. (2005). "Serial changes in neutrophil- 
endothelial activation markers during the course of sepsis 
associated with disseminated intravascular coagulation." Thromb 
Res 116(2): 91-100.
Geiger, R., A. Hammerer-Lercher, et al. (2007). "NT-proBNP 
concentrations indicate cardiac disease in pediatric patients." Int J 
Cardigi 123(1): 63-5.
Gendrel, D., M. Assicot, et al. (1996). "Procalcitonin as a marker for the 
early diagnosis of neonatal infection." J Pediatr 128(4): 570-3.
Gerard, C., C. Bruyns, et al. (1993). "Interleukin 10 reduces the release of 
tumor necrosis factor and prevents lethality in experimental 
endotoxemia." J.Exp.Med. 177(2): 547-550.
274
Gerhardt, W., H. Katus, et al. (1991). "S-troponin T in suspected ischemic 
myocardial injury compared with mass and catalytic concentrations 
of S-creatine kinase isoenzyme MB." Clin Chem 37(8): 1405-11.
Giamarellos-Bourboulis, E. J., A. Mega, et al. (2002). "Procalcitonin: a 
marker to clearly differentiate systemic inflammatory response 
syndrome and sepsis in the critically ill patient?" Intensive Care Med 
28(9): 1351-6.
Gibot, S., A. Cravoisy, et al. (2005). "Time-course of sTREM (soluble 
triggering receptor expressed on myeloid cells)-1, procalcitonin, and 
C-reactive protein plasma concentrations during sepsis." Crit Care 
Med 33(4): 792-6.
Girardin, E., G. E. Grau, et al. (1988). "Tumor necrosis factor and 
interleukin-1 in the serum of children with severe infectious 
purpura." N.EngU.Med. 319(7): 397-400.
Girardin, E., P. Roux-Lombard, et al. (1992). "Imbalance between tumour 
necrosis factor-alpha and soluble TNF receptor concentrations in 
severe meningococcaemia. The J5 Study Group." Immunology 
76(1): 20-23.
Girardin, E., P. Roux-Lombard, et al. (1992). "Imbalance between tumour 
necrosis factor-alpha and soluble TNF receptor concentrations in 
severe meningococcaemia. The J5 Study Group." Immunology 
76(1): 20-3.
Giroir, B. P., P. J. Scannon, et al. (2001). "Bactericidal/permeability- 
increasing protein-lessons learned from the phase III, randomized, 
clinical trial of rBPI21 for adjunctive treatment of children with 
severe meningococcemia." Crit Care Med. 29f7 Suppl): S130-S135.
Glitza, I. C., I. Ehrhard, et al. (2008). "Longitudinal study of meningococcal 
carrier rates in teenagers." Int J Hyg Environ Health 211(3-4): 263- 
72.
Goedhart, P. K. M., Bezemer R, Merza J, and Ince C (2007). "Sidestream 
Dark Field (SDF) imaging: a novel stroboscopic LED ring-based 
imaging modality for clinical assessment of the microcirculation." 
Optical Society of America 15(23^: 15101-15114.
Goldhill, D. R. (1997). "Calcium and Magnesium." Care Crit.III. 13: 112-115.
Goldman, D., R. M. Bateman, et al. (2004). "Effect of sepsis on skeletal 
muscle oxygen consumption and tissue oxygenation: interpreting 
capillary oxygen transport data using a mathematical model." 
Am.J.Phvsiol Heart Circ.Phvsiol 287(61: H2535-H2544.
Goodchild, C. S. and J. M. Serrao (1989). "Cardiovascular effects of 
propofol in the anaesthetized dog." Br J Anaesth 63(1): 87-92.
Gray, S. J., C. L. Trotter, et al. (2006). "Epidemiology of meningococcal 
disease in England and Wales 1993/94 to 2003/04: contribution and 
experiences of the Meningococcal Reference Unit." J Med Microbiol 
55(Pt 7): 887-96.
Grocott-Mason, R. M. and A. M. Shah (1998). "Cardiac dysfunction in 
sepsis: new theories and clinical implications." Intensive Care Med 
24(4): 286-95.
Groner, W., J. W. Winkelman, et al. (1999). "Orthogonal polarization 
spectral imaging: a new method for study of the microcirculation." 
Nat.Med. 5f10^: 1209-1212.
Groner, W., J. W. Winkelman, et al. (1999). "Orthogonal polarization 
spectral imaging: a new method for study of the microcirculation." 
Nat Med 5(10^: 1209-12.
275
Grundmann, U., A. Zissis, et al. (1997). "In vivo effects of haiothane, 
enflurane, and isoflurane on hepatic sinusoidal microcirculation." 
Acta Anaesthesioi Scand 41(6): 760-5.
Gundersen, Y., C. O. Corso, et al. (1998). "The nitric oxide donor sodium 
nitroprusside protects against hepatic microcirculatory dysfunction 
in early endotoxaemia." intensive Care Med 24(12): 1257-63.
Gundersen, Y., T. Saetre, et al. (1996). "The NO donor sodium 
nitroprusside reverses the negative effects on hepatic arterial flow 
induced by endotoxin and the NO synthase inhibitor L-NAME." 
Eur.Sura.Res. 28(5); 323-332.
Gurkan, F., A. Alkaya, et al. (2004). "Cardiac troponin-l as a marker of 
myocardial dysfunction in children with septic shock." Swiss Med 
Wkiy 134(39-40): 593-6.
Gutgesell, H. P., M. Paquet, et al. (1977). "Evaluation of left ventricular size 
and function by echocardiography. Results in norma! children." 
Circulation 56(3): 457-62.
Hackett, S. J., E. D. Carrol, et al. (2002). "Improved case confirmation in 
meningococcal disease with whole blood Taqman PCR." Arch Pis 
Child 86(6): 449-52.
Hackett, S. J., A. P. Thomson, et al. (2001). "Cytokines, chemokines and 
other effector molecules involved in meningococcal disease." 
J.Med.Microbiol. 50(101: 847-859.
Hagmolen of ten, H., A. Wiegman, et al. (2000). "Life-threatening heart 
failure in meningococcal septic shock in children: non-invasive 
measurement of cardiac parameters is of important prognostic 
value." Eur.J.Pediatr. 159(4): 277-282.
Hagmolen of ten Have, W., A. Wiegman, et al. (2000). "Life-threatening 
heart failure in meningococcal septic shock in children: non-invasive 
measurement of cardiac parameters is of important prognostic 
value." Eur J Pediatr 159(4): 277-82.
Hahne, S. J., A. Charlett, et al. (2006). "Effectiveness of antibiotics given 
before admission in reducing mortality from meningococcal disease: 
systematic review." Bmi 332(7553): 1299-303.
Hall, C. (2005). "NT-ProBNP: the mechanism behind the marker." J Card 
Fall 11(5 Suppi): S81-3.
Halstensen, A., M. Ceska, et al. (1993). "Interleukin-8 in serum and 
cerebrospinal fluid from patients with meningococcal disease." 
J.Infect.Dis. 167(2): 471-475.
Handford S, F. A. J. a. R. M. E. (2007). Surveillance Network for Invasive 
Neisseria meningitidis in Europe - 2002. Final report. 2003.
Harada, K., M. Tamura, et al. (2002). "Comparison of the right ventricular 
Tei index by tissue Doppler imaging to that obtained by pulsed 
Doppler in children without heart disease." Am J Cardiol 90(5): 566- 
9.
Harbarth, S., K. Holeckova, et al. (2001). "Diagnostic value of procalcitonin, 
interleukin-6, and interleukin-8 in critically HI patients admitted with 
suspected sepsis." Am J Resoir Crit Care Med 164(3): 396-402.
Hardman, J. M. and K. M. Earle (1969). "Myocarditis in 200 fatal 
meningococcal infections." Arch.Pathol. 87(31: 318-325.
Harris, A. G., I. Sinitsina, et al. (2000). "The Cytoscan Model E-ll, a new 
reflectance microscope for intravital microscopy: comparison with 
the standard fluorescence method." J Vase Res 37(6): 469-76.
Harris, A. G., I. Sinitsina, et al. (2002). "Validation of OPS imaging for 
microvascular measurements during isovolumic hemodilution and 
low hematocrits." Am J Phvsioi Heart Circ Physiol 282(4): H1502-9.
276
Harrison, L. H., M. A, Pass, et al. (2001), "invasive meningococcai disease 
in adolescents and young adults." Jarna 286(6): 694-9.
Hart, C. A. and I. R. Rogers (1993). "Meningococcal disease." J Med 
Microbiol 39(1): 3-25.
Hart, C. A. and T. R, Rogers (1993). "Meningococcal disease." Journal of 
Medical Microbiology 39: 3-25.
Hart, C. A. and A. P. Thomson (2006). "Meningococcal disease and its 
management in children." Bmi 333(7570): 685-90.
Hawkins, R. C. and H. L. Tan (1999). "Comparison of the diagnostic utility 
of CK, CK-MB (activity and mass), troponin T and troponin I in 
patients with suspected acute myocardial infarction." Singapore 
Med J 40(111: 680-4.
Hazelzet, J. A., I. M. Risseeuw-Appel, et al. (1996). "Age-related 
differences in outcome and severity of DIG in children with septic 
shock and purpura." Thromb.Haemost. 76(6): 932-938.
Hazelzet, J. A., d. V. van, et al. (1994). "Relation between cytokines and 
routine laboratory data in children with septic shock and purpura." 
Intensive Care Med. 20(51: 371-374,
Heger M, B. J., Stenback K, Faber DJ, and van Gemert MJC. (2005). 
"Darkfield orthogonal polarized spectral imaging for studying 
endovascular laser-tissue interactions in vivo - a preliminary study." 
Opt. Express 13: 702-715.
Herbertson, M. J., H. A. Werner, et al. (1996). "Nitric oxide synthase 
inhibition partially prevents decreased LV contractility during 
endotoxemia." Am J Physiol 270(6 Pt2): H1979-84.
Hersch, M., A. A. Gnidec, et al. (1990). "Histologic and ultrastructural 
changes in nonpulmonary organs during early hyperdynamic 
sepsis." Surgery 107(41: 397-410.
Heyderman, R. S., Y. Ben-Shlomo, et al. (2004). "The incidence and 
mortality for meningococcal disease associated with area 
deprivation: an ecological study of hospital episode statistics." Arch 
Pis Child 89(111: 1064-8.
Heyderman, R. S., Y. Ben-Shlomo, et al. (2004). "The incidence and 
mortality for meningococcal disease associated with area 
deprivation: an ecological study of hospital episode statistics." 
Arch.Dis.Child 89(111: 1064-1068.
Hiarada, K., T. Orino, et al. (2000). "Tissue doppler imaging of left and right 
ventricles in normal children." Tohoku J Exp Med 191(1): 21-9.
Hollenberg, S. M., M. Broussard, et al. (2000). "Increased microvascular 
reactivity and improved mortality in septic mice lacking inducible 
nitric oxide synthase." Circ Res 86(7): 774-8.
Holzmann, A., H. Schmidt, et al. (1995). "Propofol-induced alterations in the 
microcirculation of hamster striated muscle." Br J Anaesth 75(4): 
452-6.
Hunt, P. J., E. A. Espiner, et al. (1996). "Differing biological effects of 
equimolar atrial and brain natriuretic peptide infusions in normal 
man." J Clin Endocrinol Metab 81(111: 3871-6.
Hussain, N., D. Hodson, et al. (2008). "The biphasic transmittance 
waveform: an early marker of sepsis in patients with neutropenia." 
Thromb Haemost 100(1): 146-8.
Ince, C. (1999). "Mechanism of impaired oxygen extraction in sepsis. Shunt 
and the p02 gap." Minerva Anestesiol 65(6): 337-9.
Ince, C. (2005). "The microcirculation is the motor of sepsis." Crit Care 9 
Suppl 4: S13-9.
277
Ince, C. and M. Sinaasappel (1999). "Microcirculatory oxygenation and 
shunting in sepsis and shock." Grit Care Med 27(7): 1369-77.
Ince, C. and M. Sinaasappel (1999). "Microcirculatory oxygenation and 
shunting in sepsis and shock." Crit Care Med. 27(71: 1369-1377.
Jafri, S. M., S. Lavine, et al. (1990). "Left ventricular diastolic function in 
sepsis." Crit Care Med 18(7): 709-14.
Jakobsen, P. H., S. Morris-Jones, et al. (1994). "Increased plasma 
concentrations of slCAM-1, sVCAM-1 and sELAM-1 in patients with 
Plasmodium falciparum or P. vivax malaria and association with 
disease severity." Immunology 83(4): 665-669.
Januzzi, J. L., Jr., C. A. Camargo, et al. (2005). "The N-terminal Pro-BNP 
investigation of dyspnea in the emergency department (PRIDE) 
study." Am J Cardiol 95(8): 948-54.
Januzzi, J. L., R. van Kimmenade, et al. (2006). "NT-proBNP testing for 
diagnosis and short-term prognosis in acute destabilized heart 
failure: an international pooled analysis of 1256 patients: the 
International Collaborative of NT-proBNP Study." Eur Heart J 27(3): 
330-7.
Jensen, J. U., L. Heslet, et al. (2006). "Procalcitonin increase in early 
identification of critically ill patients at high risk of mortality." Crit 
CareMed 34(10): 2596-602.
Jensen, J. U., B. Lundgren, et al. (2007). "Meta-analysis of procalcitonin for 
sepsis detection." Lancet Infect Pis 7(8): 499-500; author reply 502- 
3.
Jobsis, F. F. (1977). "Noninvasive, infrared monitoring of cerebral and 
myocardial oxygen sufficiency and circulatory parameters." Science 
198(4323): 1264-7.
Katus, H. A., A. Remppis, et al. (1991). "Diagnostic efficiency of troponin T 
measurements in acute myocardial infarction." Circulation 83(3): 
902-12.
Kirsch, E. A., R. P. Barton, et al. (1996). "Pathophysiology, treatment and 
outcome of meningococcemia: a review and recent experience." 
Pediatr.Infect.Dis.J. 15(11): 967-978.
Kirshbom, P. M., J. M. Forbess, et al. (2007). "Cerebral near infrared 
spectroscopy is a reliable marker of systemic perfusion in awake 
single ventricle children." Pediatr Cardiol 28(1 V 42-5.
Kleiber, M. and T. A. Rogers (1961). "Energy metabolism." Annu Rev 
Physiol 23: 5-36.
Klein, N. J., G. I. Shennan, et al. (1992). "Alteration in glycosaminoglycan 
metabolism and surface charge on human umbilical vein endothelial 
cells induced by cytokines, endotoxin and neutrophils." J.Cell Sci. 
102 (Pt 4): 821-832.
Klinkhammer, M. D. and J. E. Collett! (2008). "Pediatric myth: fever and 
petechiae." Ciem 10(5): 479-82.
Knotzer, H., S. Maier, et al. (2007). "Oscillation frequency of skin 
microvascular blood flow is associated with mortality in critically ill 
patients." Acta Anaesthesiol Scand 51(6): 701-7.
Koch, M., D. De Backer, et al. (2008). "Effects of propofol on human 
microcirculation." Br J Anaesth 101(4): 473-8.
Koj, A. (1996). "Initiation of acute phase response and synthesis of 
cytokines." Biochim Biophvs Acta 1317(2): 84-94.
Kolar, F. and L. Jansky (1984). "Oxygen consumption in rat skeletal muscle 
at various rates of oxygen delivery." Experientia 40(4): 353-4.
Kornelisse, R. F., J. A. Hazelzet, et al. (1996). "The relationship between 
plasminogen activator inhibitor-1 and proinflam matory and
278
counterinflammatory mediators in children with meningococcal 
septic shock." J.Infect.Dis. 173(5): 1148-1156.
Kowluru, A. (2001). "Adenine and guanine nucleotide-specific succinyl-CoA 
synthetases in the clonal beta-cell mitochondria: implications in the 
beta-cell high-energy phosphate metabolism in relation to 
physiological insulin secretion." Diabetoloaia 44(11: 89-94.
Krown, K. A., M. T. Page, et al. (1996). "Tumor necrosis factor alpha- 
induced apoptosis in cardiac myocytes. Involvement of the 
sphingolipid signaling cascade in cardiac cell death." J Clin Invest 
98(12): 2854-65.
Krueger, M., A. Heinzmann, et al. (2007). "Adhesion molecules in pediatric 
intensive care patients with organ dysfunction syndrome." Intensive 
Care Med 33(2): 359-63.
Krupicka, J., T. Janota, et al. (2008). "Natriuretic peptides- physiology, 
pathophysiology and clinical use in heart failure." Phvsiol Res.
Kumar, A., V. Thota, et al. (1996). "Tumor necrosis factor alpha and 
interleukin 1beta are responsible for in vitro myocardial cell 
depression induced by human septic shock serum." J Exp Med 
183(3): 949-58.
Kvalsvig, A. J. and D. J. Unsworth (2003). "The immunopathogenesis of 
meningococcal disease." J.CIin.Pathol. 56(6): 417-422.
Lack, J. A. and M. E. Stuart-Taylor (1997). "Calculation of drug dosage and 
body surface area of children." Br J Anaesth 78(5): 601-5.
Lacroix, J. and J. Getting (2005). "Severity of illness and organ dysfunction 
scoring in children." Pediatr Grit Care Med 6(3 Suppl): S126-34.
Lam, C., K. Tyml, et al. (1994). "Microvascular perfusion is impaired in a rat 
model of normotensive sepsis." J.CIin.Invest 94(5): 2077-2083.
Lambert, A. J., B. Wang, et al. (2004). "Exogenous insulin can reverse the 
effects of caloric restriction on mitochondria." Biochem Biophvs Res 
Commun 316(4): 1196-201.
Lampugnani, M. G., L. Caveda, et al. (1993). "Endothelial cell-to-cell 
junctions. Structural characteristics and functional role in the 
regulation of vascular permeability and leukocyte extravasation." 
Baillieres Clin.Haematol. 6(3): 539-558.
Langer, S., P. Biberthaler, et al. (2001). "In vivo monitoring of microvessels 
in skin flaps: introduction of a novel technique." Microsurgery 21(7): 
317-24.
Langer, S., F. Born, et al. (2002). "Orthogonal polarization spectral imaging 
versus intravital fluorescent microscopy for microvascular studies in 
wounds." Ann Plast Sura 48(6): 646-53.
Langer, S., A. G. Harris, et al. (2001). "Orthogonal polarization spectral 
imaging as a tool for the assessment of hepatic microcirculation: a 
validation study." Transplantation 71(91: 1249-56.
Leach, R. M. and D. F. Treacher (1992). "The pulmonary physician and 
critical care. 6. Oxygen transport: the relation between oxygen 
delivery and consumption." Thorax 47(11): 971-8.
Leach, R. M. and D. F. Treacher (1998). "Oxygen transport-2. Tissue 
hypoxia." Bmi 317(7169): 1370-3.
Leclerc, F., S. Leteurtre, et al. (2002). "Procalcitonin as a prognostic marker 
in children with meningococcal septic shock." Arch Pis Child 87(5): 
450.
Ledingham, I. M. and C. S. McArdle (1978). "Prospective study of the 
treatment of septic shock." Lancet 1 (8075): 1194-1197.
279
Leteurtre, S., A. Martinet, et al. (2003). "Validation of the paediatric logistic 
organ dysfunction- (PELOD) score: prospective, observational, 
multicentre study." Lancet 362(9379); 192-7.
Levin, E. R., D. G. Gardner, et al. (1998). "Natriuretic peptides." N Engl J 
Med 339(5): 321-8.
Levy, M. M., M. P. Fink, et al. (2003). "2001 SCCM/ESICM/ACCP/ATS/SIS 
International Sepsis Definitions Conference." Crit Care Med 31(4): 
1250-6.
Lidington, D., K. Tyml, et al. (2002). "Lipopolysaccharide-induced 
reductions in cellular coupling correlate with tyrosine
phosphorylation of connexin 43." J.Cell Physiol 193(3): 373-379.
Lifely, M. R., S. C. Roberts, et al. (1991). "Immunogenicity in adult males of 
a Neisseria meningitidis group B vaccine composed of
polysaccharide complexed with outer membrane proteins." Vaccine 
9(1): 60-6.
Lindsay CA, B. P., Lawless S, Kitchen L, Zorka A, Garcia J et al (1998). 
"Pharmacokinetics and pharmacodynamics of milrinone lactate in 
pediatric patients with septic shock.
■" J Pediatr. 132: 329-34.
Lodha, R., S. Arun, et al. (2009). "Myocardial cell injury is common in 
children with septic shock." Acta Paediatr 98(3): 478-81.
Loke, K. E., P. I. McConnell, et al. (1999). "Endogenous endothelial nitric 
oxide synthase-derived nitric oxide is a physiological regulator of 
myocardial oxygen consumption." CircRes 84(7): 840-5.
Lominadze, D. and G. McHedlishvili (1999). "Red blood ceil behavior at low 
flow rate in microvessels." Microvasc Res 58(2): 187-9.
Lopez, A., J. A. Lorente, et al. (2004). "Multiple-center, randomized, 
placebo-controlled, double-blind study of the nitric oxide synthase 
inhibitor 546C88: effect on survival in patients with septic shock," 
Crit Care Med 32(11: 21-30.
Ma, K. K., T. Ogawa, et al. (2004). "Selective upregulation of cardiac brain 
natriuretic peptide at the transcriptional and translational levels by 
pro-inflammatory cytokines and by conditioned medium derived 
from mixed lymphocyte reactions via p38 MAP kinase." J Mol Cell 
Cardiol 36(4): 505-13.
Maat, M., C. M. Buysse, et al. (2007). "Improved survival of children with 
sepsis and purpura: effects of age, gender, and era." Crit Care 
11(5): R112.
Machado, M., L. M. Falcao, et al. (2004). "The clinical role of natriuretic 
peptides-importance of BNP and NT-proBNP. implications in heart 
failure and acute coronary syndrome." Rev Port Cardiol 23(7-8): 
1005-32.
Magga, J., M. Marttila, et al. (1994). "Brain natriuretic peptide in plasma, 
atria, and ventricles of vasopressin- and phenylephrine-infused 
conscious rats." Endocrinology 134(6): 2505-15.
Mair, G., S. Dunhill, et al. (2008). "Prognostic implications of a biphasic 
waveform for APT! analysis in a district general hospital." Int J Lab 
Hematoi 30(6): 467-72.
Maisei, A. S., P. Krishnaswamy, et al. (2002). "Rapid measurement of B- 
type natriuretic peptide in the emergency diagnosis of heart failure." 
N Engl J Med 347(31: 161-7.
Marechal, X., R. Favory, et al. (2008). "Endothelial glycocalyx damage 
during endotoxemia coincides with microcirculatory dysfunction and 
vascular oxidative stress." Shock 29(5): 572-6.
280
Marik, P. E. (2005). "Regional carbon dioxide monitoring to assess the 
adequacy of tissue perfusion." Curr Qpin Grit Care 11 (3): 245-51.
Marik, P. E. and A. Bankov (2003). "Sublingual capnometry versus 
traditional markers of tissue oxygenation in critically ill patients." Grit 
Care Med 31(3): 818-22.
Marik, P. E. and A. Lorenzana (1996). "Effect of tube feedings on the 
measurement of gastric intramucosal pH." Grit Care Med 24(9): 
1498-500.
Marra, M. N., C. G. Wilde, et al. (1992). "The role of 
bactericidal/permeability-increasing protein as a natural inhibitor of 
bacterial endotoxin." J.Immunol. 148(2): 532-537.
Martins, P, S., E. G. Kalfas, et al. (2003). "Upreguiation of reactive oxygen 
species generation and phagocytosis, and increased apoptosis in 
human neutrophils during severe sepsis and septic shock." Shock 
20(3): 208-212.
Marzouk, O., K. Bestwick, et al. (1993). "Variation in serum C-reactive 
protein across the clinical spectrum of meningococcal disease." 
Acta Paediatr. 82(9): 729-733.
Marzouk, O., A. P. Thomson, et al. (1991). "Features and outcome in 
meningococcal disease presenting with maculopapular rash." Arch 
Pis Child 66(4): 485-7.
Mathura, K. R., K. C. Vollebregt, et al. (2001). "Comparison of OPS imaging 
and conventional capillary microscopy to study the human
microcirculation." J AppI Phvsiol 91(1 V 74-8.
Mathura, K. R., K. C. Vollebregt, etal. (2001). "Comparison of OPS imaging 
and conventional capillary microscopy to study the human
microcirculation." J.Appl.Phvsiol 91(1): 74-78.
Matsumoto, T., H. Wada, et al. (2006). "Frequency of abnormal biphasic 
aPTT clot waveforms in patients with underlying disorders 
associated with disseminated intravascular coagulation." Clin AppI 
Thromb Hemost 12(2): 185-92.
McLaurin, M. D., F. S. Apple, et al. (1997). "Cardiac troponin I, cardiac
troponin T, and creatine kinase MB in dialysis patients without
ischemic heart disease: evidence of cardiac troponin T expression 
in skeletal muscle." Clin Chem 43(6 Pt 1): 976-82.
McMahon, T. (1973). "Size and shape in biology." Science 179(79): 1201-4.
Mehta, N. J., I. A. Khan, et al. (2004). "Cardiac troponin I predicts 
myocardial dysfunction and adverse outcome in septic shock." Int J 
Cardiol 95(11: 13-7.
Mercier, J. C., F. Beaufils, et al. (1988). "Hemodynamic patterns of
meningococcal shock in children." Crit Care Med 16(1): 27-33.
Mercier, J. C., F. Beaufils, et al. (1988). "Hemodynamic patterns of
meningococcal shock in children." Crit Care Med. 16(1): 27-33.
Merz, A. J., C. A. Enns, et al. (1999). "Type IV pill of pathogenic Neisseriae 
elicit cortical plaque formation in epithelial cells." Mol Microbiol 
32(6): 1316-32.
Merz, A. J. and M. So (1997). "Attachment of piliated, Opa- and Opc- 
gonococci and meningococci to epithelial cells elicits cortical actin 
rearrangements and clustering of tyrosine-phosphorylated proteins." 
Infect Immun 65(10): 4341-9.
Merz, A. J. and M. So (2000). "Interactions of pathogenic neisseriae with 
epithelial cell membranes." Annu Rev Cell Dev Biol 16: 423-57.
Mills, G. D., H. M. Lala, et al. (2006). "Elevated procalcitonin as a 
diagnostic marker in meningococcal disease." Eur J Clin Microbiol 
Infect Pis 25(81: 501-9.
281
Molesworth, A. M., M. C. Thomson, et al. (2002). "Where is the meningitis 
belt? Defining an area at risk of epidemic meningitis in Africa." 
Trans.R.Soc.Trop.Med.Hvg. 96(3): 242-249.
Monsalve, F., L. Rucabado, et al. (1984). "Myocardial depression in septic 
shock caused by meningococcal infection." Grit Care Med. 12(12): 
1021-1023.
Monsalve, F., L. Rucabado, et al. (1984). "Myocardial depression in septic 
shock caused by meningococcal infection." Grit Care Med 12(12): 
1021-3.
Morin, M. J., N. Unno, et al. (1998). "Differential expression of inducible 
nitric oxide synthase messenger RNA along the longitudinal and 
crypt-villus axes of the intestine in endotoxemic rats." Grit Care 
Med, 26(7): 1258-1264.
Mulier, K. E., D. E. Skarda, et al. (2008). "Near-infrared spectroscopy in 
patients with severe sepsis: correlation with invasive hemodynamic 
measurements." Sura Infect (Larchmtl 9(51: 515-9.
Muller, B., M. Schmidtke, et al. (1987). "Action of the stable prostacyclin 
analogue iloprost on microvascular tone and -permeability in the 
hamster cheek pouch." Prostaglandins Leukot Med 29(2-31): 187-98.
Munt, B., J. Jue, et al. (1998). "Diastolic filling in human severe sepsis: an 
echocardiographic study." Grit Care Med 26(11): 1829-33.
Murthy, V. V. and A. Karmen (1997). "Troponin-T as a serum marker for 
myocardial infarction." J Clin Lab Anal 11(31: 125-8.
Nadeau, R. G. and W. Groner (2001). "The role of a new noninvasive 
imaging technology in the diagnosis of anemia." J Nutr 131(5): 
1610S-4S.
Nadeau, R. G., W (2000). "Orthogonal polarization spectral imaging: State 
of the Art." Orthogonal polarization spectral imaging. Messmer K 
fedT Karoer. Basel
24: 9-20.
Nadel, S., B. Goldstein, et al. (2007). "Drotrecogin alfa (activated) in 
children with severe sepsis: a multicentre phase III randomised 
controlled trial." Lancet 369(9564): 836-43.
Nadel, S,, M. Levin, et al. (1995). Treatment of meningococcal disease in 
childhood. Meningococcal Disease. Chichester, John Wiley and 
Sons: 207-243.
Nagueh, S. F., K. J. Middleton, et al. (1997). "Doppler tissue imaging: a 
noninvasive technique for evaluation of left ventricular relaxation 
and estimation of filling pressures." J Am Coll Cardiol 30(6): 1527- 
33.
Nagueh, S. F., I. Mikati, et al. (1998). "Doppler estimation of left ventricular 
filling pressure in sinus tachycardia. A new application of tissue 
doppler imaging." Circulation 98(16): 1644-50.
Narula, J., B. A. Khaw, et al. (1993). "Brief report: recognition of acute 
myocarditis masquerading as acute myocardial infarction." N Enal J 
Med 328(2): 100-4.
Narula, J., J. F. Southern, et al. (1991). "Myocarditis simulating myocardial 
infarction." J Nuci Med 32(2): 312-8.
Nasser, N., Z. Perles, et al. (2006). "NT-proBNP as a marker for persistent 
cardiac disease in children with history of dilated cardiomyopathy 
and myocarditis." Pediatr Cardiol 27(1): 87-90.
Nikolaou, N. I., C. Goritsas, et al. (2007). "Brain natriuretic peptide 
increases in septic patients without severe sepsis or shock." Eur J 
Intern Med 18(7): 535-41.
282
Minis, N., C. Phillips, et al. (2005). "The role of healthcare delivery in the 
outcome of meningococcal disease in children: case-control study 
of fatal and non-fatal cases." Bm] 330(7506): 1475.
Mir, A. and N. Nasser (2005). "Clinical value of NT-ProBNP and BNP in 
pediatric cardiology." J Card Fail 11(5 Suppl): S76-80.
Nishida, J., R. S. McCuskey, et al. (1994). "Protective role of NO in hepatic 
microcirculatory dysfunction during endotoxemia." Am.J.Phvsiol 
267(6 Pt 1): G1135-G1141.
Oki, T., T. Tabata, et al. (1997). "Clinical application of pulsed Doppler 
tissue imaging for assessing abnormal left ventricular relaxation." 
Am J Cardiol 79(71: 921-8.
Ommen, S. R. (2001). "Echocardiographic assessment of diastolic 
function." Curr Ooin Cardiol 16(4): 240-5.
Ommen, S. R. and R. A. Nishimura (2003). "A clinical approach to the 
assessment of left ventricular diastolic function by Doppler 
echocardiography: update 2003." Heart 89 Supp! 3: iii18-23.
Osterud, B. and T. Flaegstad (1983). "Increased tissue thromboplastin 
activity in monocytes of patients with meningococcal infection: 
related to an unfavourable prognosis." Thromb.Haemost. 49(1): 5-7.
Osthaus, W. A., D. Boethig, et al. (2009). "First experiences with 
intraoperative Levosimendan in pediatric cardiac surgery." Eur J 
Pediatr 168(61: 735-40.
Otero, R. M., H. B. Nguyen, et al. (2006). "Early goal-directed therapy in 
severe sepsis and septic shock revisited: concepts, controversies, 
and contemporary findings." Chest 130(5): 1579-95.
Oyamada, J., M. Toyono, et al. (2008). "Noninvasive estimation of left 
ventricular end-diastolic pressure using tissue Doppler imaging 
combined with pulsed-wave Doppler echocardiography in patients 
with ventricular septal defects: a comparison with the plasma levels 
of the B-type natriuretic Peptide." Echocardiography 25(3): 270-7.
Pahernik, S., A. G. Harris, et al. (2002). "Orthogonal polarisation spectral 
imaging as a new tool for the assessment of antivascular tumour 
treatment in vivo: a validation study." Br J Cancer 86(10): 1622-7.
Parker, M. M.t J. H. Shelhamer, et al. (1987). "Serial cardiovascular 
variables in survivors and nonsurvivors of human septic shock: 
heart rate as an early predictor of prognosis." Crit Care Med 15(10): 
923-9.
Parthasarathi, K. and H. H. Lipowsky (1999). "Capillary recruitment in 
response to tissue hypoxia and its dependence on red blood cell 
deformabilitv." Am J Phvsiol 277(6 Pt2): H2145-57.
Pathan, N., C. A. Hemingway, et al. (2004). "Role of interleukin 6 in 
myocardial dysfunction of meningococcal septic shock." Lancet 
363(9404): 203-9.
Pathan, N., C. A. Hemingway, et al. (2004). "Role of interleukin 6 in 
myocardial dysfunction of meningococcal septic shock," Lancet 
363(9404): 203-209.
Pathan, N., C. Sandiford, et al. (2002). "Characterization of a myocardial 
depressant factor in meningococcal septicemia." Crit Care Med 
30(10): 2191-8.
Pathan, N., C. Sandiford, et al. (2002). "Characterization of a myocardial 
depressant factor in meningococcal septicemia." Crit Care Med. 
30(10): 2191-2198.
Pathan, N., E. J. Williams, et al. (2005). "Changes in the interleukin- 
6/soluble interleukin-6 receptor axis in meningococcal septic shock." 
Crit Care Med 33(8): 1839-44.
283
Pearson, J. D. (2000). "Normai endothelial cell function." Lupus 9(3): 183-8.
Pellett, A. A., W. G. Tolar, et al. (2004). "The Tei index: methodology and 
disease state values." Echocardiography 21 (7T 669-72.
Pennings, F. A., G. J. Bouma, et al. (2004). "Direct observation of the 
human cerebral microcirculation during aneurysm surgery reveals 
increased arteriolar contractility." Stroke 35(6): 1284-1288.
Peters, M., A. Petros, et al. (2002). "Genuine reduction in meningococcal 
deaths results from teamwork." Arch Pis Child 87(6): 560-1; author 
reply 361.
Pinto, B. B., S. Rehberg, et al. (2008). "Role of levosimendan in sepsis and 
septic shock." Curr Qpin Anaesthesiol 21 (2): 168-77.
Pittet, J. F., J. S. Lacroix, et al. (1992). "Different effects of prostacyciin and 
phentolamine on delivery-dependent 02 consumption and skin 
microcirculation after cardiac surgery." Can.J.Anaesth. 39(10): 
1023-1029.
Pittet, J. F., J. S. Lacroix, et al. (1990). "Prostacyclin but not phentolamine 
increases oxygen consumption and skin microvascular blood flow in 
patients with sepsis and respiratory failure." Chest 98(6): 1467- 
1472.
Poderoso, J. J., M. C. Carreras, et al. (1996). "Nitric oxide inhibits electron 
transfer and increases superoxide radical production in rat heart 
mitochondria and submitochondrial particles." Arch Biochem 
Biophvs 328(11: 85-92.
Poelaert, J., C. Declerck, et al. (1997). "Left ventricular systolic and 
diastolic function in septic shock." Intensive Care Med 23(5): 553- 
60.
Poeze, M. (2006). "Tissue-oxygenation assessment using near-infrared 
spectroscopy during severe sepsis: confounding effects of tissue 
edema on St02 values." Intensive Care Med 32(5): 788-9.
Pollack, M. M,, U. E. Ruttimann, et al. (1988). "Pediatric risk of mortality 
(PRISM) score." Crit Care Med 16(11): 1110-6.
Pollard, A. J. and M. C. Maiden (2003). "Epidemic meningococcal disease 
in sub-Saharan Africa-towards a sustainable solution?" Lancet 
Infect.Pis. 3(21: 68-70.
Povoas, H. P., M. H. Weil, et al. (2001). "Decreases in mesenteric blood 
flow associated with increases in sublingual PC02 during 
hemorrhagic shock." Shock 15(5): 398-402.
Powars, D. R,, Z. R. Rogers, et ai. (1987). "Purpura fulminans in 
meningococcemia: association with acquired deficiencies of 
proteins C and S." N.Enol.J.Med. 317(9): 571-572.
Pradier, O., C. Gerard, et al. (1993). "Interleukin-10 inhibits the induction of 
monocyte procoagulant activity by bacterial lipopoiysaccharide." 
Eur.J.lmmunol. 23(10): 2700-2703.
Pries, A. R. and W. M. Kuebler (2006). "Normal endothelium." Handb Exp 
Pharmacol(176 Pt 1): 1-40.
Protti, A. and M. Singer (2006). "Bench-to-bedside review: potential 
strategies to protect or reverse mitochondrial dysfunction in sepsis- 
induced organ failure." Crit Care 10(5): 228.
Rees, D. D., J. E. Monkhouse, et ai. (1998). "Nitric oxide and the 
haemodynamic profile of endotoxin shock in the conscious mouse." 
Br J Pharmacol 124(3): 540-6.
Remedi, M. S., C. G. Nichols, et a!. (2006). "The mitochondria and insulin 
release: Nnt just a passing relationship." Cell Metab 3(1): 5-7.
284
Revelly, J, P., T. Ayuse, et al. (1996). "Endotoxic shock alters distribution of 
blood flow within the intestinal wall." Grit Care Med. 24(8): 1345- 
1351.
Rey, C., A. M. Los, et al. (2007). "Procalcitonin and C-reactive protein as 
markers of systemic inflammatory response syndrome severity in 
critically ill children." intensive Care Med. 33(3): 477-484.
Rich, N., N. West, et al. (2003). "Milrinone in meningococcal sepsis." 
Pediatr Crit Care Med 4(3): 394-5.
Riordan, A., A. Thomson, et al. (1995). "Hearing assessment after 
meningitis and meningococcal disease." Arch Pis Child 72(5): 441- 
2.
Riordan, F. A., O. Marzouk, et al. (1995). "The changing presentations of 
meningococcal disease." Eur J Pediatr 154(6): 472-4.
Riordan, F. A., O. Marzouk, et al. (1996). "Proinflammatory and anti­
inflammatory cytokines in meningococcal disease." Arch.Dis.Child 
75(5): 453-454.
Riordan, F. A., A. P. Thomson, et al. (1999). "Admission cortisol and 
adrenocorticotrophic hormone levels in children with meningococcal 
disease: evidence of adrenal insufficiency?" Crit Care Med. 27(10): 
2257-2261.
Rivers, E., B. Nguyen, et al. (2001). "Early goal-directed therapy in the 
treatment of severe sepsis and septic shock." N Engl J Med 
345(19): 1368-77.
Rivers, E. P. (2006). "Early goal-directed therapy in severe sepsis and 
septic shock: converting science to reality." Chest 129(2): 217-8.
Rivers, E. P., H. B. Nguyen, et al. (2004). "Early goal-directed therapy." Crit 
Care Med 32(1): 314-5; author reply 315.
Roberson, D. A., W. Cui, et al. (2007). "Annular and septal Doppler tissue 
imaging in children: normal z-score tables and effects of age, heart 
rate, and body surface area." J Am Soc Echocardiogr 20(11): 1276- 
84.
Roch, A., J. Allardet-Servent, et al. (2005). "NH2 terminal pro-brain 
natriuretic peptide plasma level as an early marker of prognosis and 
cardiac dysfunction in septic shock patients." Crit Care Med 33(5): 
1001-7.
Rosenstein, N. E., B. A. Perkins, et al. (2001). "Meningococcal disease." 
N.Enql.J.Med. 344(181: 1378-1388.
Rudiger, A., S. Gasser, et al. (2006). "Comparable increase of B-type 
natriuretic peptide and amino-terminal pro-B-type natriuretic peptide 
levels in patients with severe sepsis, septic shock, and acute heart 
failure." Crit Care Med 34(8): 2140-4.
Sakr, Y., M. J. Dubois, et al. (2004). "Persistent microcirculatory alterations 
are associated with organ failure and death in patients with septic 
shock." Crit Care Med 32(91: 1825-31.
Sakr, Y., M. J. Dubois, et al. (2004). "Persistent microcirculatory alterations 
are associated with organ failure and death in patients with septic 
shock." Crit Care Med. 32(9): 1825-1831.
Sanders, S., A. Barnett, et al. (2008). "Systematic review of the diagnostic 
accuracy of C-reactive protein to detect bacterial infection in 
nonhospitalized infants and children with fever." J Pediatr 153(4): 
570-4.
Schmidt-Nielsen, K. and P. Pennycuik (1961). "Capillary density in 
mammals in relation to body size and oxygen consumption." Am J 
Phvsiol 200: 746-50.
285
Sharkey, I., A. V. Boddy, et al. (2001). "Body surface area estimation in 
children using weight alone: application in paediatric oncology." Br J 
Cancer 85(1): 23“8.
Shipley, J. B., D. Tolman, et al. (1996). "Milrinone: basic and clinical 
pharmacology and acute and chronic management." Am J Med Sci 
311(6): 286-91.
Simon, L, F. Gauvin, et al. (2004). "Serum procatcitonin and C-reactive 
protein levels as markers of bacterial infection: a systematic review 
and meta-analysis." Clin.Infect.Dis. 39(2): 206-217.
Sinaasappel, M., I. M. van, et al. (1999). "Microvascular oxygen pressure in 
the pig intestine during haemorrhagic shock and resuscitation." 
J.Phvsiol 514 ( Pt 1): 245-253.
Sinclair, J. F., C. H. Skeoch, et al. (1987). "Prognosis of meningococcal 
septicaemia." Lancet 2(8549): 38.
Sirithunyanont, C., W. Leowattana, et al. (2003). "Role of the plasma brain 
natriuretic peptide in differentiating patients with congestive heart 
failure from other diseases." J Med Assoc Thai 86 Suppl 1: S87-95.
Skarda, D. E., K. E. Mulier, et al. (2007). "Dynamic near-infrared 
spectroscopy measurements in patients with severe sepsis." Shock 
27(4): 348-53.
Skippen, P. W. and G. E. Krahn (2005). "Acute renal failure in children 
undergoing cardiopulmonary bypass." Grit Care Resusc 7(4): 286- 
91.
Slack, R., K. C. Hawkins, et al. (2005). "Long-term outcome of 
meningococcal sepsis-associated acute renal failure." Pediatr Grit 
Care Med 6(4): 477-9.
Smedegard, G., J. Bjork, et al. (1985). "An intravital microscopy model for 
studies of immune complex induced inflammation at the 
microvascular level." Int J Tissue React 7(1): 55-60.
Smith, E. Y., L. A. Charles, et al. (2004). "Biphasic activated partial 
thromboplastin time waveform and adverse events in non-intensive 
care unit patients." Am J Clin Pathol 121 (1): 138-41.
Snell, R. S. (2003). "Clinical Anatomy (Snell Clinical Anatomy)".
Snider AR, S. G. (1990). "Echocardiography in Pediatric Heart Disease." 
Year Book Medical Publishers.
Sohn, D. W., I. H. Chai, et al. (1997). "Assessment of mitral annulus 
velocity by Doppler tissue imaging in the evaluation of left 
ventricular diastolic function." J Am Coll Cardiol 30(2): 474-80.
Spies, C., V. Haude, et al. (1998). "Serum cardiac troponin T as a 
prognostic marker in early sepsis." Chest 113(4): 1055-63.
Springer, T. A. (1994). "Traffic signals for lymphocyte recirculation and 
leukocyte emigration: the multistep paradigm." Cell 76(2): 301-14.
Spronk, P. E., C. Ince, et al. (2002). "Nitroglycerin in septic shock after 
intravascular volume resuscitation." Lancet 360(9343): 1395-6.
Spronk, P. E., C. Ince, et al. (2002). "Nitroglycerin in septic shock after 
intravascular volume resuscitation." Lancet 360(9343): 1395-1396.
Spronk, P. E., D. F. Zandstra, et al. (2004). "Bench-to-bedside review: 
sepsis is a disease of the microcirculation." Crit Care 8(6): 462-468.
Spronk, P. E., D. F. Zandstra, et al. (2004). "Bench-to-bedside review: 
sepsis is a disease of the microcirculation." Crit Care 8(6): 462-8.
Sprung, C. L., D. Annane, et al. (2008). "Hydrocortisone therapy for 
patients with septic shock." N Engl J Med 358(2): 111-24.
Stephens, D. S. (1999). "Uncloaking the meningococcus: dynamics of 
carriage and disease." Lancet 353(9157): 941-942.
286
Stephens, D. S., L. H. Hoffman, et al. (1983). "Interaction of Neisseria 
meningitidis with human nasopharyngeal mucosa: attachment and 
entry into columnar epithelial cells." J.Infect.Pis. 148(3): 369-376.
Stuart, J. M., P. N. Monk, et al. (1997). "Management of clusters of 
meningococcal disease. PHIS Meningococcus Working Group and 
Public Health Medicine Environmental Group." 
Commun.Dis.Rep.CDR Rev. 7f1V R3-R5,
Subbaswamy, A., A. A. Hsu, et al. (2008). "Correlation of Cerebral Near- 
Infrared Spectroscopy (cNIRS) and Neurological Markers in 
Critically III Children." Neurocrit Care.
Sudoh, T., K. Kangawa, et al. (1988). "A new natriuretic peptide in porcine 
brain." Nature 332(6159): 78-81.
Suffredini, A. F., R. E. Fromm, et al. (1989). "The cardiovascular response 
of normal humans to the administration of endotoxin." N Engl J Med 
321(5): 280-7.
Suga, S., K. Nakao, et al. (1992). "Receptor selectivity of natriuretic peptide 
family, atrial natriuretic peptide, brain natriuretic peptide, and C-type 
natriuretic peptide." Endocrinology 130(1): 229-39.
Tang, B. M., S. J. Huang, et al. (2007). "Predictive value of N-terminal pro­
brain natriuretic peptide in sepsis." Crit Care Med 35(10): 2464.
Tavernier, B., J. M. Li, et al. (2001). "Cardiac contractile impairment 
associated with increased phosphorylation of troponin l in 
endotoxemic rats." Faseb J 15(2): 294-6.
Taylor, K. R. and R. L. Gallo (2006). "Glycosaminoglycans and their 
proteoglycans: host-associated molecular patterns for initiation and 
modulation of inflammation." Faseb J 20(1 V 9-22.
Tedder, T. F., D. A. Steeber, et al. (1995). "The selectins: vascular 
adhesion molecules." Faseb J 9(10): 866-73.
Tei, C. (1995). "New non-invasive index for combined systolic and diastolic 
ventricular function." J Cardiol 26(2): 135-6.
Tei, C., L. H. Ling, et al. (1995). "New index of combined systolic and 
diastolic myocardial performance: a simple and reproducible 
measure of cardiac function--a study in normals and dilated 
cardiomyopathy." J Cardiol 26(6): 357-66.
Theilen, U., L. Wilson, et al. (2008). "Management of invasive 
meningococcal disease in children and young people: summary of 
SIGN guidelines." Bmi 336(7657): 1367-70.
Thiru, Y., N. Pathan, et al. (2000). "A myocardial cytotoxic process is 
involved in the cardiac dysfunction of meningococcal septic shock." 
Crit Care Med 28(8): 2979-83.
Thiru, Y., N. Pathan, et al. (2000). "A myocardial cytotoxic process is 
involved in the cardiac dysfunction of meningococcal septic shock." 
Crit Care Med. 28(8): 2979-2983.
Thomale, U. W., K. D. Schaser, et al. (2001). "Visualization of rat pial 
microcirculation using the novel orthogonal polarized spectral (OPS) 
imaging after brain injury." J Neurosci Methods 108(11: 85-90.
Thomson, A. P., J. A. Sills, et al. (1991). "Validation of the Glasgow 
Meningococcal Septicemia Prognostic Score: a 10-year 
retrospective survey." Crit Care Med 19(1); 26-30.
Thomson APJ, R. F. (2000). "The management of meningococcal disease." 
Current Paediatrics 10: 104-9.
Thorburn, K. and P. Baines (2002). "Predicting mortality or recognizing 
death in meningococcal disease? Pediatric Risk of Mortality 
(PRISM) and Pediatric Index of Mortality (PIM)." Crit Care Med 
30(7): 1675-6.
287
Thorburn, K., P. Baines, et a). (2001). "Mortality in severe meningococcal 
disease." Arch Pis Child 85(5): 382-5.
Tikhomirov, E., M. Santamaria, et al. (1997). "Meningococcal disease: 
public health burden and control." World Health Stat.Q. 50(3-4): 
170-177.
Toet, M. C., A. Flinterman, et al. (2005). "Cerebral oxygen saturation and 
electrical brain activity before, during, and up to 36 hours after 
arterial switch procedure in neonates without pre-existing brain 
damage: its relationship to neurodevelopmental outcome." Exp 
Brain Res 165(3): 343-50.
Toh, C. H., J. Samis, et al. (2002). "Biphasic transmittance waveform in the 
APTT coagulation assay is due to the formation of a Ca(++)- 
dependent complex of C-reactive protein with very-low-density 
lipoprotein and is a novel marker of impending disseminated 
intravascular coagulation." Blood 100(7): 2522-9.
Toh, C. H., L. O. Ticknor, et al. (2003). "Early identification of sepsis and 
mortality risks through simple, rapid clot-waveform analysis. 
Implications of lipoprotein-complexed C reactive protein formation." 
Intensive Care Med 29(1): 55-61.
Toller, W. G. and C. Stranz (2006). "Levosimendan, a new inotropic and 
vasodilator agent." Anesthesiology 104(3): 556-69.
Tomaru Ki, K., M. Aral, et al. (2002). "Transcriptional activation of the BNP 
gene by lipopolysaccharide is mediated through GATA elements in 
neonatal rat cardiac myocytes." J Mol Cell Cardiol 34(6): 649-59.
Top, A., C. Ince, et al. (2011). "Persistent low microcirculatory vessel 
density in nonsurvivors of sepsis in pediatric intensive care." Crit 
Care Med 39(11: 8-13.
Top, A. P,, C. Ince, et al. "Persistent low microcirculatory vessel density in 
nonsurvivors of sepsis in pediatric intensive care." Crit Care Med 
39(1): 8-13.
Toth, M., K. H. Vuorinen, et al. (1994). "Hypoxia stimulates release of ANP 
and BNP from perfused rat ventricular myocardium." Am J Physiol 
266(4 Pt 2): H1572-80.
Treacher, D. L, RM (1998). "ABC of oxygen. Oxygen transport—1. Basic 
principles." BMJ 317: 1302-6.
Trzeciak, S., I. Cinel, et al. (2008). "Resuscitating the microcirculation in 
sepsis: the central role of nitric oxide, emerging concepts for novel 
therapies, and challenges for clinical trials." Acad Emera Med 15(5): 
399-413.
Trzeciak, S., R. P. Dellinger, et al. (2006). "Translating research to clinical 
practice: a 1-year experience with implementing early goal-directed 
therapy for septic shock in the emergency department." Chest 
129(2): 225-32.
Trzeciak, $., R. P. Dellinger, et al. (2007). "Early microcirculatory perfusion 
derangements in patients with severe sepsis and septic shock: 
relationship to hemodynamics, oxygen transport, and survival." Ann 
Emera Med 49(11: 88-98, 98 e1-2.
Turhan, H., A. R. Erbay, et al. (2005). "Plasma soluble adhesion molecules; 
intercellular adhesion molecule-1, vascular cell adhesion molecule-1 
and E-selectin levels in patients with isolated coronary artery 
ectasia." Coron Artery Pis 16(1): 45-50.
Turner, A., M. Tsamitros, et al. (1999). "Myocardial cell injury in septic 
shock." Crit Care Med 27(91: 1775-80.
288
Uji, Y., H. Sugiuchi, et al. (1992). "[Evaluation of serum troponin T 
measurement in acute myocardial infarction]." Rinsho Byori 40(7): 
775-82.
Umans, J. G., M. E. Wylam, et al. (1993). "Effects of endotoxin in vivo on 
endothelial and smooth-muscle function in rabbit and rat aorta." Am 
Rev Respir Pis 148(6 Ft 1): 1638-45.
Uzzan, B., R. Cohen, et al. (2006). "Procalcitonin as a diagnostic test for 
sepsis in critically ill adults and after surgery or trauma: a systematic 
review and meta-analysis." Crit Care Med 34(7): 1996-2003.
Vallet, B. (2002). "Endothelial cell dysfunction and abnormal tissue 
perfusion." Crit Care Med. 30(5 Suppl): S229-S234.
Van Amersfoort, E. S., T. J. Van Berkel, et al. (2003). "Receptors, 
mediators, and mechanisms involved in bacterial sepsis and septic 
shock." Clin Microbiol Rev 16(3): 379-414.
van den, B. G., P. Wouters, et al. (2001). "Intensive insulin therapy in the 
critically ill patients." N.Enal.J.Med. 345(19): 1359-1367.
Van der Kaay, D. C., E. D. De Kleijn, et al. (2002). "Procalcitonin as a 
prognostic marker in meningococcal disease." Intensive Care Med 
28(11): 1606-12.
Van der Poll, T., J. A. Romijn, et al. (1991). "Tumor necrosis factor mimics 
the metabolic response to acute infection in healthy humans." Am J 
Phvsiol 261(4 Pt 1): E457-65.
van der Poll, T., S. J. van Deventer, et al. (1992). "Effects on leukocytes 
after injection of tumor necrosis factor into healthy humans." Blood 
79(3): 693-8.
van Deuren, M., J. van der Ven-Jongekrijg, et al. (1995). "Correlation 
between proinflammatory cytokines and antiinflammatory mediators 
and the severity of disease in meningococcal infections." J Infect 
D]s 172(2): 433-9.
Van Zee, K. J., T. Kohno, et al. (1992). "Tumor necrosis factor soluble 
receptors circulate during experimental and clinical inflammation 
and can protect against excessive tumor necrosis factor alpha in 
vitro and in vivo." Proc.Natl.Acad.Sci.U.S.A 89(11): 4845-4849.
Varani, J. and P. A. Ward (1994). "Mechanisms of neutrophil-dependent 
and neutrophil-independent endothelial cell injury." Biol.Sianals 3(1): 
1-14.
Varpula, M., K. Pulkki, et al. (2007). "Predictive value of N-terminal pro­
brain natriuretic peptide in severe sepsis and septic shock." Cnt 
Care Med 35(5): 1277-83.
Victor, V. M., M. Rocha, et al. (2004). "Immune cells: free radicals and 
antioxidants in sepsis." Int Immunopharmacol. 4(3): 327-347.
Vila, G., M. Resl, et al. (2008). "Plasma NT-proBNP increases in response 
to IPS administration in healthy men." J AppI Phvsiol 105(6): 1741- 
5.
Vincent, J. L, D. C. Angus, et al. (2003). "Effects of drotrecogin alfa 
(activated) on organ dysfunction in the PROWESS trial." Crit Care 
MM 31 (3): 834-40.
Vink, H. and B. R. Duling (1996). "Identification of distinct luminal domains 
for macromolecules, erythrocytes, and leukocytes within 
mammalian capillaries." Circ Res 79(3): 581-9.
von Dobschuetz, E., P. Biberthaler, et al. (2003). "Noninvasive in vivo 
assessment of the pancreatic microcirculation: orthogonal 
polarization spectral imaging." Pancreas 26(2): 139-43.
289
Voss, R., F. R. Matthias, et al. (1990). "Activation and inhibition of
fibrinolysis in septic patients in an internal intensive care unit." 
Br.J.Haematol. 75(1): 99-105.
Waage, A., P. Brandtzaeg, et al. (1989). "The complex pattern of cytokines 
in serum from patients with meningococcal septic shock.
Association between interleukin 6, interleukin 1, and fatal outcome." 
J.Exp.Med. 169(1): 333-338.
Waage, A., A. Halstensen, et ai. (1987). "Association between tumour 
necrosis factor in serum and fatal outcome in patients with
meningococcal disease." Lancet 1(8529): 355-7.
Waage, A., A. Halstensen, et al. (1987). "Association between tumour 
necrosis factor in serum and fatal outcome in patients with
meningococcal disease." Lancet 1(8529): 355-357.
Waage, A., A. Halstensen, et al. (1989). "Local production of tumor 
necrosis factor alpha, interleukin 1, and interleukin 6 in 
meningococcal meningitis. Relation to the inflammatory response." 
J.Exp.Med. 170(6): 1859-1867.
Walley, K. R. (1996). "Heterogeneity of oxygen delivery impairs oxygen 
extraction by peripheral tissues: theory." J AppI Physiol 81(2): 885- 
94.
Wang, P., Z. F. Ba, et al. (1995). "Endothelium-dependent relaxation is 
depressed at the macro- and microcirculatory levels during sepsis." 
Am J Phvsiol 269(5 Pt 2): R988-94.
Wang, T. J., M. G. Larson, et al. (2004). "Plasma natriuretic peptide levels 
and the risk of cardiovascular events and death." N Engl J Med 
350(7): 655-63.
Watson, R. S., J. A. Carcillo, et al. (2003). "The epidemiology of severe 
sepsis in children in the United States." Am J Respir Grit Care Med 
167(5): 695-701.
Weibel, E. R. and H. Hoppeler (2005). "Exercise-induced maximal 
metabolic rate scales with muscle aerobic capacity." J Exp Biol 
208(Pt 9): 1635-44.
Weil, M. H., Y. Nakagawa, et al. (1999). "Sublingual capnometry: a new 
noninvasive measurement for diagnosis and quantitation of severity 
of circulatory shock.11 Grit Care Med 27(7): 1225-9.
Weisel, R. D., L. Vito, et al. (1977). "Myocardial depression during sepsis." 
Am JSurg 133(4): 512-21.
Weisinger, J. R. and E. Beliorin-Font (1998). "Magnesium and 
phosphorus." Lancet 352(9125): 391-396.
Weiss, J., P. Elsbach, et al. (1978). "Purification and characterization of a 
potent bactericidal and membrane active protein from the granules 
of human polymorphonuclear leukocytes." J.Biol.Chem. 253(8): 
2664-2672.
Wells, L. C., J. C. Smith, et al. (2001). "The child with a non-blanching rash: 
how likely is meningococcal disease?" Arch Pis Child 85(3): 218-22.
West, G. B., J. H. Brown, et al. (1999). "The fourth dimension of life: fractal 
geometry and allometric scaling of organisms." Science 284(5420): 
1677-9.
Westendorp, R. G., J. A. Langermans, et al. (1995). "Release of tumor 
necrosis factor: an innate host characteristic that may contribute to 
the outcome of meningococcal disease." J.Infect.Dis. 171(4): 1057- 
1060.
Whalen, M. J., L. A. Doughty, et al. (2000). "intercellular adhesion 
molecule-1 and vascular cell adhesion molecule-1 are increased in
290
the plasma of children with sepsis-induced multiple organ failure." 
Crit Care Med 28(7): 2600-7.
Witthaut, R., C. Busch, et al. (2003). "Plasma atrial natriuretic peptide and 
brain natriuretic peptide are increased in septic shock: impact of 
interleukin-6 and sepsis-associated left ventricular dysfunction." 
Intensive Care Med 29(10): 1696-702.
Wong, H. R., J. A. Carcillo, et al. (1996). "Nitric oxide production in critically 
ill patients." Arch Pis Child 74(6): 482-9.
Wood, M. J. and M. H. Picard (2004). "Utility of echocardiography in the 
evaluation of individuals with cardiomyopathy." Heart 90(6): 707-12.
Wright, S. P., R. N. Doughty, et al. (2003). "Plasma amino-terminal pro­
brain natriuretic peptide and accuracy of heart-failure diagnosis in 
primary care: a randomized, controlled trial." J Am Coll Cardiol 
42(10): 1793-800.
Wu, A. H., Y. J. Feng, et al. (1998). "Characterization of cardiac troponin 
subunit release into serum after acute myocardial infarction and 
comparison of assays for troponin T and I. American Association for 
Clinical Chemistry Subcommittee on cTnl Standardization." Clin 
Chem 44(6 Pt 1): 1198-208.
Xu, H., J. A. Gonzalo, et al. (1994). "Leukocytosis and resistance to septic 
shock in intercellular adhesion molecule 1-deficient mice." J Exp 
Med 180(1): 95-109.
Yamamoto, K„ M. M. Redfield, et al. (1996). "Analysis of left ventricular 
diastolic function." Heart 75(6 Suppl 2): 27-35.
Yvonne-Tee, G. B., A. H. Rasool, et al. (2005). "Reproducibility of different 
laser Doppler fluximetry parameters of postocclusive reactive 
hyperemia in human forearm skin." J Pharmacol Toxicol Methods 
52(2): 286-92.
Zakariah, A. N., S. M. Cozzi, et al. (2008). "Combination of biphasic 
transmittance waveform with blood procalcitonin levels for diagnosis 
of sepsis in acutely ill patients." Crit Care Med 36(5): 1507-12.
Zenz, W., B. Zoehrer, et al. (2004). "Use of recombinant tissue 
plasminogen activator in children with meningococcal purpura 
fulminans: a retrospective study." Crit Care Med. 32(8): 1777-1780.
Zhou, M., A. J. Arthur, et al. (2001). "The small intestine plays an important 
role in upregulating CGRP during sepsis." Am.J.Phvsiol 
Reaul.Intear.Comp Physiol 280(2): R382-R388.
